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ABSTRACT 
Background: The majority of self-poisonings treated at emergency departments are the result 
of suicidal behaviour (suicide attempts or acts of appeal) and substance use. Both of these 
groups exhibit aspects of self-destructive behaviour. However, most studies focus on 
subgroups such as suicide attempters, non-fatal drug overdoses, etc. Knowledge of this patient 
group is therefore fragmented with respect to toxic agents, extent, common features and 
prognosis. Despite this, there are well-known interactions because substance use is known to 
be a risk factor for suicidal behaviour, and affective and personality disorders are commonly 
seen among substance users. The evaluation of intention can be difficult in an acute setting 
because of reduced consciousness, unwillingness to report the use of illicit drugs and even 
instability in the wish to die. The overlap between patient groups may therefore be 
considerable. The long-term prognosis for different subgroups has been documented in terms 
of increased mortality and a high number of suicides. More information about socio-
demographic, psychiatric and toxicological factors is needed for this patient group, as well as 
risk factors for death and suicide. Furthermore, treatment options need to be documented, 
both in the acute setting and in referral to follow-up services. 
 
Research questions: The aim of this thesis is to study patients with self-poisonings who have 
been treated at the Emergency Department as a single risk group. The pattern of toxic agents, 
the extent of substance use and the psychosocial risk factors among these patients need to be 
investigated. The long-term prognosis, as well as the treatment offered, will be studied. The 
thesis attempts to answer six main research questions. 
1. What are the patterns of toxic agent usage, especially for drugs of abuse, according to 
age, gender and suicidal intention for all patients admitted to medical departments in 
Oslo for acute poisoning over a one-year period? (Papers I and II) 
2. What is the concordance between the clinical assessments by the physicians on duty and 
drug analyses in patients treated for acute poisonings? (Paper II) 
3. What kind of treatment are patients offered in the acute setting, and to what extent are 
the patients referred to follow-up services at discharge? (Papers III and VI) 
4. Are there differences in psychosocial factors, substance use and referral to follow-up 
services at discharge according to the intention of the self-poisoning? (Paper VI) 
5. Compared with the general population, what are the 20-year overall and cause-specific 
mortality rates for all patients admitted to medical departments for self-poisoning in Oslo 
in 1980, in particular for hospital-treated opioid addicts? (Papers IV and V) 
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6. What factors might differentiate those who died in the follow-up period from those who 
survived, and what factors might predict suicide or other causes of death? (Paper IV) 
 
Material and methods: This thesis, which consists of six papers, includes five different 
samples of acute poisonings and self-poisonings. Acute poisonings are mainly self-
poisonings. In the following, the term self-poisoning will be used. 
The inclusion criteria required a primary diagnosis of self-poisoning, irrespective of 
intention. Patients with an additional diagnosis of self-poisoning, but with other major 
diagnoses, were excluded. The pattern of toxic agents, as well as clinical course and outcome, 
were studied in a cross-sectional multicentre study conducted in Oslo in 2003/2004 (n=947). 
Accidental non-self-poisonings were excluded from this sample when studying psychosocial 
factors and referral to follow-up services (n=908). The extent of drug abuse among this 
patient group was studied in a cross-sectional single-centre study from 2001 (n=405). Two 
papers followed a cohort of hospitalized self-poisonings, first admitted in Oslo in 1980, for 20 
years. One paper includes all self-poisonings in all medical departments (n=946). The other 
follows a subgroup of opioid addicts treated for self-poisoning and/or voluntary detoxification 
during 1980/81 (n=185). Standardized mortality ratios (SMRs) were used to compare 
mortality in the cohort to that of the general population. Cox regression analyses were used to 
find predictors for death and suicide. Multinomial regression analyses were used to study 
differences in psychosocial factors and intended referral to further treatment. 
 
Results: The incidence of acute poisonings in Oslo in 2003/04 was 2.0 per 100 000, of which 
95.9% were self-poisonings. Benzodiazepines (18%), ethanol (17%), paracetamol (12%), 
opioids (7%), and gamma hydroxybutyric acid (GHB) (7%) were most frequently taken as the 
main toxic agent. Males drank ethanol more often and used more illicit drugs, while females 
tended to use more prescription drugs (benzodiazepines, paracetamol, neuroleptics, zopiclone 
and anti-epileptics). Females were more often evaluated as having taken the drugs in a 
suicidal attempt or as an act of appeal. 
In analyses of urine or blood samples, drugs of abuse were found in 92% of all self-
poisonings irrespective of intention. Benzodiazepines (50%) ethanol (40%), opiates (35%), 
cannabis (24%) and amphetamine (21%) were the most common, including both main and 
additional agents. The only gender difference was that cannabis was found more often among 
males. The agreement between clinical diagnosis and drug analysis for GHB and ethanol was 
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moderately good. Because kappa was lower than 0.20 for benzodiazepines and cannabis, the 
agreement was considered to be poor. 
Of all admissions in 2003/04, 75% received treatment as well as observation, and 39% 
received antidotes, an increase from 21% in 1980. Complications were observed in 18% of 
cases, a slight reduction since 1980 (22%). Ten (1.1%) died and six (0.6%) developed 
permanent sequelae, of which seven and five were drug- or alcohol-related, respectively. 
Although in-hospital mortality was low, 40% of the patients were treated in the ICU. 
According to the physicians, 37% of all self-poisonings in 2003/2004 were suicide 
attempts, 26% were appeals and 38% were drug-related poisonings. Overall, patients treated 
for self-poisonings showed a lack of social integration. Only a third of them were employed, a 
third were married and half were living alone. Suicide attempters and appealers had more 
previous suicide attempts and reported more psychiatric treatment than did those with drug-
related poisoning. However, there was considerable overlap between patient groups. A third 
of all drug-related poisonings reported previous suicide attempts, and a third of suicide 
attempters reported daily substance use. Gender distribution was the only statistically 
significant difference between appealers and suicide attempters. 
In a 20-year follow-up of self-poisonings from 1980, it was found that 37.5% of the 
patients had died, the SMR being 4.6 (95% C.I., 4.2–5.1). Among males, 45.3% died and 
30.2% of all females died. The SMRs were 5.0 (95% C.I., 4.3–5.7) for males, and 4.2 (95% C.I., 
3.6–4.9) for females. After 20 years, 7.4% of all patients had died from cardiovascular diseases, 
7.1% from suicide, 4.3% from accidents, 3.3% from cancer, 1.1% had suffered another type of 
violent death and 14.4% had died from other diseases. Lower social group, drug abuse and a 
lower level of consciousness were all independent predictors of death. A suicidal motive upon 
admission was the only risk factor for suicide. In the cohort of opioid addicts, 70 opiate 
addicts died during follow-up (37.8%), with an SMR of 23.6 (95% C.I., 18.7–29.9). The risk 
remained high for the entire follow-up period, and the risk of death was significantly higher 
for all causes of death compared with the general population. There were no significant 
differences in SMR between self-poisonings and those admitted for voluntarily detoxification. 
One out of every five patients treated for self-poisoning was discharged without any 
plans for follow-up. Among drug-related poisonings, 36% left hospital without plans for 
further treatment. Among those who were suicidal, 5% were not referred to further treatment, 
as also were 10% of the appealing patients. Thirty-eight percent of all suicide attempters were 
admitted to a psychiatric ward. Only 10% of drug-related poisonings were referred to 
substance abuse treatment. 
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Conclusions: Benzodiazepines and ethanol, which remained the most common toxic agents 
in self-poisonings, were found more often than suspected. Drugs of abuse were found in 9 out 
of 10 self-poisonings irrespective of intention. Although in-hospital mortality was low, the 
long-term prognosis for self-poisonings was rather poor. Although the risk of death increased 
for all causes, the suicide risk needs to be emphasized. A suicidal motive was an important 
predictor for later suicide. The risk was increased even when patients were considered to be 
neither suicidal nor substance abusers, indicating that focusing on intention alone did not 
capture all patients at increased risk. The lack of social integration, the high number of 
previous suicide attempts and extensive substance use may contribute to the risk of death in 
general and of suicide in particular. The evaluation of intention had a major impact on referral 
to further treatment, in spite of the increased mortality among all patients. 
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ABBREVIATIONS AND GLOSSARY 
 
CK: creatine phosphokinase 
 
GHB: gamma-hydroxy-butyrate 
 
ICD: International classification of diseases 
 
ICU: intensive care unit 
 
Multinomial regression analyses: is used when the dependent variable in question is 
nominal (a set of categories which cannot be ordered in any meaningful way) and consists of 
more than two categories 
 
NAC: N-acetyl-cysteine 
 
Opioids: a chemical substance that has a morphine-like action in the body and binds to opioid 
receptors 
 
SSRIs: selective serotonin reuptake inhibitors 
 
Standardized Mortality Ratio (SMR): the ratio of observed to expected deaths, i.e., the ratio 
of the number of deaths observed in the study group to the number of deaths that would be 
expected if the study population had the same specific rates as the standard population 
 
TCA: tricycle antidepressants 
 
WHO: World Health Organization 
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PREFACE 
 
I owe my interest in suicidology in general, and self-poisonings in particular, to my 
supervisor, Professor Øivind Ekeberg. When I was a medical student, he was my teacher in 
communication skills, and during our group discussions and training sessions, the complex 
background and the need for treatment among this patient group were emphasized. When we 
discussed the opportunity for me to participate in a mortality study as part of my mandatory 
student report, it became clear that more questions needed to be answered than could be 
covered by such a format. I became a student at the Medical Student Research Program from 
the autumn of 2003 and worked full-time as a fellowship student for one year. During this 
period, Professor Dag Jacobsen, who became my co-tutor, elaborated the toxicological view 
in this field. From March 2003, I was included in the group that organized a study of all self-
poisonings in Oslo over a one-year period from 1 April 2003 to 31 March 2004. Knut Erik 
Hovda, and later Fridtjof Heyerdahl, were closely involved with this group while completing 
their doctoral fellowships. Gradually I became more involved in the collection of data, 
participating in the interviewing of the patients at Ullevaal University Hospital, scanning the 
forms collected by other participants and double-checking that the forms were complete. In 
parallel, the cohort study from 1980 was adjusted to produce a new project that investigated 
the 20-year mortality among self-poisonings. In addition, the study of drugs of abuse from 
2001 was organized by combining the plotting of the forms and the analyses to enable the 
data analyses to be performed. Since the data collection period has concluded, the main focus 
of the work has been on statistical analyses and writing papers. I have worked closely with 
Knut Erik Hovda, Fridtjof Heyerdahl and Tor Haldorsen, both in drafting the manuscripts and 
in performing the statistical analyses. 
During the last three years as a medical student, I did research part time, in accordance 
with the Medical Student Research Program. Luckily, I was allowed to be part of the milieu, 
both at the Department of Acute Medicine, Ullevaal University Hospital and the Department 
of Behavioural Sciences in Medicine, University of Oslo. I graduated from the research 
programme in the autumn of 2006 but continued to work part time on this project through 
medical school and into my internship at SIHF Lillehammer. 
The Medical Student Research Program required that I complete the mandatory 
courses and tests according to the PhD programme and that I present the results of our 
research at international congresses in our field. Therefore, I presented our results at annual 
conferences in suicidology organized by the International Association for Suicide Prevention 
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(IASP) since 2004, and at the European Association of Poisons Centres and Clinical 
Toxicologists (EAPCCT) in 2005. Together with other students at the Medical Student 
Research Program in Oslo, in 2005 I participated in the founding of the first national 
conference for medical students’ research in Norway called Frampeik. In 2007, we founded 
the sequel called Frampeik Alumni. 
Attempted suicide has been long recognized as a strong predictor of later suicide, and 
this group of patients has been closely studied in the field of suicidology. The main aim of 
this thesis was to study the group involved in self-poisoning irrespective of intention, to 
expand our perspective on self-destructive behaviour. Less is known about emergency 
department patients who have been evaluated as being non-suicidal. To answer the research 
questions raised by this thesis, six papers have been included. Although this is slightly more 
than usual, my hope is that all of them will provide useful information about this patient 
group. It is hoped that more knowledge about epidemiology and substance use, as well as 
psychiatric treatment and socio-demographic factors, will be helpful in understanding the 
background of these patients to identify and organize better treatment for those at special risk. 
The prognosis for such patients, both in the acute setting and in the longer term, needs to be 
studied. Hopefully, more precise diagnosis and knowledge of this patient group will be useful 
in any attempt to reduce the risk of suicide, in particular, and to reduce the overall mortality 
rate. 
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1. INTRODUCTION 
 
1.1 Self-poisonings 
Acute poisoning is a frequent cause of hospitalization in industrialized countries (74). Acute 
poisonings can be defined as exposure to a drug or another agent in assumed toxic amounts 
leading to hospital admission (70). About 15 to 20% of the work load of medical units, and 
10% of the workload of accident and emergency departments in the United Kingdom are due 
to acute poisonings (73). Self-poisonings accounts for the vast majority of acute poisonings. 
Jacobsen et al found in a study from 1980 that 98.3% of all acute poisonings were self-
poisonings (70), and this thesis will focus on this patient group. Almost all acute poisonings 
are self-poisonings, and this term will be used in the following. 
Self-poisonings is defined as an acute poisoning where the patient has taken the toxic 
agent, i.e. excluding accidental poisonings. For self-poisonings, suicidal behavior and substance 
abuse are the main reasons behind the poisonings. Many studies focus on subgroups of self-
poisonings, such as suicide attempters (125), medically serious suicide attempters (12), 
deliberate self-harm (66), deliberate self-poisonings (24), non-fatal drug overdoses (101) and 
so on. The fundamental principle behind this classification is the correct evaluation of the 
intention. However, the evaluation of intention among patients presenting at the Emergency 
Department can be difficult; the patients are often comatose, unwilling to report the use of 
illicit drugs and even the ambivalence and instability in the wish to die can complicate the 
evaluation. The validity of the patients’ own given reason for the self-poisoning has been 
questioned (51). Both suicidal behaviour and accidental self-poisonings as a result of 
substance use can be seen as aspects of self-destructive behaviour, the latter as “accident 
proneness” (108). Self-poisonings can therefore in many respects be studied as a single risk 
group. Intention may be studied as one of the factors characterising the patients, and the 
relationship to toxic agents, treatment, substance use, psychosocial factors and prognosis can 
be explored. When including all self-poisonings presenting at the Emergency Department, the 
generalization from the sample back to a well-defined background population is made 
possible.  
 
1.2. Suicidal behaviour 
Suicidal behaviour is a central term in the field of suicidology. The term suicidal behaviour as 
used in this thesis covers three main categories: suicidal ideation, suicide attempt and suicide1. 
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There are alternative definitions, however, since the terms used in suicidology still are lacking 
consensus (93).  
 Suicidal ideation is usually equivalent to suicidal thoughts, and the terms cover 
thoughts about committing suicide. These thoughts may be spontaneously expressed to others, 
or confirmed, when the person concerned is asked (108).  
 Suicide attempts can be defined as “an act with non-fatal outcome, in which an 
individual deliberately initiates a non-habitual behaviour that, without intervention from 
others, will cause self-harm, or deliberately ingests a substance in excess of the prescribed or 
generally recognized therapeutic dosage, and which is aimed at realizing changes which the 
subject desired via the actual or expected physical consequences “(WHO) (102). However, 
this definition is wide, and includes self-harm without necessarily a wish to die. The term has 
also been used equivalently to the term parasuicide (102), and will be referred to as the latter 
in this thesis. In Norway, the definition of suicide attempts given by Retterstol has been 
commonly used: “A suicide attempt is a conscious and deliberate act the individual has 
undertaken in order to injure himself, and which the individual could not have been entirely 
certain of surviving, but where the outcome was not fatal. A wish to die, however weak, has 
been present” (108) (Translated from Norwegian by M.A.B). Here, the act might have caused 
death without intervention, not self-harm, and a wish to die has been present, not merely a 
desire for changes. This corresponds to the understanding of the term suicide attempt which is 
used in this thesis, and will be used in the following. The term attempted suicide has been 
criticised because it is used to describe a behaviour that may lack any suicidal intention. This 
is not the case with the definition used above, as a wish to die needs to be present.  
 There are several definitions of suicide. In Norway, a commonly used definition of 
suicide has been as follows: “Suicide is a conscious and deliberate act, which the individual 
undertakes to injure him- or herself, and where the injuries have led to death” (108) 
(Translated from Norwegian by M.A.B). In the present study, the term suicide is used 
according to the ICD criteria at time of death for the subject. This is consistent with the 
classification of suicide on death certificates provided by Statistics Norway. 
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Table 1. Some terms used in the field of suicidology 
 
Term Definitions 
Suicidal behaviour Cover three main categories: suicidal ideation, suicide attempt and 
suicide (Wassermann, 2001)1 
Suicidal intention A wish to die  
Suicidal ideation Suicidal thoughts  
Parasuicide An act with non-fatal outcome, in which an individual deliberately 
initiates a non-habitual behaviour that, without intervention from 
others, will cause self-harm, or deliberately ingests a substance in 
excess of the prescribed or generally recognized therapeutic dosage, 
and which is aimed at realizing changes which the subject desired via 
the actual or expected physical consequences (WHO, 1992)2 
Suicide attempt A suicide attempt is a conscious and deliberate act the individual has 
undertaken in order to injure himself, and which the individual could 
not have been entirely certain of surviving, but where the outcome 
was not fatal. A wish to die, however weak, has been present 
(Retterstol et al, 2002)3 
Suicide Suicide is a conscious and deliberate act, which the individual 
undertakes to injure him- or herself, and where the injuries have led 
to death (Retterstol et al, 2002)4 
Intentional self-harm As defined by ICD-10 X60-X84.  The term includes “purposely self-
inflicted poisoning or injury, and suicide (attempted)”5  
  
Ambivalence is an important characteristic of suicidal behaviour (108). There is an 
aspect of ambivalence in most suicide attempts; “should I/should I not? “ An example of this 
can be seen when a person ingests an almost lethal dose of a toxic compound, not a certain 
lethal dose, letting “fate” (for example, the intervention of others) decide the outcome. The 
                                                          
1  Suicide  - An Unnecessary death. Danuta Wassermann 2001. Page 18-19. 
2 Parasuicide in Europe: The WHO/EURO multicentre study on parasuicide. Platt et al, Acta Psychiatr. Scand. 
1992.  
3 Selvmord – et personlig og samfunnsmessig problem. Retterstol et al 2002. Page 13. 
4 Selvmord – et personlig og samfunnsmessig problem. Retterstol et al 2002. Page 12. 
5 International Classification of Diseases (ICD) 10, Chapter X. 
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changes in intention over time is another aspect, as some persons ingest a lethal dose, but 
when they can feel the effect setting in, make contact with health care services or other people 
and hence survive. Furthermore, a common feature of suicidal behaviour is the aspect of 
communication. The suicide attempt can be seen as a message to an important other. In some 
cases this aspect is more obvious than in others, for example when some persons ingest a 
merely toxic dose when the important other (spouse, friend etc.) can see it. This aspect is 
included in the term parasuicide, as the aim of the act is to realize “changes which the subject 
desired”. But this act would not necessarily mean a wish to die, and is therefore not always a 
suicide attempt. The act would be seen as an appeal for changes, not as a wish to die. In this 
thesis such acts will be referred to as acts of appeal.  
Self-destructive behaviour is an important aspect of suicidal behaviour. Related to this 
is the “accident proneness”; persons who kill themselves over time by their ways of living 
(108). This is also known as to be “chronically suicidal” (108). Substance abusers can be seen 
as an example of this (see below).  
It is estimated that worldwide between 500 000 and 1.2 million people die by suicide 
each year (United Nations, 1996)(65). In Norway, the suicide rate in 2006 was 16.9/100 000 
for males and 6.0/100 000 for females6. A total of 532 persons committed suicide in 2006; 
391 males and 141 females. Suicide attempts are many times more frequent, and only a small 
proportion of suicide attempters will eventually complete suicide (96). The lifetime 
prevalence of suicide attempts have been found to be 1 - 4% in some studies (75;100). 
However, this is probably an underestimation. For example, for the past 5 years in Norway, 
approximately 43 000 persons have died each year, of whom about 550 were suicides. These 
numbers give an approximately prevalence of suicide of 1-1.5% whereas suicide attempts 
occur much more frequently. Ystgaard et al found that among adolescents 15-16 years old, 6.6 
% reported one or more acts of deliberate self harm over the course of the previous twelve-
month period. Cutting and self-poisoning were most prevalent (135). The life time prevalence 
of suicide attempts is therefore probably higher than the minimum numbers given above.  
 The methods used for suicide and suicide attempts are somewhat different, as some 
methods are more lethal, such as hanging and shooting. In suicide attempts, methods are 
mostly “non-violent”, as the persons survive. In the WHO/EU Multicentre Study of parasuicides, 
64% of males and 80% of females used self-poisoning (here, the terms parasuicide and suicide 
attempt was used equivalently, according to the definition of parasuicide, see page 14) (84).  
                                                          
6 http://www.ssb.no/emner/03/01/10/dodsarsak/tab-2008-06-27-08.html 
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 Most suicide attempters will never commit suicide. There has been questioned whether 
suicide attempters and those who commit suicides are two populations or one. Beautrais 
found in a case-control study in 2001 that there were common risk factors for the groups such 
as current mood disorder, previous suicide attempts, prior outpatient psychiatric treatment, 
admission to psychiatric hospital within the previous year, low income, a lack of formal 
educational qualifications, and exposure to recent stressful interpersonal, legal and work 
related life events (10). Statistically significant differences were found, however, showing that 
suicides were more likely to be male, older, and to have a current diagnosis of non-affective 
psychosis. Suicides and suicide attempts can therefore be seen as two overlapping populations 
that share common psychiatric diagnostic and history features, but are distinguished by gender 
and pattern of psychiatric disorder. More males commit suicide, whereas more females 
attempt suicide –this is known as the gender paradox in suicide (23).  
 Harris et al found in a meta-analysis that virtually all mental disorders have an 
increased risk of suicide excepting mental retardation and dementia (54). The suicide risk was 
highest for functional and lowest for organic disorders with substance use disorders lying 
between. However, within these broad groupings the suicide risk varies widely. 
Psychiatric disorders among those who make serious suicide attempts have been studied. 
Beautrais et al found that 90.1% had a mental disorder at the time of the attempt (12). Mood 
disorders, substance use disorders, and personality disorders were more common than among 
controls. The incidence of co-morbidity was high: 56.6% of those who made serious suicide 
attempts had two or more disorders. The risk of a suicide attempt increased with increasing 
psychiatric morbidity: subjects with two or more disorders had odds of serious suicide 
attempts that were 89.7 times the odds of those with no psychiatric disorder. A WHO-study of 
parasuicides found that subjects with physical illnesses considered psychiatric symptoms and 
disorders to be relevant factors in triggering suicidal behaviour, and more so than non-
sufferers (34). Furthermore, Hawton et al found a considerable co-morbidity between axis I 
and II disorders: Co-morbidity of psychiatric and personality disorders was present in 49 
patients (44%) (62). More patients with co-morbid disorders had made previous suicide 
attempts, and were more depressed and hopeless, reported more episodes of aggression, were 
more impulsive, and had lower self-esteem and poorer problem-solving skills. Co-morbidity 
may therefore contribute to greater suicide risk.  
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1.3 Substance use  
Substance use disorders includes a pattern of psychoactive substance use that is causing 
damage to health (see drug dependence syndrome, International Classification of Diseases 
(ICD) -10, table 2 (1)). In ICD-10, chapter F10-F19 contains a wide variety of disorders that 
differ in severity and clinical form but that are all attributable to the use of one or more 
psychoactive substances, which may or may not have been medically prescribed. 
According to ICD-10, identification of the psychoactive substance should be based on 
“as many sources of information as possible. These include self-report data, analysis of blood 
and other body fluids, characteristic physical and psychological symptoms, clinical signs and 
behaviour, and other evidence such as a drug being in the patient's possession or reports from 
informed third parties”. Therefore, the classification of substance use disorders is based on an 
evaluation of all available information regarding the use of psychoactive substances, and not 
one form or scale in particular.   
 The extent of use, and hence the proportion of abuse, is hard to evaluate. The 
European Monitoring Centre for Drugs and Drug Addiction7  estimated in 2002 that up to 
28% of Norwegians aged 21-30 had ever tried cannabis, 8% amphetamine, 6% cocaine, 5% 
ecstasy, 1 % GHB and 1% heroine. This was based on a National Questionnaire Survey 
conducted by the Norwegian Institute for Alcohol and Drug Research (Statens instituttt for 
rusmiddelforskning, SIRUS). Injecting drug users is another term used in the field, but the 
methodology used gives only highly uncertain estimates. The number of injecting drug users 
were, however, estimated to be 9 000 – 12 000 in Norway in 2001, of whom the majority 
injected opioids and 10% amphetamine. Alcohol was not included in this survey, nor was 
prescribed medication such as benzodiazepines. Of the numbers mentioned above, a smaller 
proportion of the population will have pattern of use corresponding to the term substance 
abuse.  
 
                                                          
7 http://www.emcdda.europa.eu/html.cfm/index55188EN.html 
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Table 2. Diagnoses in ICD-10 related to substance use: Mental and behavioural disorders due 
to psychoactive substance use (F10-F19)  
 
Terms Definitions 
Acute 
intoxication  
 
A condition that follows the administration of a psychoactive substance 
resulting in disturbances in level of consciousness, cognition, perception, 
affect or behaviour, or other psycho-physiological functions and 
responses. The disturbances are directly related to the acute 
pharmacological effects of the substance and resolve with time, with 
complete recovery, except where tissue damage or other complications 
have arisen. Excludes: intoxication meaning poisoning (T36-T50). 
Harmful use A pattern of psychoactive substance use that is causing damage to health. 
The damage may be physical (as in cases of hepatitis from the self-
administration of injected psychoactive substances) or mental (e.g. 
episodes of depressive disorder secondary to heavy consumption of 
alcohol). 
Dependence 
syndrome 
A pattern of psychoactive substance use that is causing damage to health. 
The damage may be physical (as in cases of hepatitis from the self-
administration of injected psychoactive substances) or mental (e.g. 
episodes of depressive disorder secondary to heavy consumption of 
alcohol). The dependence syndrome may be present for a specific 
psychoactive substance (e.g. tobacco, alcohol, or diazepam), for a class 
of substances (e.g. opioid drugs), or for a wider range of 
pharmacologically different psychoactive substances. 
Withdrawal 
state, 
with or without 
delirium 
A group of symptoms of variable clustering and severity occurring on 
absolute or relative withdrawal of a psychoactive substance after 
persistent use of that substance. The onset and course of the withdrawal 
state are time-limited and are related to the type of psychoactive 
substance and dose being used immediately before cessation or reduction 
of use. The withdrawal state may be complicated by convulsions. 
Delirium: as defined in F05. 
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 Binger et al found that in a Emergency Department, 6.9% of all patient attendances 
were directly or indirectly related to illegal drug use, and the majority were acute injuries, 
overdose, and the medical complications of drug use (17). In addition, polydrug use is very 
common among patients treated for acute poisonings (129), and is seen frequently in fatal 
poisonings (49). 
Substance users can be viewed as an important risk group for suicidal behaviour. The 
“accident proneness” which follows a long career as a substance user is considerable (108). 
Rossow et al found more suicide attempts among substance users who had overdosed, and the 
number of life-threatening overdoses and number of suicide attempts were associated (111), 
illustrating the risk-taking behavior and the carelessness which may be seen as a part of  a 
self-destructive behavior.   
 Substance use disorders, alcohol included, is the second most frequent psychiatric 
precursor to suicide, only exceeded by depressive disorders (88). It is found in one fifth to one 
half of the cases. There is a substantial co-morbidity between drug dependence and affective 
disorders (89), and major depression has been seen as a late complication of alcoholism much 
more often than the other way around. Other substances have gained popularity in the past 
decades, but less is known about their relationship to psychiatric disorder. However, there is a 
known co-morbidity between cannabis (121), opioids (27), substance use in general (32)  and 
a variety of mental disorders. Furthermore, substance use disorders  is found to complicate 
nearly all of the diagnosed personality disorders identified retrospectively in suicides (112). 
Bakken et al found in a study of suicide attempters seeking substance use treatment, that 19% 
of the patients had new suicide attempts in a six-year follow-up (5). There was no difference 
between those who then had quit using drugs and those who were still using them.  
 
1.4 Epidemiology of self-poisonings 
Epidemiology is defined as all the elements contributing to the occurrence or nonoccurrence 
of a disease in a population8. In some contexts it is defined as the branch of medicine that 
investigates the causes and control of epidemics. In this thesis, however, the first definition 
will be used.  
The evaluation of toxic agents in self-poisonings is a crucial element in the 
epidemiology of self-poisonings. The development of new drugs and a changing pattern in 
substance abuse may have changed the diagnostic panorama (67), and the impact on the 
                                                          
8 http://www.yourdictionary.com/epidemiology 
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diagnostic evaluation and the clinical course of the patients need to be explored. The patterns 
of toxic agents changes over time (80;115). The diagnosis regarding toxic agents in self-
poisonings is made by the physician on duty. Today, laboratory tests are secondary to clinical 
assessments, and normally include screening tests for ethanol, paracetamol and acetylsalicylic 
acid only. Knowing the patterns of toxic agents in a population supports the evaluation of 
which toxic agents the patient has taken. Previous studies suggest that there is a good 
correlation between clinical suspicion and laboratory findings (87;116). However, information 
about new patterns of toxic agents is scarce, and the emerging use of γ-hydroxy butyric acid 
(GHB) (43) and ecstasy (131) need to be assessed, as well as changes in prescriptions 
regarding new antidepressants such as selective serotonin reuptake inhibitors (SSRIs) 
(47;119), and regulatory withdrawal and prescription recommendations for  barbiturates 
(28;41).  
Although the treatment of self-poisonings is mainly symptomatic, a correct evaluation 
of the toxic agents would optimize treatment and aftercare. However, the clinical impact of an 
imprecise diagnosis in these patients is being questioned. It is claimed that an inaccurate 
diagnosis is not affecting mortality (87), nor being the cause of complications (103). 
However, knowing the correct diagnosis could enable optimal treatment of acute poisoning by 
reducing the need for supervision and costly treatments and facilitating the identification of 
cases that require prompt drug-specific treatment (68;87;103;129). The use of antidotes has 
increased during the last decades, and the specificity of this use needs to be addressed. Thus, 
both morbidity and costs may be reduced.   
Drugs of abuse are of special interest, as the use of illicit drugs may indicate substance 
use disorders. Emergency departments can be important venues for detecting persons in need 
of substance use treatment (110). Thus, correct evaluation of toxic agents is important in 
tailoring proper aftercare for these patients. Furthermore, underestimation of drugs of abuse 
can partly explain why antidotes do not reverse the effects of the suspected toxic agent in 
some cases. 
 
1.5 Self-poisonings and the risk of later suicide 
A previous suicide attempt is the strongest known predictor of later suicide (54). Furthermore, 
there is a considerable co-morbidity between psychiatric disorders and substance use, and 
substance use is an independent risk factor for later suicide among suicide attempters (59). Both 
suicide attempts and suicides occur more frequently among heroine users (31) and chronic 
alcohol consumers (58), which emphasizes the need to address both the intention and the history 
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of substance abuse when a patient presents with self-poisoning (49). 
 The problems of substance use and suicidality are related, see figure 1. Among suicide 
attempters, alcohol or drug abuse has been found to be a strong risk factor for completing 
suicide (29). Among patients treated for drug dependence, a large proportion has attempted 
suicide (2). The co-morbidity between substance use disorders and mental illnesses are 
described both as an association between substance use and mental illnesses and between 
known risk factors both for substance use and suicide, such as being male, living alone and 
unemployment (60;63).  
 
Figure 1. Relationship between variables  
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluating suicide risk in a patient is a complex task. It is a paradox that many of the 
factors recognized as risk factors for suicidal behavior are commonly seen among the general 
population. Combined with the low base line of suicides, the prediction of which patients who 
will eventually commit suicide is inaccurate. The number of false positives is high (48). 
However, the risk factors are important in the evaluation of the suicidal patient, the idea being 
that the more risk factors, the stronger the risk for suicide.  More than 60 risk factors have 
been identified (109). 
This may be seen as the background for risk-factor research. According to Amsel and 
Mann (4)  ”the goals of this type of research are focused on prevention in populations, its 
methodology is probabilistic and not deterministic, it seeks to operationalize its concepts and 
it is concerned with modeling the intervening paths between a risk factor and its associated 
Suicidal thoughts
Substance abuse
Psychiatric disorders
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outcome.” Risk factors may be used to divide the population in two groups in which the 
probabilities of the outcome, i.e. suicide, and therefore identifying a high risk group. “The key 
is to identify a subgroup of the population sufficiently enriched for the adverse outcome such 
that a preventive intervention can have a measureable impact” (4). In the context of 
suicidology, identifying a high risk group will be important for prevention, such as referral to 
further treatment. Both mortality in general and suicide in particular may be used as outcome 
variables.  
   
Table 3. Some commonly recognized risk factors for suicide9  
Risk factors for suicide Increased suicide risk 
Demographic factors 
Gender 
Age 
Living conditions 
Migration 
 
Males > females 
M: after 70 yrs. F: highest risk 40-60yrs 
Living alone > living in a family 
Immigration  
Psychiatric factors 
Psychiatric illness 
 
 
 
Previous suicide attempts 
 
Depression 
Personality disorders 
Psychosis 
Substance use disorders 
Previous attempt or appeals 
Social factors 
Parental divorce 
Employment status 
Socioeconomic class 
Survivors 
 
If occurring < 15 yrs 
Unemployment 
High or low social class 
Suicides among relatives or close friends 
  
Given several reports on the risk factors for suicidal behavior, one would expect the 
suicidal patients to differ from the non-suicidal patients treated for self-poisonings in these 
respects. The number of risk factors would be expected to be increased among the suicidal 
compared to the non-suicidal patients, but this has not been evaluated systematically for self-
poisonings. The main focus for research has been the immediate risk of suicide, i.e. in the 
                                                          
9 Selvmord – et personlig og samfunnsmessig problem. Retterstol et al. 2002. Chapter 7, 8, 11 and 13.  
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short term. Less is known about the importance of risk factors at admission for increased risk 
of suicide in the long term.  
A history of a suicide attempt indicates an increased suicide risk both in the first years 
after the episode (57), and over the long term (123;125). Owens et al found in a meta-analyses of 
risk of suicides following self-harm that the strong connection between self-harm and later 
suicide lies somewhere between 0.5% and 2% after one year and above 5% after nine years. 
Suicide risk among self-harm patients is more than hundred times higher than in the general 
population (95). The suicide rate varies from 2% 10 years after deliberate self-poisoning (107) to 
11% 10 years after a serious suicide attempt (99). A 37-year follow-up study of 100 suicide 
attempts by self-poisoning in Finland found a suicide rate of 13% and an elevated suicide risk 
over the entire adult lifetime (125). A 22-year follow-up study of suicide attempters from 
psychiatric services in London, reported similar trends, but in a different population – suicide 
attempters referred to psychiatric wards (72).  
 The diversity in definitions and inclusion criteria in different studies is problematic. The 
different inclusion criteria make the results harder to compare, but also to turn into 
recommendations for clinical practice. Is a medically serious suicide attempt to be seen as a more 
profound wish to die, and therefore at special risk for later suicide? Does the patient’s choice of 
toxic agent always reflect the seriousness of the intent? If so, the level of complications would be 
seen as a marker of increased suicide risk. But studies of self-poisonings have found predictors 
of later suicide to be unspecific (3), and further studies of clinical predictors of patients at special 
risk are needed. When evaluating the suicidal intent by using a psychiatric scale, this is found to 
be of value for identifying those at special risk (56). However, the use of psychiatric scales and 
surveys in a study of patients treated in an Emergency Department is problematic, as long as the 
referral to psychiatric services is done by the physician on duty, mostly residents in internal 
medicine. Their evaluation of intent is the gatekeeper of admission to psychiatric services, and is 
a result of complex decision making (24), but often not with the help of psychiatric surveys. 
Furthermore, if focusing solely of the wish to die, other risk factors for suicide might be 
overlooked. Groholt et al found that among adolescent suicide attempters, the morbidity among 
those with no wish to die was high regarding psychosocial problems and substance abuse (51). 
The need for follow-up among patients with no intent to die may therefore be underestimated.  
 
1.6 Self-poisonings and mortality 
Individuals who self-poison can be seen as a risk group for increased mortality in general. Excess 
mortality of suicide attempters by natural and unnatural causes has been noted after five years 
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(11;94), eight years (57), 10 years (91), and 12 years (124). The risk was increased for death in 
genereal, but also for specific causes such as suicide, homicide, accidents and diseases (94). Both 
Ostamo et al and Nordentoft et al concluded that the risk factors found were not specific enough 
to predict who would eventually commit suicide, nor who had increased risk of premature death 
(91;94). Preventive measures must therefore be directed towards most suicide attempters. 
 The same pattern of excess mortality is seen in drug abusers, both over the short term 
(49) and in a 20-year follow-up study (97). Mortality rates among opioid addicts are higher 
than for the general population, although there are differences between countries and regions. 
Standardized mortality ratios (SMRs) vary from 15 times higher than expected for male drug 
users in Rome (7), 22 times higher for drug injectors in Glasgow (44) to 28.5 times higher for 
heroin addicts in Catalonia, Spain (118). 
 The majority of deaths among opioid addicts are from accidental poisonings (97), but 
death by other unnatural causes such as suicides are also increased (76;98). The AIDS 
epidemic has also had a major effect on this group of patients during the last decades (105). 
Although there has been found an increasing mortality among opioid addicts from 1980 to 
1988 (33), but the emerging of AIDS can only partly explain this increase (35). A four-year 
prospective study of cause-specific mortality rates among opioid addicts has been done, but 
standardized mortality ratios were not obtained (49). Longer prospective follow-up studies 
show how overall mortality changes over time (46), and there would be expected that also 
cause-specific mortality differ between the long-term versus short-term follow-up. However, 
no such studies exist for this group of patients.   
   
1.7 Referral to further treatment  
The intention has traditionally a major impact on the referral of patients to secondary follow-
up after treatment of the actual self-poisoning: Being referred for specialist follow-up reduces 
the risk for repetition (20). The well-known risk of further suicidal behaviour in patients 
reporting a suicidal intention has led to psychiatric follow-up of these patients. The group 
reporting substance abuse is less likely to receive psychiatric follow-up (21), although the co-
morbidity of substance abuse and psychiatric disorders is well known (12). Differences in 
referrals would be expected, as different approaches probably are needed. But Suominen et al 
found that even suicide attempters were less likely to receive psychiatric follow-up when they 
reported substance abuse disorder (22). Further, it has been questioned whether or not the 
morbidity of the substance users treated in the Emergency Department has been 
underestimated (23).  
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 In spite of the increased mortality and hence the need for intervention,  Cook et al 
found that 67% of patients referred to The Emergency Department because of acute opioid 
overdose were not referred to any therapeutic programme for drug addiction (26). Throughout 
the last decades, studies have focused on abstinence versus continued use after different 
treatment programmes as an outcome measure (106), but the question remains whether or not 
this has an effect on mortality in the long term. Sorensen et al found in a 15-year follow-up 
that people who had achieved stable abstinence from injecting narcotics use were at lower risk 
of premature death than people with continued drug use (122). But even in the presumed 
abstinence group, standardized mortality ratio (SMR) was increased seven-fold. This raises 
the question whether or not referral to a detoxification programme has the desired effect on 
long term mortality in this group.  
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2. RESEARCH QUESTIONS 
The aim of this thesis is to study self-poisonings treated at the Emergency Department as a 
single risk group. The pattern of toxic agents, the extent of substance use and the psychosocial 
risk factors among these patients need to be investigated. The long-term prognosis will be 
studied, as well as the follow-up treatment offered. The thesis tries to answer six main 
research questions:  
1. What are the patterns of toxic agents, especially for drugs of abuse, according to age 
and gender for patients admitted to medical departments for acute poisoning during one 
year in Oslo? (Papers I  and II) 
i. What is the annual incidence of acute poisonings in Oslo in 2003/04? 
ii. What are the patterns of toxic agents according to intention? 
2. What is the concordance between the clinical assessments (including patient history) by 
the physicians on duty and the drug analyses in patients treated for acute poisonings? 
(Paper II) 
3. What kind of treatment is offered to the patients in the acute setting and to what extent 
are the patients referred to follow-up services at discharge?  (Paper III and VI) 
i. What is the clinical outcome for these patients in terms of 
morbidity, mortality and sequelae? 
ii. Are there changes in the clinical course of these patients 
compared to a similar study from 1980? 
iii. Are there differences in referral to follow-up services according 
to intention? 
4. Are there differences in psychosocial factors, history of substance use and referral to 
follow-up services at discharge according to the intention of the self-poisoning? (Paper 
VI) 
5. What are the 20-year overall and cause-specific mortality rates for all patients admitted to 
medical departments for self-poisoning in Oslo in 1980, and for hospital-treated opioid 
addicts in particular, compared to those for the general population? (Papers IV and V) 
i. Are there differences in mortality between opioid addicts 
voluntarily admitted for detoxification and those admitted solely 
for self-poisonings? 
6. What factors might differentiate those who died in the follow-up period from those 
who survived, and what factors might predict suicide or other causes of death? (Paper 
IV) 
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3. MATERIAL AND METHODS 
 
3.1 Materials 
Five different samples, although some of them overlapping, are studied in this thesis:  
 
Table 4. Overview of the materials included in the thesis 
Paper Inclusion Year N Area Median 
age 
Females Design 
I , III Acute 
poisonings 
2003/04 947 All medical 
departments 
in Oslo 
36 54% Cross-
sectional 
II Acute 
poisonings 
2001 405 Ullevaal 
university 
hospital 
31 48% Cross-
sectional 
IV Self-
poisonings 
1980 946 All medical 
departments 
in Oslo 
31 51% Prospective 
cohort 
V Opioid† 
addicts 
1980/81 185 All medical 
departments 
in Oslo 
24 47% Prospective 
cohort 
VI Self-
poisonings†† 
2003/04 908 All medical 
departments 
in Oslo 
36 54% Cross-
sectional 
 
† Only self-poisonings classified as opioid addicts in the sample from paper IV are included 
†† The sample corresponds to paper I and III, but accidental non-self-poisonings are excluded 
 
3.1.1 Inclusion criteria 
The main inclusion criteria in paper I-IV and VI were exposure to a drug or another agent in 
assumed toxic amounts leading to hospital admission in adults (≥ 16 years). Exclusion criteria 
were chronic poisoning and patients with other primary diagnosis, such as pneumonia, even if 
there was an additional self-poisoning. The intention behind the self-poisoning was evaluated 
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in all papers except paper II, but patients were included irrespective of intention. Patients 
leaving the emergency room after treatment were also included.  
The terms acute poisoning and self-poisoning are overlapping. The difference is that 
accidental non-self-poisonings such as fire accidents (i.e. CO as the toxic agent), occupational 
accidents (i.e. gas exposure etc.) and taking prescribed medication in wrong doses 
(misspelling of the prescription, wrong dosage administered from nurse and so on) are 
included in acute poisonings, whereas these patients are excluded from the samples of self-
poisonings.  
Two patient groups are included in paper V. Firstly, from the cohort of self-poisonings 
in the 1980 cohort study, all patients classified as opioid addicts are included. Secondly, all 
opioid addicts admitted for voluntarily detoxifications in 1980 and 1981 in Oslo are included. 
Thus, the cohort consists of all hospital-treated opioid addicts in Oslo in 1980, and all voluntarily 
detoxifications from 1981 as well, in order to obtain comparable groups.  
 
Paper I, III and VI: Acute poisonings/self-poisonings in 2003/04 
The study population in these papers was part of a larger prospective cross-sectional multi-
centre study performed from April 1st 2003 until March 31st 2004, involving all four hospitals 
in Oslo, including the pediatric departments, and the Oslo Emergency ward (outpatient clinic), 
the ambulance service, and the Institute of Forensic Medicine (Figure 2). From the larger 
sample, the study population in these papers consists of all hospital-treated admissions in 
adults (older than 16 years) for self-poisonings during the study period. The form which was 
used in the study is included in the appendix.  
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Figure 2. Acute poisonings in Oslo in 2003/04 
 
 
 
Physicians obtained data by completing a standardized form the morning after admission, or 
as soon as the patient was ready for an interview. For patients who never woke up or had 
cerebral damage, data were obtained from the medical file after consent from relatives. In 
paper VI, the intention, psychosocial factors and plans for further treatment, i.e. referral, are 
studied for self-poisonings only, compromising 95.9% of the acute poisonings (Figure 3). 
Accidental non-self-poisonings are excluded from further analyses. There were 39 such cases 
which were excluded because of this; including carbon monoxide poisonings caused by fire 
accidents (n=13), taking prescribed medication in wrong doses according to a 
misunderstanding (n=24), and forced intake or accidental poisoning (n=2). 
 
Ambulance service  
n=1899: 
1870 adults, 29 children 
Oslo Emergency Ward 
(outpatient clinic) 
n=996: 
958 adults, 38 children 
Child 
hospitalizations  
n=62 
Adult hospitalizations 
n=947 
(780 patients) 
Adults found dead outside 
hospital; n=99 
Adults dead by 
poisoning; n=109 
n=7 
n=10 
n=14 
n=129 n=506 
n=560 
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Figure 3. Self-poisonings in Oslo 2003/04 treated in hospital (included in paper VI) 
 
 
 
Paper II: Acute poisonings in 2001 
This sample included all patients admitted to the Department of Acute Medicine at Ullevaal 
University Hospital in Oslo, Norway, because of an acute poisoning between January 1 st and 
December 31 st 2001. Ullevaal University Hospital covers about 140 000 inhabitants of Oslo, 
in addition to seriously poisoned patients from other parts of Oslo as well.  
Both a completed form and a urine or blood sample were needed to do the comparison, 
and if either a form or a urine or blood sample was missing, the patient was excluded from 
further analyses. The comparison was possible in 320 cases, and 79% of the patients were 
included in further analyses. 
The physicians were informed to write down all suspected toxic agents, not 
differentiating between main and additional agents. They were asked to include all suspected 
agents, and were not aware that drugs of abuse were the main purpose of the study. The 
treating physicians did not know the results of the urine or blood screening. Urine sample was 
obtained if possible, either in the Emergency room or later when the patient had moved to 
another unit. If a urine sample was not obtained, a blood sample was taken.  
 
Paper IV and V: Self-poisonings in 1980 and voluntary detoxifications in 1981 
From a cohort of acute poisonings in 1980 (70), all accidental non-self-poisonings were 
947 
Admissions 
780 
Patients 
892 discharged with 
no sequelae  
6 discharged with 
permanent sequelae 
10 died in hospital 
908 admissions of self-
poisonings 
39 admissions of 
accidental non-self-
poisonings  
101 Patients with 
167 readmissions 
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excluded. The remaining patients consisted of all hospital-treated self-poisonings in Oslo in 
1980, and included 98.3% of the acute poisonings. Six patients were foreigners who could not be 
traced and were excluded. Thus, the cohort included 946 patients, 51% of whom were females. 
The median age was 31 years (range 13–93 years). The first or the most serious admission (i.e., 
relating to the toxic agent and the amount taken) was chosen as the index episode.  The 
mortality in the cohort has been studied after 5 and 10 years by Ekeberg et al (38;39). 
 All patients treated for self-poisonings who were classified as opioid addicts in 1980 
were included in paper V. In addition, all opioid addicts admitted to Ullevaal University Hospital 
for voluntarily detoxification during 1980 and 1981 were included in the study.  The present 
cohort consists of 185 opioid addicts either treated for self-poisoning (n=93), voluntary 
detoxification (n=75) or both (n=17). Those who were admitted both for self-poisonings and 
for detoxification were classified as voluntarily detoxifications in further analyses, as a 
marker of their willingness to undergo further treatment and rehabilitation. 
 Patients were followed to death, emigration or to the end of year 2000, whichever 
occurred first.  
 
3.2 Methods 
 
3.2.1 Design of studies 
Paper I, II, III and VI are prospective cross-sectional studies, and paper I and III are studying 
the same sample. Paper VI studies a major subgroup from this sample. Paper IV and V are 
prospective cohort studies and paper V studies a subgroup of opioid addicts from paper IV in 
addition to opioid addicts admitted for voluntary detoxification.  
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3.2.2 Variables 
Table 5. Variables included in the papers 
 
 Paper I Paper II Paper III Paper IV Paper V Paper VI 
Age  x x x x x x 
Gender x x x x x x 
Main toxic agent x  x    
Toxic agents  x     
Evaluation of intention  x  x x  x 
Consciousness x  x x   
Respiratory insufficiency   x    
Hypotension   x    
Cardiac arrhythmias   x    
Hypothermia   x    
Hypoglycaemia   x    
Use of antidotes   x    
Drugs of abuse  x     
Drug dependence    x x  
Socio-economic groups    x   
Main cause of death    x x  
Marital status      x 
Living conditions      x 
Country of origin      x 
Employment status      x 
Education      x 
Previous suicide attempts      x 
Psychiatric treatment      x 
Substance use      x 
Follow-up services      x 
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Age and Gender 
In paper I, II, III and VI, patients older than 16 years at time of admission were included. In 
paper IV and V, patients older than 15 years were included. In all papers except paper II and 
VI, the patient’s age was used as absolute numbers in the analyses, and no age categories 
were made. In paper VI, the sample was divided in age groups for further analyses, in order to 
study differences between age groups. The categories were 16-29 years, 30-49 years and  ≥50 
years. Gender was recorded.  
 
Main toxic agent 
The main agent was defined as the substance supposed to be most toxic in the amounts taken: 
The physicians made an overall evaluation of the substance thought to cause the most severe 
toxicity based on information from patients, bystanders, clinical manifestations and routine 
laboratory analyzes. Other ingested agents were defined as additional agents.  
 
Toxic agents 
Toxic agents were defined as any substance supposed to be toxic which might contribute to 
the patient’s condition. The physicians were informed to write down all suspected toxic 
agents, not differentiating between main and additional agents.  
 
Evaluation of intention 
The physician’s evaluation of the reason for the poisoning was based on all information 
available; including the patient’s own reported intention. Special attention was paid to 
possible written letters confirming their suicidal intent, supposed lethal doses of the toxic 
agent, or other active procedures to secure a lethal outcome, for example intake in remote 
places, or hiding themselves after intake. Information from other sources like ambulance 
personnel and companions were also used when available. Thus, the evaluation of intention 
was defined to these categories: 
1. Suicide attempt (definite or possible) 
2. Appeal 
3. Accidental poisoning as a result of substance use / drug-related poisoning 
4. Accidental non-self-poisonings  
Category 4 is included in acute poisonings (paper I, II and III), but patients evaluated to be in 
this category are excluded from self-poisonings (paper IV, V and VI). This included fire 
accidents (i.e. CO as the toxic agent), occupational accidents (i.e. gas exposure etc.) and 
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taking prescribed medication in wrong doses (misspelling of the prescription, wrong dosage 
administered from nurse and so on). Manual inspection of the journals revealed these 
categories to fit well. 
 In paper VI, the patient’s own evaluation of intent was recorded, and the patient was 
given eight different possibilities: intention to die, to escape from problems, to make impact 
on personal relationships, drug-related poisoning, do not remember, do not want to give 
information, other reasons and unknown. Only one category was chosen for each patient.  
Subsequently these answers were grouped into the following categories: suicide attempt 
(intention to die), appeal (to escape from problems and to make impact on personal 
relationships) and drug-related poisoning (the same category was used). Other answers were 
excluded from the studies of agreement.  
 
Consciousness 
In paper I and III: Consciousness was classified according to the following classification: (1) 
awake, (2) somnolent – can be kept awake when stimulated, (3) coma, response to painful 
stimuli and (4) deep coma, no response to painful stimuli. Coma and deep coma corresponded 
to Glasgow Coma Score <8. 
In paper IV: Consciousness was classified according to the following: (1) awake; (2) 
soporous; (3) somnolent – can be kept awake when stimulated; (4) coma – response to painful 
stimuli; and (5) deep coma – no response to painful stimuli. Coma and deep coma 
corresponded to a Glasgow Coma Score < 8.  
 
Clinical variables  
Respiratory insufficiency was defined as either arterial blood-gas analysis showing respiratory 
acidosis by standard criteria (pH<7.3, pCO2>7.0 kPa) or hypoxia (pO2<8.0 kPa), or clinical 
need for ventilation support. Hypotension was defined as systolic blood pressure below 85 
mmHg in at least two subsequent measurements. Cardiac arrhythmias were registered from 
the cardiac monitoring screens or EKG. Conduction disturbances were classified as 
arrhythmia, but sinus tachycardia was not. Cardiac arrest was classified as such, not as 
arrhythmia. Hypothermia was defined as body temperature below 35ºC and hypoglycaemia as 
serum-glucose level below 3.5mmol/L. Further criteria were according to general clinical 
terminology. The use of antidotes and treatment were recorded.  
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Drugs of abuse 
The term “drugs of abuse” include prescribed medication (benzodiazepines, opiates), illicit 
drugs (cannabis, cocaine, ecstasy, GHB, amphetamine, opiates) and ethanol. The patients 
might have taken other drugs as well, but this was not investigated. 
 
Drug dependence 
Classification of abuse was based upon patient interviews and records. The basic criteria 
included information on daily or regular use of the respective compound or its substitute (i.e., 
barbiturates for heroine), including withdrawal symptoms if the compounds were not 
administered. This was therefore based upon all information available, in accordance with the 
ICD criteria, see page 19. 
 
Socio-economic groups 
Education level and income were used to define four socio-economic groups based on education 
and yearly income, where socio-economic group 1 was considered the highest and 4 the lowest. 
For those under 30 years of age the same parameters in the parents in part also determined the 
social class. Of the couples included, the person with the highest social score determined the 
social class for both subjects.  
 
Main cause of death 
The underlying cause of death was chosen as the main cause of death, according to the criteria 
given both by International Classification of Diseases (ICD) and Statistics Norway. This 
corresponded to the classification of causes of death in the reference population provided by 
Statistics Norway (table 7). Death certificates were based on forensic autopsy records in all cases 
that were not due to natural causes of death. ICD-8 was used for deaths occurring before 1987, 
ICD-9 for deaths from 1987 until 1996, and ICD-10 for deaths from 1996 to 2000.  
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Table 6. Classification according to the ICD system  
 
 ICD-8 
(1969-85) 
ICD-9 
(1986-95) 
ICD-10 
(1996-) 
All causes 001-989 001-E989 A00-Y89 
All diseases 001-796 001-799 A00-R99 
Cancer 140-209 140-208 C00-C97 
Cardiovascular 
diseases 
390-441.1 
444.3-458 
782.4 
390-459 I00-I99 
Accidents E800-E929 
E940-E942 
E800-E929 V01-X59 
Y85-Y86 
Suicides E950-E959 E950-E959 X60-X84 
Y87.0 
Other violent 
deaths 
E930-939 
E960-989 
E930-958 
E960-989 
Y88-89 
 
 
Psychosocial factors  
Socio-demographic variables recorded were marital status, living conditions, country of origin 
according to place of birth or parental place of birth, occupational status and education 
(highest degree completed according to the Norwegian education system).  
Previous suicide attempts and psychiatric treatment (both current and former) were 
recorded, as reported by the patients. For former psychiatric treatment, the highest level of 
treatment was used in further analyses, i.e. psychiatric ward admission was rated higher than 
psychiatric outpatient treatment.  The patients were asked to report the frequency of their 
substance use, and what kind of substances they were using. 
 
Follow-up services 
The categories for referral were:  General Practitioner (GP), suicide prevention team, 
substance abuse treatment, psychiatric outpatient clinic, psychiatric ward (voluntarily or 
involuntarily), other arrangements, left hospital against medical advice and discharge without 
any plans for aftercare. More than one category could be offered each patient. 
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3.2.3 Chemical analyses (Paper II) 
Blood or urine samples were obtained from each patient, and frozen (-20 ° C) for later 
analyses. Analyses were performed at the Department of Clinical Chemistry, Ullevaal 
University Hospital.  
 Urine samples were analyzed for amphetamine, benzodiazepines, cannabis, cocaine 
and opiates using an immunologic assay. The samples were analyzed for ethanol using an 
enzymatic assay. Analysis of ecstasy in urine was based upon fluorescence polarization 
immunoassay (FPIA) and if above cut-off (250ng/mL), by gas chromatography with mass 
spectrometer (GC-MS) GHB was measured by a gas-chromatographic method with flame 
ionization detection (GC-FID) and a head-space-injector  
If the sample was positive for amphetamine, the cut-off value for ecstasy was set to 
250ng/mL and the sample was analysed using GC-MS. This method would specify the 
presence of amphetamine, methamphetamine, MDMA and/or MDA in the sample. With the 
exception of amphetamines, the initial screening was not confirmed by a second test. 
Serum analyses of benzodiazepines, cannabis, opiates and cocaine were performed as 
for urine, except for the reagents. Ethanol, GHB, amphetamine and ecstasy in serum was 
measured almost the same way as for urine; see paper II for further details. The immunologic 
methods gave semi-quantitative answers only. Although the chromatographic methods for 
amphetamine and ecstasy gave quantitative answers too, we only used qualitative results in 
the statistical analyses. The relative importance of each substance was therefore not evaluated.  
  
3.2.4 Statistical analyses 
The standardized registration forms were optically scanned and processed using TeleForm 
Desktop version 9.1 (TeleForm, Verity Inc., Sunnyvale, California) in paper I, III and VI. In 
paper II, IV and V the variables were plotted manually in SPSS (SPSS Inc., Chicago, IL, 
USA). In paper IV and V, data were analysed using programs for survival analysis and for 
Cox regression analysis in Stata (StataCorp 2003, Stata Statistical Software Release 8.0, Stata 
Corporation, College Station, TX, USA). For all other data analyses, SPSS version 12.01 – 
16.0 was used.  The level of statistical significance was set at p<0.05. 
 
Paper I, II and III  
Groups were compared using Pearson’s chi-square tests. In paper II, Cohen’s Kappa was used 
to measure agreement between clinical assessments and laboratory analyses. Kappa > 0.21 
was considered fair, > 0.41 was considered moderate and >0.61 was considered good (77). 
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Kappa = 1 indicates complete agreement. Logistic regression analyses were used to adjust for 
independent variables in paper III. All comparisons with the former study from 1980 (70;71) 
were corrected for this difference by excluding accidental non-self-poisonings in the 
calculations. 
 
Paper IV and V  
The mortality in the cohort was compared to the mortality in the general population, with 
reference rates according to age and gender.  Person-time under observation, categorized by 
five-year calendar periods and five-year age groups (15–19, 20–24, etc.), was obtained for 
each gender. Mortality rates in the general population for the same cross-classification served 
as reference rates. Expected death was computed by multiplying the observed person-time in 
the cohort by the reference rate. Standardized mortality ratios (SMRs) were computed by 
taking the ratio of observed to expected deaths. The mortality ratios were adjusted for age 
changing in the cohort over time. 
 For SMRs, the 95% confidence intervals (95% CI) were computed, based on the 
assumption that observed deaths follow the Poisson distribution. In the analysis of total 
mortality, attained age was chosen as the time variable. In the analysis of suicide, time since 
discharge was used as the time variable. Univariate analysis was performed first, followed by 
multivariate analysis, which included all variables with P < 0.15 in the univariate analysis.  
 In Paper IV, predictors for death and for suicide were found using Cox regression 
analyses.  
 
Paper VI 
To compare agreement between the doctor’s and the patient’s evaluation of intention, Cohen’s 
Kappa was used (see paper II). Multinomial regression analyses were used to compare the 
groups according to psychosocial factors, with the physician’s evaluation of intention as the 
dependent variable. Suicide attempt was used as the reference category. Multinomial analyses 
included all variables with p≤0.02 in the crude analyses. 
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4. SUMMARY OF RESULTS 
 
4.1 Paper I 
Hovda KE, Bjornaas MA, Skog K, Opdahl A, Drottning P, Ekeberg O, Jacobsen D.  
Acute poisonings treated in hospitals in Oslo: A one-year prospective study (I): Pattern 
of poisoning.  
Clin Toxicol. 2008; 46:35-41. 
 
This paper presents the results from a prospective cross-sectional multi-centre study of all 
adult patients (16 years or older) hospitalized in Oslo with a main diagnosis of acute 
poisoning, irrespective of intention, over a one-year period (n=947, 54% females, median age 
36 years). 
 
The aims of this paper were to study:  
 The incidence of hospital treated acute poisonings during one year  
 The patterns of toxic agents according to age and gender 
 The intention behind the poisoning according to gender and toxic agents 
 
There were 947 (31 %) hospitalizations; annual incidence 1.9 (per 1,000) in males and 2.1 in 
females. Benzodiazepines (18%), ethanol (17%), paracetamol (12%), opioids (7%), and 
gamma hydroxybutyric acid (GHB) (7%) were most frequently taken. Males drank more often 
ethanol (p=0.008) and used more illicit drugs (opioids: p<0.001, GHB: p<0.001, 
amphetamine: p=0.046, and cocaine: p=0.013), while females tended to use more prescription 
(and over-the counter, i.e., paracetamol) drugs (benzodiazepines: p=0.012, paracetamol: 
p<0.001, neuroleptics: p=0.024, zopiclone: p=0.012, and anti-epileptics: p=0.02). Overall, 
physicians defined 10% as a definite and 25% as a possible suicidal attempt (total 35%). 
Females were statistically significantly more often evaluated to have taken the drugs in a 
definite or possible suicidal attempt, or it was considered done as an appeal for help. Males 
were more often classified to have done it for intoxication purposes. The different intentions 
were also reflected by the differences in main agents taken, where suicide attempters more 
often used prescribed medications.  
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4.2 Paper II 
Bjornaas MA, Hovda KE, Mikalsen H, Andrew E, Rudberg, N, Ekeberg O, Jacobsen D. 
Clinical versus laboratory identification of drugs of abuse in patients admitted for acute 
poisoning.  
Clin Toxicol 2006;44: 127-134  
 
This paper presents the results from a prospective cross-sectional study of all acute poisonings 
treated at the Department of Acute Medicine, Ullevaal University Hospital, during one year in 
2001 (n= 405, 52% males, median age 31 years). The focus of the study was drugs of abuse, 
which was defined as ethanol, benzodiazepines, opiates, cannabis, amphetamine, GHB, 
cocaine and ecstasy. Both an evaluation form and a blood or urine sample were needed to 
compare the results, and therefore 320 (79%) of the cases were included in the analyses.  
 
The aims of the study were:  
 To assess the pattern of drugs of abuse according to age and gender 
 To evaluate the concordance between the clinical assessments (including patient 
history) by the physicians on duty and the drug analyses in these patients  
 
A total of 478 drugs of abuse were suspected and 621 were found. The most frequent toxic 
agents found were benzodiazepines (50%), ethanol (40%), opioids (35%), cannabis (24%) and 
amphetamine (21%). Ninety-two percent of all patients treated for acute poisonings had used 
drugs of abuse, irrespective of suicidal intention.  
 The agreement between the clinical assessments and the laboratory findings was best 
for GHB and ethanol (kappa=0.43) and for opiates (k=0.38). For benzodiazepines and 
cannabis, the concordance was poor (k=0.18 and 0.10, respectively). However, the correct 
clinical evaluation for these substances was 59% and 79%, respectively.  
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Paper III 
Heyerdahl F, Bjornaas MA, Hovda KE, Skog K, Opdahl A, Drottning P, Ekeberg O, Jacobsen 
D.  
Acute poisonings treated in hospital in Oslo: A one-year prospective study (II): Clinical 
outcome. 
Clin Toxicol  2008;46: 42-49. 
 
This paper presents the results from a prospective cross-sectional multi-centre study of all 
adult patients (16 years or older) hospitalized in Oslo with a main diagnosis of acute 
poisoning, irrespective of intention, over a one-year period (n=947, 54% females, median age 
36 years).  
 
The aims of this study were:  
 To register the level of consciousness, use of antidotes and other treatments, 
complications, and outcomes related to toxic agents, gender, age, and the intentions of 
the poisonings. 
 To study the impact on clinical outcome and treatment from the apparent changes in 
the toxicological panorama since 1980 
 
Of 947 admissions, 222 (23%) were comatose. Seventy-five percent received treatment 
besides observation; 39% received antidotes, increased from 21% in 1980, most frequently 
flumazenil (23%) and naloxone (14%). Complications were observed in 173 (18%), slightly 
reduced from 1980 (22%). Complication rates were highest for methanol (67%), 
cardiovascular drugs (55%), amphetamine (44%), and opioid (42%) poisonings. Ten (1.1%) 
died and six (0.6%) got permanent sequelae, of which seven and five were drug- or alcohol-
related, respectively. Although the overall mortality was low, and the median duration of the 
hospital stay was only one day, 40% of the patients were treated in the ICU. Drug- and 
alcohol-abuse related poisonings were most severe. 
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4.4 Paper IV 
Bjornaas MA, Jacobsen D, Haldorsen T, Ekeberg O.  
Mortality and causes of death after hospital-treated self-poisoning in Oslo: A 20-year 
follow-up. 
Clin Toxicol 2009;47: 116-23 
 
This paper presents the results from a prospective cohort study of all patients discharged after 
self-poisonings from all medical departments in Oslo in 1980, with a follow-up period of 20 
years (n=946, 51 % females, median age 31 years).  
 
The aims of this study were to determine:  
 The 20-year overall mortality rate for all patients admitted to medical departments for 
self-poisoning in Oslo in 1980 
 The mortality in the cohort compared with the general population of Norway 
 The causes of death 
 Factors that might differentiate those who died in the follow-up period from those who 
survived  
 Factors that might predict suicide or other causes of death. 
 
During follow-up 355 (37.5%) of the patients died. Among males, 45.3% died, and 30.2% of 
all females died. The SMRs were 4.6 (95% C.I., 4.2–5.1) in total, 5.0 (95% C.I., 4.3-5.7) for 
males, and 4.2 (95% C.I., 3.6–4.9) for females. After 15 years, the SMR was still 3.3 (95% C.I., 
2.5–4.2). Sixty-seven patients committed suicide; SMR 26.7 (95% C.I., 20.8–33.9). After 20 
years, 7.4% of all patients had died from cardiovascular diseases, 7.1% by suicide, 4.3% by 
accidents, 3.3% from cancer, 1.1% from other violent death, and 14.4% from other diseases.  
The risk of death from all causes was significantly higher during the entire follow-up period. 
The risk factors for death were not specific enough to identify those at special risk, and were  
male sex, a lower level of consciousness upon admission, substance abuse, and lower socio-
economic class. A suicidal motive upon admission was the only risk factor for suicide.  
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4.5 Paper V 
Bjornaas MA, Bekken AS, Ojlert A, Haldorsen T, Jacobsen D, Rostrup M, Ekeberg O.  
A 20-year prospective study of mortality and causes of death among hospitalized opioid 
addicts in Oslo. 
BMC Psychiatry 2008, 8:8 (13 February 2008). 
 
This paper presents the results from a prospective cohort study of 185 hospitalized opioid 
addicts either treated for self-poisonings in 1980 (n=93), voluntary detoxifications in 1980/81 
(n=75), or both (n=17). Median age at inclusion was 24 years, range 16-41, 53% males. These 
included admissions to all medical departments in Oslo. The cohort was followed for 20 
years.  
 
The aims of this study were:  
 To study mortality rate and causes of death among opioid addicts treated for self-
poisonings or voluntary detoxifications during a 20 year follow-up 
 To compare the mortality of the cohort with the general population 
 To investigate whether or not participation in a detoxification program can be 
protective 
 
During the follow-up period, 70 opiate addicts died (37.8 %), with a SMR equal to 23.6 (18.7-
29.9). The SMR remained high during the whole period, ranging from 32.4 in the first five-
year period, to 13.4 in the last five-year period. Among females, 23 (31.4%) died, whereas 47 
(48.5%) of all males died during follow-up. The registered causes of death were accidents 
(11.4%), suicide (7.1%), cancer (4.3%), cardiovascular disease (2.9%), other violent deaths 
(2.9%), other diseases (71.4%). Among the 50 deaths classified as other diseases, the category 
"drug dependence" was listed in the vast majority of cases (37 deaths, 52.9% of the total). The 
risk of death was significantly higher for all causes of death compared to the general 
population. There were no significant differences in SMR between self-poisonings and those 
admitted for voluntarily detoxification. 
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4.5 Paper VI 
Bjornaas MA, Hovda KE, Heyerdahl F, Ekeberg O, Skog K, Drottning P, Opdahl A, Jacobsen 
D.  
Suicidal intention, psychosocial factors and referral to further treatment – a one year 
cross-sectional study of self-poisonings.  
Submitted.  
 
This paper presents the results of a cross-sectional multi-centre study of 908 self-poisonings 
treated in medical departments in Oslo during one year. Accidental non-self-poisonings were 
excluded. There were 54% females, median age was 36 years. Multinomial regression 
analyses were used; suicide attempts were used as reference category.  
 
The aims of this study were:  
To study the socio-demographic and psychiatric characteristics of patients presenting with 
self-poisonings in the Emergency Departments in Oslo during one year:  
 How do the patients and the physicians evaluate the intention in each case?  
 How do these characteristics vary according to the evaluated intention?  
 What are the plans for follow-up of these patients at discharge? 
 
Overall, there were a good correlation between the patients and the physician’s evaluation of 
intention. According to the physicians, 37% were suicide attempts, 26% appeals and 38% 
were drug-related poisonings. Overall, patients showed a lack of social integration. In 
addition, more than half of the patients reported previous suicide attempts and 58% reported 
previous or current psychiatric treatment. Daily substance use was reported by a one third of 
all patients. Those who were males, younger than 30 years old, reporting substance use of any 
frequency or were living with their parents were more likely to be evaluated as drug-related 
poisonings than suicide attempters. Being from Asia, being temporarily on sick-leave or 
reporting previous suicide attempts and/or psychiatric treatment made it less likely to be 
evaluated as a drug-related poisoning.  Females were more likely to be evaluated as appeals, 
but in all other aspects there was no difference between appeals and suicide attempters. 
Almost one out of five patients was discharged without plans for follow-up, including 36% of 
drug-related poisonings. Among suicide attempters, 5% were discharged without such plans, 
as were 10% of appeals. 
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5. DISCUSSION  
This thesis includes a broad spectre of data for all patients treated for self-poisonings in Oslo, 
the capital of Norway. The papers presented give an overview of the epidemiology, substance 
use, psychosocial characteristics and prognosis of self-poisonings in Oslo. Six papers are 
included in the thesis in order to study the complexity of this patient group. Our main findings 
were that even today, ethanol and benzodiazepines remained the most common agents, and 
the substance use was substantial among all patients. The patient group showed a lack of 
social integration irrespective of intention. More than half of all patients reported previous 
suicide attempts and psychiatric treatment, although more among suicide attempters than 
drug-related poisonings. The short term prognosis in terms of mortality was good for 
hospitalized patients. However, the long-term prognosis showed a markedly increased 
mortality and risk of suicide for all subgroups. In this context, one out of five patients was 
discharged without plans for follow-up.   
A strength of the studies presented is that the whole city is included (except for paper 
II), and the inclusion period is one year. The inclusion of all patients presenting as self-
poisonings at the acute departments is quite uncommon in the field of suicidology, where 
different terms and inclusion criteria have been used to select subgroups of patients within the 
group of self-poisonings such as self-harm, medically serious suicide attempters, deliberate 
self-poisonings etc. (11;95;130). However, the inclusion of all self-poisonings, irrespective of 
intent, is in consistence with the treatment of the patients at the acute departments, as seen in 
paper III. This inclusion is also common in the field of toxicology. The patient group is 
therefore complex, and six papers are included in order to describe different aspects: 
epidemiology, substance use, psychosocial factors and prognosis for self-poisonings.  
Self-poisonings can be investigated by studying hospital figures and statistics, but   
due to the retrospective design these studies are inaccurate and tend to underestimate 
morbidity (18;53). The studies presented here were designed to ensure that patients were 
included consecutively, and the cohort studies were prospective. It is however possible that 
some cases were missed due to several collaborators in four different hospitals, both in 1980 
and 2003/04. Extensive follow-up of all participating hospitals were done to ensure that the 
number of possible missed cases was low.  
The exclusion of accidental non-self-poisonings in papers IV and VI were done to get 
a more homogenised material. These patients were not included in the main groups defined as 
suicide attempters, appeals and drug-related poisonings, and therefore not meaningful to study 
in the context of self-destructive behaviour. The slightly different inclusion criteria in the 
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studies included may therefore be seen as a weakness of the thesis. However, paper IV and VI 
included 98.3% and 95.9% of all acute poisonings respectively.  
The inclusion of all patients treated as self-poisonings in the acute departments in a 
whole city made it possible to generalize from the study population back to a well-defined 
background population. The epidemiological and clinical data presented in papers I and III 
may therefore be seen as representative for the city of Oslo at the time. The comparison 
between our study from 2003/04  and  the study by Jacobsen et al in 1980 was possible due to 
similar methodology (70;71). For paper II, only patients treated at Ullevaal University 
Hospital were included. The hospital covers an area including all social classes, and it 
represents a fairly good cross-section of the population of Oslo, but being a tertiary care 
centre means that severe poisonings are somewhat overrepresented. For paper IV and V, the 
SMRs were calculated based on mortality rates from Norway in general, not Oslo in 
particular. However, around 1980 the clustering of substance users was more extensive in 
Norway than today, and people moved from rural areas to Oslo where the drug market was 
more evolved. Thus, for opioid addicts, those treated at medical departments in Oslo could be 
seen as representing other parts of the country as well. As for self-poisonings in general, the 
comparison of these patients with mortality rates from the rest of the country could lead to a 
possible bias, slightly overestimating the increased mortality in the cohort.  
 In the following, the main findings of the thesis will be discussed in comparison with 
other studies.  
 
5.1 Incidence 
The annual incidence of hospitalization due to acute poisonings in 2003/04 in Oslo was 2.0 
per 1000; 1.9 in males and 2.1 in females (paper I). Eighty-seven percent of the patients were 
admitted once, whereas the rest had more than one admission. This included 947 admissions 
among 780 patients, compared to 1212 admissions among 1047 patients in 1980 (70). The 
annual incidence in 1980 was 2.7 per 1000. The reduction from 1980 was statistically 
significant (p<0.001), and the incidence decreased more for males (3.0-1.9 per 1000, p 
<0.001) than for females (2.5 – 2.1 per 1000, p=0.01).  
 The studies, although separated by 23 years, used the same inclusion criteria and 
methodology, and both studies covered the whole city of Oslo. Therefore, a comparison is 
valid. The reduction observed is probably partly due to the present treatment of most of the 
opioid overdoses on site (20), which has increased with the use of naloxone as an antidote. 
The exclusion of patients with other primary diagnoses, such as pneumonia, could have 
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excluded important acute poisonings from the present study. However, most of these patients 
would have their clinical course affected by the primary, non-poisoning diagnoses. Again, this 
was similar for the 1980 study.   
 The female dominance persisted, in accordance with other studies reporting 51-56% 
females (9;22). Compared to the 1980 study, the patients were somewhat older (median age 
36 years versus 31 years), probably partly because of the already mentioned pre-hospital 
treatment of the young opioid addicts (median age in paper V was 25 years). The age 
distribution observed fits another Norwegian study from Trondheim during 1978 to 2000 
(117), where the median age was 34.4 years. A Spanish study found a median age of 33 years 
(22), whereas patients were younger in Sri Lanka (median age 25 years), probably due to 
young people taking pesticides and a generally younger population (37). 
 
5.2 Pattern of toxic agents 
Benzodiazepines and ethanol were the main toxic agents in 2003/04, suspected in 18% and 
17% of the cases, respectively (paper I). Not differing between main and additional agents, 
benzodiazepines and ethanol were the drugs of abuse most frequently found by laboratory 
analyses in paper II as well; in 50% and 40% of all cases, respectively. They were also the 
most frequently suspected agents in paper II, but the agreement between suspected and found 
agents for each case was inaccurate, with kappa 0.18 for benzodiazepines and kappa 0.43 for 
ethanol.  
 The clinical evaluation of toxic agents is difficult, and although routine drug analyses 
were available for the physicians in paper I, these only included ethanol, benzodiazepines, 
salicylate and paracetamol. Clinical assessments alone are known to be inaccurate  (103). 
However, Rygnestad et al found a concordance of 86 to 96% when combining results from 
routine screening and clinical evaluation of the patients (116). The findings are therefore 
considered valid. The treatment of self-poisonings is mainly symptomatic (paper III), with the 
exception of the use of antidotes, and it may be argued that an accurate diagnosis regarding 
toxic agents is not necessary in the acute setting. However, the use of antidotes were extensive 
in the 2003/04 study (paper III), where 39% of all patients received such agents. The 
corresponding figures in 1980 were 21%, despite the fact that opioid addicts now are mainly 
treated on site. Flumazenil may cause seizures (81), and allergic reactions are reported in 
patients treated with NAC intravenously (30). Therefore, an accurate application of antidote is 
preferable, which in turn relies upon a precise diagnosis regarding toxic agents.  
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 The higher number of found than suspected cases in paper II may be caused in part by 
the physicians focusing mainly on the main agents, while the laboratory analyses detected 
most agents. The results from routine laboratory analyses were not available to them as they 
were in the 2003/04 study, which may have contributed to higher discrepancies. The relative 
importance of each agent was not evaluated, as only qualitative answers were used for further 
analyses. Some of the agents had long half-lives such as cannabis (42), whereas other had 
short half-lives, for example GHB and ethanol, and may not be detected up to 24 hours. The 
eventual therapeutic use of some substances (benzodiazepines, opiates) was not taken into 
account. However, even therapeutic use needs to be taken into account when evaluating 
patients treated for self-poisonings. Therefore, the evaluation of agreement in paper II was 
considered representative.  
 Benzodiazepines and ethanol were followed by paracetamol (12%), opioids (7%) and 
GHB (7%) as the most frequently suspected main agents in paper I. In paper II, which focused 
on drugs of abuse, opiates were identified in 35% of the cases and GHB in 12%. 
Amphetamine was found in 21% of all cases in paper II, but was only suspected in 5% in 
paper I, including both main and additional agents. The difference was seen in spite of the fact 
that both papers included all acute poisonings, although paper II focused solely on drugs of 
abuse in further analyses. In paper VI, 4% of all patients reported a daily use of amphetamine. 
Compared to 1980, benzodiazepines and ethanol were the main agents in 18% and 20% of the 
cases, respectively, corresponding to our findings in 2003/04. In 1980, these agents were 
followed by opioids (15%), neuroleptics (11%) and antidepressants (10%). Paracetamol 
becoming more frequent and opioids becoming less frequent corresponds to other reports 
(9;130). As mentioned before, the pre-hospital treatment of opioid addicts contributes to the 
reduction of opioid poisonings (20). The frequency of suspected GHB poisoning (7% in paper 
I) was twice the number found in a Spanish study (85), but lower than the figures in paper II 
(GHB found in 12% of the cases). However, the relative importance of GHB in each case 
found in paper II is not known. Nevertheless, the relatively high percentage seen in paper I 
could be an underestimate rather than an overestimate, when consulting the findings of paper 
II. Since 1980, SSRI’s have become extensively used (119), and this can probably explain 
why TCA’s were only seen in 2% of the cases in 2003/04.  
 There were gender differences in the pattern of toxic agents used, as males tended to 
use more illegal substances and alcohol, while females used more prescription drugs (paper I). 
This was in accordance with findings in the 1980 study, as well as other studies regarding 
paracetamol and opioids for example (9;130). Paracetamol mainly dominated among the 
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younger patients, whereas antidepressants and tranquilizers were more commonly seen among 
the elderly, in correspondence with other studies (9;130).  
 
5.3 Substance use 
In Paper II, 92% of all patients had used one or more drugs of abuse prior to admission to 
hospital, irrespective of intention. Physicians tended to underestimate the use of these 
substances, as there were 30% more agents found in the laboratory analyses than suspected 
clinically. In paper VI, 37% of all patients reported daily substance use. Not surprisingly, 
those treated for drug-related poisonings reported more (48%). However, the daily substance 
use was quite substantial even among suicide attempters and appeals, with 35% and 25% 
respectively. Ethanol and prescribed drugs (such as benzodiazepines) were most commonly 
used (by 52% and 51% of the daily users, respectively).  
 Clinical assessments alone did not uncover all substances administrated in paper II. 
The physicians may, however, have focused mainly on the main toxic agents, whereas drugs 
of abuse were frequently additional agents. As only the presence of each substance was 
evaluated, not the relative importance, this may have contributed to the underestimation. 
However, the physicians were aware of the ongoing study and may have recorded more 
substances than they normally would have suspected, reflecting a possible information bias. 
They were, however, not aware that drugs of abuse were the main purpose of the study. In 
paper I, ethanol and benzodiazepines were the most frequently suspected main agents, closely 
followed by opioids and GHB. This emphasises the importance of drugs of abuse in these 
patients. The results are therefore considered representative.  
 The validity of self-reported substance use has been questioned. A study of 
adolescents treated for substance use disorders found that both underestimation and 
overestimation of substance use was quite common (133). This is probably also true for 
patients treated for self-poisonings reporting their substance use. In addition, patients may be 
reluctant to report the use of illicit drugs (such as heroin, cocaine, amphetamine, ecstasy, 
GHB). In the study from 2003/04, the patient’s self-reported substance use was not confirmed 
by laboratory analyses, and the validity of the reports was therefore not evaluated. Due to the 
high figures of drugs of abuse found in paper II, and the recognition of  substance use as a risk 
factor for  suicide attempt (55) and vice versa (63), the self-reported substance use in paper VI 
seems relevant.  
 Amphetamine was surprisingly common (paper II), and were found in one fifth of all 
cases. Amphetamine was detected about twice as often as GHB in all age groups. Even 8% of 
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patients older than 50 years old had positive tests for amphetamine. The use of  amphetamine 
seems to have increased since the 1980s, where Taylor et al found the drug in only 2% of 
patients (129), corresponding to 1.8% found in the 1980 study by Jacobsen et al. In paper I, 
amphetamine was suspected in 5% of the cases, but this was not confirmed by laboratory 
analyses. However, this was an increase compared to the 1980 study. The presence of 
ephedrine from cold remedies cannot be distinguished from drug abuse and may have 
contributed to some cases, but the difference between suspected and found cases of 
amphetamine cannot be fully explained by this. The self-report of substance use in paper VI 
suggests that 4% of all patients use amphetamine on a daily basis. Among drug-related 
poisonings, 12% used amphetamine, 5% daily. Among suicide attempters, 4% reported a 
daily use of amphetamine. There is a marked difference between the prevalence of 
amphetamine in paper I and II, indicating that this “old” drug of abuse is more commonly 
used than suspected clinically.  
 One out of three patients had positive findings for opioids in paper II, and 43% of 
patients older than 50 years had traces of opioids in blood or urine. Opioids were considered 
the main agent in 7% of the cases in paper I. When including additional agents, opioids were 
suspected in 17% of all cases.  Although opioids can be misused as drugs of abuse, they are 
not illicit per se. The high number of cases is therefore not necessarily an indication of abuse. 
It was not possible to make a distinction between therapeutic use and drug abuse in the 
laboratory analyses. Popular painkillers containing codeine is the most likely explanation. 
Skelton et al found that codeine accounted for 63% of all opiate-positive samples (120). 
However, even therapeutic use needs to be taken into account in the treatment of self-
poisonings. There can even be a fine balance between use and misuse for prescribed opioids. 
The percentage of opioids as the main toxic agents in the 1980 study was 15%, a reduction 
probably caused by the current onsite treatment of overdoses (20), and not a reduction in the 
use of opioids as drugs for substance use.  
GHB was considered the main toxic agent in 7% of all self-poisonings in paper I. This 
is a quite new drug, and was therefore not used in 1980. The concordance between suspected 
and found agents was rather good for GHB, kappa 0.43, possibly due to recognition of the 
“toxidrome” of this drug: a combination of bradycardia, hypotension and a state of 
consciousness varying between coma and agitation in the same patient (78). GHB were more 
frequently seen among the young, but were seen in 8% of those aged 50 or older as well. The 
emerging use of this drug may be seen as an indicator of its availability; the patients using 
whatever drugs are at hand.  
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The polydrug use in 60% of all hospitalized patients in paper II and the recognition of 
nine out of ten patients testing positive for drugs of abuse, indicates a substantial substance 
use in the patient population. Addressing the substance use in these patients is important both 
in the acute treatment, as a basis for the use of antidotes (paper III), but also for detecting 
patients in need of substance use treatment in (paper VI). Emergency departments can be 
important venues for detecting the need of such treatment (110).  
 
5.4 Psychosocial characteristics of self-poisonings 
Paper VI demonstrated a lack of social integration and a high proportion of previous suicide 
attempts and substance use among self-poisonings in all subgroups based on intention. Only 
one third of the patients were employed, one third was married and more than half of all 
patients were living alone. More than half of the patients reported previous suicide attempts 
and 37% daily substance use.  
 The patients were grouped according to intention as assessed by the physician. No 
forms or scales were used, and thus the inter-rater variability was not evaluated. The same 
method was used in paper IV. This method resembles how patients are evaluated at the 
emergency departments in everyday practice, and was therefore considered clinically relevant. 
The same argument may be used for the self-reported data on psychosocial characteristics: the 
validity of the answers remains unknown, but the situation is similar to the clinical setting.   
The lack of social integration is known from studies of suicide attempters as an 
important risk factor for suicidal behaviour (16;36;90;92). It is therefore interesting that socio-
demographic factors did not vary more between the intentional groups: education and marital 
status had no impact. Those being on sick leave were more likely to be evaluated as suicide 
attempters, whereas those living with parents were more likely to be evaluated as a drug-
related poisonings. Social isolation as a risk factor for suicidal behaviour may be associated to 
the increased risk of suicide for self-poisonings in general (paper IV). The risk was increased 
not only for suicide attempters and substance abusers including opioid addicts (paper V), but 
for patients neither suicidal nor substance abusers as well. The lack of social integration has 
also been found to be a risk factor for increased mortality in a sample of healthy employees 
(14). The increased mortality for self-poisonings may therefore be related to this factor as 
well.  
A previous suicide attempt is the strongest known predictor for suicide (54) and 
further suicidal behaviour. The higher proportion reporting previous suicide attempts among 
the present suicide attempters corresponds to this (paper VI), as well as the increased suicide 
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risk among suicide attempters during 20 years (paper IV). Substance abuse is the second most 
frequent precursor to suicide (88), and 37% of all patients reported daily substance use. The 
importance of this risk factor must be recognized when treating self-poisonings, since so 
many patients report substance use. Moreover, the figures are probably an underestimate, 
since 30% more drugs of abuse were found than suspected in paper II.  
Appeals and suicide attempters did only differ in the gender distribution, as females 
were more likely to be evaluated as appeals than suicide attempters. For all other psychosocial 
characteristics, the groups were similar. The difference in evaluated intention probably means 
that the suicide attempters were in a deeper crisis at time of admission. Medically serious 
suicide attempts are at higher risk and use different substances (11;130). However, the 
proportion of risk factors for suicidal behaviour among appeals might explain some of the 
increased long-term mortality and risk of suicide among non-suicidal patients in paper IV, and 
the follow-up of patients classified as appeals must take this into account.  
One third of all drug-related poisonings had previous suicide attempts and one third of 
suicide attempters reported daily substance use. The subgroups were therefore overlapping. 
This corresponds to a study of repetitions among the same cohort of self-poisonings from 
2003/04, which found that for 24% of the repeaters of self-poisonings, the evaluated intention 
changed during one year (69).  
 
5.5 Short-term prognosis  
The short-term prognosis was good for hospitalized patients, the in-hospital mortality being 
1.1% in the 2003/04 study (paper III). There were 0.8% of patients who were discharged with 
permanent sequelae.  
 The mortality in the 1980 study was 0.5%, but the increase was not statistically 
significant. Our samples were not large enough to detect even a substantial change in 
mortality, given the low numbers of in-hospital mortality, and hence the number of cases 
needed for the power of the study. 
The mortality observed resembles a Finnish study from 1992, where the in-hospital 
mortality was 0.7%. A study from Zimbabwe found a mortality of 4.4%, reflecting the high 
number of pesticide poisonings in developing countries (128). In our study, three deaths 
resulted from opioids, two from ethanol and in two cases benzodiazepines were the main 
agents.  Methanol, paracetamol and cocaine poisoning resulted in one death each. It is worth 
emphasizing that even such common agents as ethanol and benzodiazepines can result in fatal 
poisonings. Recent studies from Belgium found that three out of ten fatal poisonings were due 
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to benzodiazepines (19). Few studies supports similar high numbers, but the cause of death 
may often be diagnosed as the respiratory complications, such as aspiration pneumonia, rather 
than the actual poisoning. The number of lethal cases may therefore be underestimated.  
 Although the in-hospital mortality was low, 99 persons died of fatal poisoning outside 
hospital as well (paper I), i.e. 91% of all deaths in the study period. These patients were not 
included in the figures presented here, but must be taken into account when discussing the 
short-term mortality of self-poisonings. A study of the Norwegian Patient Register and the 
Norwegian Causes of Death Register from 1999 to 2004 by Lilleeng et al, found that 80% of 
deaths by acute poisoning occurred outside hospital (79). The mortality of self-poisonings is 
therefore higher than the in-hospital mortality. However, based on these registers, Lilleeng et 
al estimated the mortality rate in hospital to 0.8%, slightly less than in our study. It is possible 
that the figures for Oslo are somewhat higher than for the country in general, due to clustering 
of substance use in urban areas as a consequence of availability.  
 For those who survived with permanent sequelae, anoxic brain damage was most 
common (paper III). This was observed in 0.6% of the cases, the corresponding figures in 
1980 was 0.1%. The increase may be attributed to more extensive intensive care treatment 
during the last decades, i.e. more severe poisonings survive, but the figures are too small to be 
statistically significant.  
 
5.6 Long-term prognosis 
The long-term prognosis for this patient group was rather poor. During 20 years 37.5% of the 
patients treated for self-poisonings in Oslo in 1980 died (paper IV). The mortality was 4.6 
times higher than expected, compared to the general population. For opioid addicts, 37.8% 
were dead during 20 years of follow-up, the mortality being 23.6 times higher than expected 
according to age distribution.  
 The physician on duty, i.e. at the acute departments, classified the patients according 
to suicidal motive and substance abuse. The classification was based on clinical evaluation, 
including patient records, information from companions and from the patients themselves. No 
scales or forms were used. The criteria for being classified as a suicide attempt was rather 
strict and tried to rule out cases considered to be solely an appeal, i.e. where there was no 
serious wish to die. For substance abusers, the classification was based upon all information 
available, with reference to the ICD criteria. However, this was a subjective measure, and the 
inter-rater reliability was unknown. The lack of standardization may be seen as a weakness of 
the studies. However, the approach reflects how the assessments are done in the clinical 
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setting, and is relevant as the physicians are important gatekeepers for referral to further 
psychiatric evaluation.  As discussed in paragraph 5.4, the method allowed us to generalize 
our findings back to clinical practise. The method turned out to be clinically relevant, as those 
considered to be suicidal at admission had an increased risk of suicide, corresponding to other 
studies (11;125). Also, in paper VI, the agreement between the evaluation made by patients 
and physicians was found to be good (kappa 0.68).    
 The causes of death were obtained from Statistics Norway. Although the validity of 
these data regarding suicides was satisfactory in 1985 (40), the autopsy rate in Norway has 
declined since then (13). Therefore, the accuracy of death certificates is probably less valid, 
and our numbers regarding suicides must be considered a minimum.  
 The high mortality of patients treated for self-poisonings was observed in a rather 
young cohort; median age in 1980 was 31 years. The SMR remained increased for the whole 
period, indicating that admission for self-poisoning is a serious predictor for increased risk of 
death not only through an immediate crisis or illness, but is a marker of increased risk at least 
for 20 years. Suominen et al found an increased risk of suicide even after 37 years in a cohort 
of suicide attempters (125). A suicidal motive upon admission was not associated with 
increased mortality during the period, as SMR for the suicide attempters was 3.4. Increased 
mortality for suicide attempters has  been found in other studies (94), but in a group of 
patients with self-poisonings, a suicidal motive had no additional effect on mortality in 
general. For those classified as substance abusers, the SMR was 7.3 (paper IV). However, for 
opioid addicts, the SMR was 23.6 (paper V). The mortality in the 1980 cohort versus the 
cohort of opioid addicts was rather similar (37.5% versus 37.8%), but the median age was 
only 24 years among opioid addicts and thus, the estimated number of death was lower. The 
high SMR found among this subgroup of self-poisonings corresponds to other European 
studies (6).  
Even for patients considered to be neither suicidal nor substance abusers the risk of 
death was increased, with a SMR of 2.6 (paper IV). The risk was increased for all causes of 
death. This indicates that identifying subgroups of self-poisonings at risk of death and 
completing suicide, does not capture all individuals at risk.  It might be more meaningful to 
consider all patients with self-poisonings to be at risk.  
 In paper V, mortality did not change from referral to voluntary detoxification. 
Unfortunately, information about compliance for each patient was not known, and we don’t 
know who achieved abstinence or not. Those who were admitted to voluntary detoxification 
may also have been in a poor medical and physical state, as this was one of the criteria for 
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admittance. These patients were generally not motivated for the treatment required to achieve 
abstinence. Other studies indicate that achieving abstinence reduces mortality, although the 
mortality rate is still increased compared to the general population (122).  
The risk of death was significantly increased for all causes, both for self-poisonings in 
general and opioid addicts in particular. The increased risk of death, even from natural causes, 
is consistent with the increased mortality associated with mental disorders (55). Drug 
dependence was the underlying cause of death in 53% of all deaths among opioid addicts 
(paper V), and in 13% of all deaths among substance abusers in general (paper IV). Although 
the death of unintentional overdoses was of major concern in these patients, there is no 
category literally equivalent to this term in the ICD system. Therefore, drug dependence as 
the underlying cause of death was included in the group called other diseases when computing 
the SMRs. This was done to obtain the same categories as used by Statistics Norway. The 
SMR for this single cause of death was not calculated. These figures would have provided 
minimal additional information. If drug dependence is a chronic disease, a symptom of which 
is opioid addiction, one would expect that only those suffering from the disease would die 
from it; that is, there would be a low number of death in the general population. Even when 
all other diseases were included in the general population, death from drug dependence 
outnumbered the total number of deaths from all other diseases.  
 
5.7 The risk of suicide 
The suicide rate, like the mortality rate, remained high for the entire follow-up period in paper 
IV. The SMR for suicide was 26.7 for all self-poisonings. The suicide risk was highest the 
first two years after the index episode, but after five years there was no further decline. Even 
in the last five year period, the suicide risk was increased 23.4 times. The continuing risk of 
suicide is consistent with the life time risk after suicide attempts reported by Suominen et al in 
Finland (125).  
 The risk of suicide was increased for opioid addicts as well (paper V). The SMR was 
10.7 for opioid addicts, whereas the SMR for substance abusers in general (paper IV) was 
21.5. The difference here may be due to the smaller cohort in paper V, meaning that the 
figures have broader confidence interval, i.e. they are less accurate. However, this could also 
be attributed to the increased overall mortality in this subgroup (23.4 times vs. 7.3), where 
more opioid addicts would die of other causes such as drug dependence. Those who take the 
highest risks will probably die early. It has been shown that the number of active drug addicts 
declines mainly from death, rather than from long-term abstinence (52).  
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 For suicide attempters, the risk of suicide was increased 64.1 times. A former suicide 
attempt is the strongest known risk factor for completing suicide (54), and our finding is 
consistent with this. But the SMR for suicide was increased even for patients considered 
neither suicidal nor substance abusers (SMR 22.9, paper IV). Since both suicide attempters 
and substance users are known risk groups for suicidal behaviour, it would be indicated to 
focus on these subgroups in a population of self-poisonings when planning further referral to 
follow-up services. However, our finding indicates that focusing on these subgroups does not 
capture all patients at increased risk. This could be because their ideation was either missed or 
inadequately investigated, or because the burden of mental illnesses including personality 
disorders was higher among these patients than for the general population. However, this also 
reflects the variability in the wish to die for suicidal patients, complicating the evaluation of 
intention. Even acts of appeal (i.e. not evaluated as having a wish to die in the initial episode) 
have increased risk of suicide. Clinicians may underestimate the seriousness of such acts. Our 
findings suggest that a substantial number of such patients will in time complete suicide, and 
their suicidal behaviour calls for more systematic follow-up of these patients.  
 
5.8 Predictors of death and suicide 
Male gender, lower socio-economic class, substance abuse and a lower level of consciousness 
at admission were all independent predictors of death among self-poisonings (paper IV). 
Suicidal intent was the only independent predictor of suicide during the 20-year follow-up 
period. 
 The clinical variables were obtained in a cross sectional study from 1980 (70;71), and 
the  classification of suicidal intent, socioeconomic class and substance abuse was done by the 
physician on duty. However, the inter-rater variability was not evaluated. The lack of 
standardization may be questioned, but the method reflects the way evaluations are made in 
clinical setting. The assessments turned out to be clinically relevant.  
 Mortality rates for males are generally higher for males than for females10, and our 
findings correspond to this. Accordingly, the difference in SMRs between genders was not 
statistically significant. The lack of gender differences were also seen in studies of homeless 
people with drug addiction (25). Other studies of drug addicts have found higher SMRs for 
either males (49;97) or females (7;55). The diversity of findings may be due to different 
inclusion criteria. Our sample of hospitalized opioid addicts may have been more prone to 
                                                          
10 http://www.ssb.no/emner/02/nos_befolkning/nos_c607/tab/t-501.html 
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accidental poisoning, and such incidents are perhaps less correlated to gender than 
behavioural traits, such as the pattern of drug use.  
 Cause-specific mortality is known to be related to socio-economic class; for 
cardiovascular diseases (83), cancer (134) and suicide (61), mortality rates are higher for 
lower socio-economic classes. This is generally reflected in overall mortality rates. Our 
findings correspond to this. Drug abuse as a predictor of increased mortality was confirmed in 
paper V, as the risk of death among opioid addicts was higher than for self-poisonings in 
general. In paper III, drug-related poisonings led to coma more frequently than other 
poisonings. Lower level of consciousness at admission may be a marker of a more serious 
poisoning, i.e. a more serious suicide attempt or a more serious overdose.  
Interestingly, suicidal intent was not a predictor for death among self-poisonings. 
Suicide attempters are known to have increased mortality even from natural causes (104). But 
being suicidal gave no additional effect on mortality figures for self-poisonings in general. 
However, suicidal intent was an independent predictor of suicide, in concordance with other 
studies (54). Male gender, substance abuse and lower socio-economic class are well-known 
risk factors for suicide (109), but were not independent risk factors for suicide among self-
poisonings.  
 
5.9 Referral to follow-up 
Almost one out of five patients treated for self-poisonings in 2003/04 were discharged without 
any plans for follow-up, even when excluding those who left hospital against medical advice 
(paper VI). Those evaluated as suicide attempters had plans for follow-up in 93% of the cases, 
whereas drug-related poisonings had no plans in 36% of the cases.  
 Unfortunately, there was no information in this study about whether or not the patients 
did actually receive the treatment planned, nor if they chose not to accept the treatment 
offered. However, the information, although scarce, was useful, since one can hardly hope 
that patients receive more treatment than what is planned at discharge. A study of suicide 
attempters found that compliance was better when plans for follow-up were made before 
discharge (50). Furthermore, the inclusion of all self-poisonings made comparison between 
subgroups possible. Traditionally, studies have focused on the follow-up of subgroups such as 
suicide attempters (127) or acute opioid overdoses (26). Different approaches are probably 
needed for different subgroups, but the number of patients discharged without any follow-up 
seems too large in the context of the high mortality found in paper IV and V.  
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 Among suicide attempters 38% were admitted to a psychiatric ward, 20% 
involuntarily. In a Swedish study from 1994, 57% of suicide attempters were admitted to 
psychiatric in-patient care (114), but since then the use of outpatient care has increased in 
psychiatry as well as in other parts of the health care services. However, 5% of suicide 
attempters in paper VI were discharged without any plans for aftercare. Suominen et al 
concluded in a study from 1998 that few suicide attempters with major depression receive 
adequate treatment prior to the attempt, but surprisingly, the treatment situation was not 
necessarily any better after the attempt (126). The 64-fold increased risk of suicide among 
suicide attempters found in paper IV indicates that the follow-up of these patients is of major 
importance.  
 Only 10% of drug-related poisonings were referred to substance use treatment 
(institution or outpatient care). The low proportion of drug-related poisonings who were 
referred to follow-up corresponds to a study of patients treated for an acute opioid overdose, 
finding that 67% of the patients were not referred to substance use treatment (26). Although 
our study includes a broader spectre of substance users, and therefore the treatment need may 
vary, paper IV found that substance abuse was an independent risk factor for increased 
mortality. Furthermore, the 24-fold increased mortality of opioid addicts in paper V was 
higher than for suicide attempters, where the risk of death was increased 3.4 times. However, 
there was no difference in mortality between those admitted for voluntary detoxifications and 
those treated for self-poisonings among opioid addicts in paper V. Unfortunately we do not 
know whether or not they completed the treatment. Sorensen et al found in a 15-year follow 
up that abstinence gave lower mortality rates than continuing drug addiction, although 
mortality was still increased compared to the general population (122). Thus, the referral to 
further treatment seems justified. The motivation for further treatment among many drug 
abusers may be moderate or low, but the serious prognosis calls for motivational work by 
professionals who may have contact with them, e.g. general practitioners or social workers. 
 Patients with appeals were referred to psychiatric outpatient treatment in 47% of the 
cases, and admitted to a psychiatric ward in 15% of the cases. Ten percent were discharged 
without plans for follow-up. On group level the patients were treated at lower level in the 
health care services compared to suicide attempters, probably related to the lower perceived 
risk of suicide in the short term. However, the appeals and the suicide attempters differed only 
in gender distribution when comparing psychosocial factors. Surprisingly, the appeals 
reported previous suicide attempts and psychiatric treatment to the same extent as suicide 
attempters. This corresponds to the increased risk of suicide even among patients considered 
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to be neither suicidal nor substance abusers found in paper IV. If intention is given too much 
weight, physicians may be tempted to underestimate the increased mortality risk for these 
patients. The treatment offered may not be sufficient.   
 Overall, the studies regarding the follow-up of self-poisonings are few and generally 
too small, even for subgroups. Little is known about the effectiveness of different types of 
physical and psychosocial treatment of self-harm (64). However, this must not be an excuse 
for not trying to establish proper aftercare for these patients in the clinical setting, as long as 
their risk for suicide and increased mortality is well established. 
  
5.10 Self-poisonings as a high risk group 
According to Amsel and Mann (4), the importance of identifying a risk group is the 
opportunity for a more targeted prevention strategy. The hypothesis that patients treated for 
self-poisonings are a high risk group for suicidal behaviour and increased mortality in the 
long term was investigated in paper IV and V. Not only suicide risk, but death by all causes 
was increased for patients treated for self-poisonings. All subgroups were at increased risk 
compared to the general population.  
Traditionally, the patients included in this thesis are viewed as risk groups according 
to intention. To determine the correct intention can be problematic in patients presenting with 
self-poisonings, as a substantial number of patients are comatose on admission (paper III), and 
tend to under-report the use of drugs of abuse (paper II). Acts of appeals are in many cases not 
related to a wish to die (i.e., not a suicide attempt), but the communicative aspect of the act is 
substantial (108). Nor is hospitalization because of substance use to be seen as a suicide 
attempt, but like appeals, it can be seen as a mark of self-destructive behaviour (45). 
However, the fact that the patients classified as neither suicidal nor substance abusers still had 
increased risk for both death in general and suicide in particular, is an argument for 
considering all self-poisonings as a high risk group. Not revealing the patients’ true intention 
or substance use behaviour may be argued as a reason for misclassification. However, paper 
VI shows that risk factors used in the evaluation of suicidality are overlapping for different 
intentional groups.  
  All self-poisonings must be considered a high risk group in terms of increased 
mortality and suicide risk over time. The term self-poisoning is useful in the emergency 
departments, where the patient group is easy to identify. This is clinically relevant for referral 
to further treatment. Paper VI shows that a substantial number of patients are discharged 
without plans for further aftercare. This may not be sufficient, as long as their prognosis on 
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group level in the long term is rather poor. In the Emergency Departments, focus will usually 
be on treatment of the actual poisoning episode, focusing on short-term mortality, whereas 
mortality in the long-term is of secondary importance. Furthermore, this patient group may 
not be regarded as highly as for example those treated for acute myocardial infarction, a 
disease which tends to affect patients in more prominent positions in the society. The follow-
up of patients treated for self-poisonings often seems casual, not structured and well-funded in 
clinical trials such as the follow-up of those treated for myocardial infarctions or cancer, 
patient groups which also have an increased mortality in the long term. Patients treated for 
self-poisonings may not be motivated for further treatment. They may not accept the 
treatment offered, which makes it hard to establish proper aftercare. But do we focus enough 
on increasing the patient’s motivation, or identifying his or her perceived needs? This is a 
major challenge in the treatment of self-poisonings.  
 
 
In order truly to help someone else, I must understand more than he–but certainly first and 
foremost understand what he understands.   
Søren Kierkegaard  
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6. CLINICAL IMPLICATIONS 
Knowing the pattern of toxic agents used among patients treated for self-poisonings is useful 
in the clinical setting, as acute treatment is based upon clinical evaluation rather than 
laboratory analyses because of the delay before these results become available. Suspecting the 
correct toxic agents means a more precise use of antidotes and better supportive treatment. 
This thesis demonstrated that the most common substances taken are also the most common 
toxic agents used for self-poisoning (Papers I and VI). Ethanol and benzodiazepines, which 
were found among half of all patients (Paper II), must always be taken into account. Four out 
of 10 patients who died had taken ethanol and benzodiazepines, which emphasizes that these 
common agents are also potentially lethal (Paper III). Although opioid overdoses are now 
mainly treated on site, a third of all hospitalized patients had traces of opiates in blood or 
urine samples (Paper I). Paracetamol was suspected as being used by 12% of all patients. The 
recognition of paracetamol, benzodiazepines and opioids is important for the use of antidotes. 
The emerging use of GHB is interesting, as this drug was found in 12% of the patients (Paper 
II). The “toxidrome” of this drug seems to be recognized by physicians, as the agreement 
between suspected and found agents was good. The extensive use of amphetamine, which was 
found in 21% of the patients in Paper II, was only suspected in 5% of the patients in Paper I. 
This “old” drug of abuse seems to be much more commonly used than suspected clinically. 
Overall, physicians seem to underestimate the use of drugs of abuse, as we found 30% more 
agents than were suspected clinically. 
Physicians found that a third of self-poisonings were suicide attempts, a third were 
acts of appeal and a third were drug-related poisonings (Paper VI). Risk factors for suicidal 
behaviour were found among all intention groups, such as a lack of social integration, 
substance abuse, previous suicide attempts and previous or current psychiatric treatment as a 
marker of psychiatric disease. Although there were differences between those who attempted 
suicide and drug-related poisonings, there was an extensive overlap between the groups. A 
third of all suicide attempters indicated daily substance abuse, whereas a third of those 
suffering drug-related poisonings had attempted suicide previously. Gender distribution was 
the only risk factor that differentiated between those with appeals and those who had 
attempted suicide, thus emphasizing the importance of not underestimating the seriousness of 
such acts when plans are made for follow-up at discharge. 
Although the short-term prognosis was good for hospitalized self-poisonings, the long-
term prognosis was rather poor. All self-poisonings had an increased risk of death compared 
with the general population, and this risk was increased for both natural and unnatural causes 
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of death (Paper IV). Opioid addicts were at special risk and drug dependence was the major 
cause of death (Paper V). Although suicide attempters were at special risk for completing the 
suicide, the risk was also increased for those who were neither suicidal nor substance abusers. 
Therefore, being hospitalized for self-poisoning was an important marker of increased risk for 
both suicide and increased mortality for up to 20 years after the initial admission. Therefore, 
patient follow-up must be directed towards all patients including those who had attempted 
suicide, appealers and those with drug-related poisoning. However, more than a third of all 
those with drug-related poisoning were discharged without any plans having been made for 
their aftercare. Even among suicide attempters, 5% were discharged without such plans. In the 
context of their increased risk of death in general and suicide in particular, this hardly seems 
sufficient. Because in 2003/04 the median age of these patients was 36 years, reducing the 
mortality rates among this patient group is of major importance. Although different 
approaches are probably needed, the follow-up of patients treated for self-poisonings should 
include all patients. Plans need to be made prior to discharge, in accordance with the patient’s 
needs as evaluated by both the patient and the physician. 
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7. FUTURE RESEARCH 
Any comparison between studies of poisoned patients requires some uniformity of 
classifications. Today, the borders between the groups are vague and are adopted differently 
in different studies (64;102;115). Consensus regarding definitions and inclusion criteria may 
not be the main goal, but explicit criteria are crucial to apply the results in clinical practice. 
Furthermore, differently defined samples might be useful in different clinical settings, a topic 
that should be explored. For example, self-poisonings might be a useful term in the 
emergency department, while self-harm might be more useful in psychiatric services, because 
of the way health care services are organized. However, these classifications may be 
influenced by regional differences and differences between countries (15). This aspect must 
be included in future studies. 
Finding a suitable classification of consciousness in the poisoned patient is another 
challenge. As in other fields of emergency and intensive-care medicine, evidence-based 
treatment for this group may be difficult to obtain through prospective, randomized and 
double-blind trials. 
Although guidelines on treatments such as gastric lavage and activated charcoal are 
available, there is criticism of the evidence upon which they are based (21). Differences in 
reports and recommendations regarding antidotes such as flumazenil (8;81;132)  and naloxone 
(20;82;86) reveal that comprehensive trials regarding their most common effects in the 
treatment of acute poisoning are still needed. 
In the future, predictors of a correct evaluation of toxic agents might be sought. Are 
patient and companion histories truthful, in particular, when it comes to drugs of abuse? The 
relative importance of these substances in the intoxicated patient may also need to be 
examined further. 
The persistent high suicide ratio found in Paper IV might be investigated further in 
empirical studies to evaluate further developments of the suicidal process in these patients 
(108), and factors that might influence this process. 
Studies of mortality and suicide rely on official statistics regarding causes of death. In 
Norway, the reliability of these statistics and death certificates should be investigated further, 
as the autopsy rate has decreased (13). 
The long-term prognosis after an episode of self-poisoning calls for improved aftercare 
for these patients. Although they can be considered to be a single risk group, different 
approaches for aftercare are probably needed for these patients. The lack of intervention 
studies should be the main focus for future studies in the field. Evaluations of the 
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effectiveness of treatments for deliberate self-harm (64),  have concluded that there is still 
considerable uncertainty about which forms of psychosocial and physical treatments for self-
harm patients are the most effective, the inclusion of insufficient numbers of patients in trials 
being the main limiting factor. For patients presenting with self-poisonings, an evaluation of 
the types of aftercare currently offered to these patients, resource availability, patient 
satisfaction and their effectiveness on symptoms and quality of life would be useful. Some 
studies suggest that the need for intervention is greater than that which is currently offered 
(113;126). 
Treatment for substance abuse has showed a beneficial effect on mortality (122), 
although we were not able to reveal such an effect in our analyses. It is worth emphasizing 
that not all drug addicts die early. More research is needed to determine what makes patients 
who survive different from those who die. Such information would be helpful both in 
choosing therapy and in identifying those at special risk. 
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8. CONCLUSIONS 
In this study, the annual incidence of acute poisonings in Oslo was 1.9 (per 1000) in males 
and 2.1 in females. Ethanol and benzodiazepines were the main toxic agents, although new 
agents such as GHB were surprisingly common. Substance use was considerable irrespective 
of intention, as even a third of all suicide attempters reported daily substance use. Laboratory 
analyses discovered drugs of abuse in 92% of all patients, and the usage of drugs of abuse was 
generally underestimated by physicians. Overall, there was a lack of social integration among 
those who self-poisoned, as a third of them were permanently disabled, a third had only the 
lowest level of education, and half of the patients were living alone. Half of all the patients 
had previous suicide attempts. The short-term prognosis for self-poisonings was good for 
hospitalized patients, as 99% survived the initial episode. However, after 20 years, almost half 
of all males and a third of all females had died, the mortality being 4.6 times higher than 
expected. The mortality rates increased for all causes of death, but clinical predictors were too 
broad to identify individuals at special risk. For opioid addicts, mortality increased 23.6 times 
compared with the general population. The risk of suicide increased for all self-poisonings 
irrespective of intention, but a suicidal motive upon admission was the only independent 
predictor of suicide. Among drug-related poisonings, 36% were discharged without plans for 
further follow-up. However, all cases of self-poisoning must be considered a high risk group 
in terms of their increased mortality and suicide risk over time. Therefore, the follow-up 
services that these patients are offered must be investigated further. 
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ERRATA 
1. Paper IV: During the proof reading stages of Paper IV, I asked the editors to correct one 
paragraph in the results section. Unfortunately, they were not able to do this before the initial 
print of the paper, but they declared that they would implement the changes in the electronic 
version. This has not been done yet, and I therefore provide the corrected paragraph below. 
The corrected figures are used in the discussion of the results in the thesis.  
Paper IV: Mortality and causes of death after hospital-treated self-poisonings in Oslo: A 20-
year follow-up 
Page 4, in the section called “Risk of suicide”, line 15:  
Twenty-four patients considered to be suicidal at admission died by suicide (SMR, 64.1; 95% CI, 
43.0–95.7). This equates to 15.6% of those considered suicidal on admission died by suicide 
during the follow-up. Forty-three patients considered to be non-suicidal at the time of admission 
died by suicide during the follow-up period (SMR, 19.3; 95% CI, 14.2–26.3), of whom 28 were 
classified as substance abusers. Among those classified as substance abusers, the SMR was 21.5 
(95% C.I., 14.6-31.5). In patients considered to be neither suicidal nor substance abusers at 
admission, 15 (4.2%) died by suicide during follow-up (SMR, 22.9; CI, 14.9–35.1). 
2. List of papers, page 13 and Summary of results, p. 44: “accepted for publication” changed to 
“Clin Toxicol 2009;47:116-23”.  
3. The numbering of tables: “table 4” is changed to “table 3”, “table 5” to “table 4”, “table 6” 
to “table 5” and “table 7” to “table 6”.  
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Objectives. Prospective design is mandatory to study pattern of poisoning and suicidal intention of patients. Material and Methods.
Prospective cross-sectional multi-center study of all patients contacting health care services because of acute poisoning during one year in
Oslo, irrespective of intention. Data on the adult hospitalized patients (≥16 years) are presented here. Results. Of a total of 3,775 such
adult contacts (3,025 episodes), there were 947 (31 %) hospitalizations; annual incidence 1.9 (per 1,000) in males and 2.1 in females.
Median age was 36 years (range 16–89); 54% females. Benzodiazepines (18%), ethanol (17%), paracetamol (12%), opioids (7%), and
gamma hydroxybutyric acid (GHB) (7%) were most frequently taken. Patients stated suicidal intention in 29% of the admissions;
physicians in 10%. Conclusion. Benzodiazepines and ethanol were the most common agents, but newer illicit drugs were frequent,
especially GHB. Males often took ethanol and drugs of abuse; females often used prescription drugs with suicidal intention.
Keywords Toxicology; Acute poisoning; Epidemiology; Drug abuse; Alcohol; Suicide
Introduction
Acute poisonings are common with reported annual hospitaliza-
tion rates of 1.4 and 1.5 per 1,000 inhabitants in Norway and in
the USA, respectively (1,2). Deliberate self-poisoning accounts
for the vast majority of these poisonings (3). Further, the Oxford
database suggest that 87.9% of deliberate self-harm cases
involves poisoning, reflecting that intention is an important
aspect of acute poisonings (4). Reports on self-poisonings based
on hospital figures and official statistics are often retrospective
and therefore tend to underestimate morbidity (5,6). The few pro-
spective studies performed are old (7), small (8), or selective in
catchment area (9). The Oslo-1980 study on all hospitalized poi-
soned patients was – and still are – one of the few larger prospec-
tive studies on an unselected material of poisoned patients (3,7).
Because the pattern of self-poisonings changes over time
associated with changes in prescription patterns and drug abuse
(10,11), update studies are necessary. We therefore performed
a new prospective study and designed it as similar as possible
to that performed 23 years earlier (7). We expanded the study
to include the pre-hospital services (the ambulance service and
the Emergency ward (outpatient clinic)), in order to evaluate
all the acute poisonings (except those associated with or result-
ing in trauma) in the defined geographical area during the
whole year. The pattern of poisoning from the adult hospital-
izations are presented here, and the clinical course of the
patients are presented in paper II (12). The pre-hospital treated
patients (the ambulance service and the Emergency ward), the
children (13), and the dead patients evaluated by the Institute
of Forensic Medicine will be presented elsewhere. The aims in
the present article were to study 1) the incidence of hospital
treated acute poisonings during one year, 2) the patterns of
toxic agents according to age and gender, and 3) the intention
behind the poisoning according to gender and toxic agents.
Methods
Design of study
This prospective cross-sectional multi-center study was
performed from April 1, 2003 until March 31, 2004, involving
all four hospitals treating poisoned patients in Oslo, including
the pediatric departments, and the Oslo Emergency ward
Received 16 November 2006; accepted 22 December 2006.
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(outpatient clinic), the ambulance service, and the Institute of
Forensic Medicine (Fig. 1). This was done to obtain a complete
and unselected one-year picture of all medical patients contact-
ing the health care services because of acute poisoning. The
present design gave a total number of contacts, as well as a
total number of episodes: One episode of poisoning can be
reflected by up to three contacts (ambulance service, Emer-
gency ward, and hospital). The population of Oslo in 2003 was
521 886, of whom 428 198 were ≥ 16 years (1).
The inclusion criteria for the present part of the study were
exposure to a drug or another agent in toxic amounts leading to
hospital admission in adults (≥ 16 years). Both deliberate self-
poisoning and accidental poisoning were included. Exclusion
criteria were chronic poisoning, patients admitted to hospital
with another primary diagnosis, such as traumas, even if poison-
ing (e.g., ethanol) was the underlying reason for the accident.
Data collection and statistics
Physicians obtained data by completing a standardized form
the morning after admission, or as soon as the patient was
conscious. For patients who never woke up or had cerebral
damage, data were obtained from the medical file after con-
sent from relatives. The standardized forms were optically
scanned and processed using TeleForm Desktop version 9.1
(TeleForm, Verity Inc., Sunnyvale, California).
Statistics were performed using SPSS version 12.01 (SPSS
Inc., Chicago, Illinois). The statistical analyzes used were
Pearson Chi Square to compare categorical data, and t-test to
compare continuous data. P-values <0.05 were considered
statistically significant.
Criteria for classifications
The main agent was defined as the substance supposed to be
most toxic in the amounts taken: The physicians made an
overall evaluation of the substance thought to cause the most
severe toxicity based on information from patients, bystand-
ers, clinical manifestations and routine laboratory analyzes.
Other ingested agents were defined as additional agents.
The classification of the intention of the poisoning was
separated in two; the patient’s own reported reason for the
poisoning, and the interviewing physician’s evaluation of the
same. For the clinician’s evaluation, special attention was
paid to possible written letters confirming their suicidal
intent, supposed lethal doses of the toxic agent, or other
active procedures to secure lethal outcome, for example
intake in remote places, or hiding themselves after intake.
Ethics
Treatment was given according to the standard hospital
protocols, and in accordance with the Helsinki declaration.
Permission was obtained from The National Data Inspec-
torate, and the Regional Ethics Committee. Informed consent
was asked for, and only one patient refused to participate. All
data were stored anonymously.
Results
Incidence
There were 3,904 contacts due to acute poisoning, of which
3,775 were adults. The adult contacts consisted of 3,025 differ-
ent episodes, which lead to 947 admissions (in 780 patients) to
hospital, giving an adult hospitalization rate of all episodes of
31% (Fig. 1). Eighty-seven percent of the patients were admit-
ted only once during one year and 8% were admitted twice,
while the remaining 5% were admitted from three to seven
times. Of the 947 admissions, 850 (89.8%) were by residents
permanently living in Oslo, which gave an annual incidence
for the residents of Oslo of 2.0 per 1,000, 1.9 in males, and 2.1
in females. 908 (95.9%) of the poisonings were deliberate self-
poisonings, 24 (2.5%) took their prescribed medication in
wrong doses, 8 (0.9%) were carbon monoxide from fire acci-
dents, 5 (0.5%) were other gas exposures related to work, and 2
(0.2%) claimed to have been poisoned by other accident.
Of all hospitalizations, there were 512 females (54%) and
435 males (46%) with a median age of 36 years (range 16–89)
(Fig. 2). Fifty-four percent of the males and 52% of the females
Fig. 1. Contacts with the health services in Oslo over the course of one
year with the primary diagnosis of acute poisoning. We registered
3,904 contacts in 2,410 different patients in total (excluding 99 found
dead outside of the hospital). This consisted of 3,025 episodes (one
episode could theoretically include up to three contacts: the ambulance
service, the outpatient clinic, and finally hospitalization). The direct
admissions to hospital consisted of 312 adults and 41 children.
Ambulance service
n = 1899:
1870 adults, 29 children 
Oslo Emergency Ward
(outpatient clinic) 
n = 996:
958 adults, 38 children 
Child
hospitalizations
n = 62
Adult hospitalizations
n = 947
(780 patients)
Adults found dead
outside hospital
n = 99
Adults dead by
poisoning 
n = 109
n=7
n = 10
n = 14
n = 129n = 506
n = 560
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were between 20 and 40 years old. The incidence of poisoning
decreased with age, most clearly among females (Fig. 2).
Pattern of toxic agents
The most frequent main agents taken were benzodiazepines
(18%), ethanol (17%), paracetamol (12%), opioids (7%), and
gamma hydroxybutyric acid (GHB) (7%) (Table 1). Regard-
ing the main agents, there were different patterns between
genders (Table 1) and different age groups (Fig. 3). Males
drank more often ethanol (p=0.008) and used more illicit
drugs (opioids: p<0.001, GHB: p<0.001, amphetamine:
p=0.046, and cocaine: p=0.013), while females tended to use
more prescription (and over-the counter, i.e., paracetamol)
drugs (benzodiazepines: p=0.012, paracetamol: p<0.001,
neuroleptics: p=0.024, zopiclone: p=0.012, and anti-epilep-
tics: p=0.02). For the rest of the main agents, there were no
significant differences.
Multiple toxic agents were taken in 592/947 (62.5%)
admissions with no gender differences. The patients below 20
Fig. 2. Incidence, age, and gender among the poisoned patients.
*=statistically significant differences between the genders.
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Table 1. Main and additional agents taken by the patients, separated by gender
Main agent Male n (%) Female n (%) Total n (%) Sign. diff.
Additional agent n 
(%)
Sum of adm. with 
this agent n (%)
Benzodiazepines 70 (16) 102 (20) 172 (18) p = 0.015 202 (21) 374 (40)
Ethanol 98 (23) 64 (13) 162 (17) p = 0.008 238 (25) 400 (42)
Paracetamol 23 (5) 93 (18) 116 (12) p < 0.001 97 (10) 213 (23)
Opioids 50 (12) 19 (4) 69 (7) p < 0.001 93 (10) 162 (17)
GHB 49 (11) 19 (4) 68 (7) p < 0.001 6 (1) 74 (8)
Neuroleptics 23 (5) 41 (8) 64 (7) p = 0.024 42 (4) 106 (11)
Carisoprodol 13 (3) 22 (4) 35 (4) ns 20 (2) 55 (6)
SSRI 12 (3) 22 (4) 34 (4) ns 32 (3) 66 (7)
Zopiclone 7 (2) 19 (4) 26 (3) p = 0.019 49 (5) 75 (8)
TCA 6 (1) 14 (3) 20 (2) ns 15 (2) 35 (4)
Anti-histamines 6 (1) 12 (2) 18 (2) ns 25 (3) 43 (5)
Amphetamine 12 (3) 4 (1) 16 (2) p = 0.046 32 (3) 48 (5)
Anti-epileptics 3 (1) 12 (2) 15 (2) p = 0.020 14 (2) 29 (3)
Cocaine 11 (3) 2 (0) 13 (1) p = 0.013 13 (1) 26 (3)
Other antidepressant 4 (1) 8 (2) 12 (1) ns 17 (2) 29 (3)
Cardiovascular drugs 4 (1) 7 (1) 11 (1) ns 13 (1) 24 (3)
CO and fire smoke 7 (2) 3 (1) 10 (1) ns 2 (0) 12 (1)
NSAID’s 2 (1) 8 (2) 10 (1) ns 27 (3) 37 (4)
Other sedatives 2 (1) 7 (1) 9 (1) ns 8 (1) 17 (2)
Lithium 1 (0) 6 (1) 7 (1) ns 0 (0) 7 (1)
Ecstasy 3 (1) 2 (0) 5 (1) ns 10 (1) 15 (2)
Methanol 2 (1) 1 (0) 3 (0) ns 2 (0) 5 (1)
Other gases 5 (1) 0 (0) 5 (1) NA 0 (0) 5 (1)
Ethylene glycol 0 (0) 4 (1) 4 (0) NA 3 (0) 7 (1)
ASA 1 (0) 1 (0) 2 (0) NA 5 (1) 7 (1)
Cannabis 0 (0) 0 (0) 0 (0) NA 21 (2) 21 (2)
Dextropropoxyphen 0 (0) 0 (0) 0 (0) NA 3 (0) 3 (0)
Others 21 (5) 20 (4) 41 (4) ns 24 (3) 65 (7)
Total 435 (100) 512 (100) 947 (100)
Sign. diff.=Significant differences between the genders regarding main agent, using Pearson’s Chi-square.
ns=non-significant, NA=Not applicable.
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years were suspected to take multiple drugs less frequently
than others (41%), while the 51–60 year olds were the oppo-
site extreme (73%).
Suicidal intention
Overall, patients stated a suicidal intention (i.e., a wish to die)
in 29% (271/947) of the admissions; 31% by the females and
25% by the males (p=0.002). Females also more frequently
reported intoxication due to “escape from problems”
(p<0.001), or to “influence relationships” (p<0.001). Males,
on the other hand, more often used drugs for intoxication pur-
poses or claimed to have overdosed by accident (p<0.001)
(Table 2). Similarly, there was a distinct gender difference in
the physician’s evaluation of the reason: Overall, physicians
defined 10% as a definite and 25% as a possible suicidal
attempt (total 35%) (Table 3). More females were evaluated
to have taken the drugs in a definite or possible suicidal
attempt (p<0.001), or it was considered done as an appeal for
help (p<0.001). Males were more often classified to have
done it for intoxication purposes (p<0.001) (Table 3).
The different intentions are also reflected by the differ-
ences in main agents taken: 41% of the patients stating sui-
cide attempt took benzodiazepines, while only 11% took
ethanol (Table 2). Physicians’ considered a definite suicidal
attempt for the same substances in 15% and 2%, respectively
(Table 3). Neuroleptics (50%), tricyclic antidepressants
(TCA) (50%), selective serotonin re-uptake inhibitors (SSRI)
(47%), or other antidepressants (42%), were frequently taken
with a suicidal intention according to the patients themselves.
The same figures from the physicians’ evaluation (definite/
possible suicide attempt) were neuroleptics (17%/30%), TCA
(10%/45%), SSRI (9%/47%), and other antidepressants (8%/
50%).
Discussion
We are not aware of other studies like the present performed
on all acute poisonings contacting health care services during
one year in a defined geographical area which includes the
pre-hospital services. Interestingly, only 31% episodes (Fig. 1)
lead to hospitalization and the remaining 69% were taken
care of by the ambulance service or the outpatient emergency
ward only. This demonstrates that most poisonings are mild,
and that studying hospitalized patients alone underestimates
Fig. 3. The five most frequently found main agents in the different
age-groups.
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Table 2. Patients’ own given reason for poisoning according to gender and to the most frequent main agents taken
Patients’ given 
reason
Gender Main toxic agent
Male 
n = 435
%
Female 
n = 512
%
Sign. 
diff.
p
BZD 
n = 172
%
etOH 
n = 162
%
Parac 
n = 116
%
Opioids 
n = 69
%
GHB 
n = 68
%
Total (all agents) 
n = 947 
%
To die 25.3 31.4 = 0.002 41.3 10.5 42.2 21.7 2.9 28.6
Escape from 
problems
10.8 24.2 < 0.001 25.6 13.6 24.1 8.7 5.9 18.1
Influence 
relationship
3.7 9.8 < 0.001 7.0 5.6 8.6 2.9 2.9 7.0
Accident/ 
intoxication
35.6 15.0 < 0.001 9.9 48.2 4.3 36.2 60.3 24.5
Do not remember/
do not know
5.5 4.1 No 4.1 5.6 6.9 1.4 5.9 4.8
Will not tell 2.1 2.1 No 2.3 2.5 1.7 1.4 0 2.1
Other 7.1 7.8 No 5.8 3.1 8.6 7.2 1.5 7.4
Unknown 10.3 5.7 No 4.1 11.1 3.4 20.3 20.6 7.6
100% 100% 100% 100% 100% 100% 100% 100%
Acute poisonings in Oslo 5
the size of the problem. The extended use of pre-hospital
treatment without hospitalization is currently a subject of dis-
cussion (14).
Incidence
Compared to 1980 (7), there were now fewer hospitalizations
(947 admissions versus 1,145 admissions in 1980) which in
part may be explained by most of the opiate overdoses being
treated on site (14). The total reduction in incidence from
1980 to 2003 was 2.7–2.0 per 1,000 (p<0.001), whereas the
incidence decreased more for males (3.0–1.9 per 1000,
p<0.001), than females (2.5–2.1 per 1000, p=0.01) (7). In
Scotland, an incidence of 3.32 per 1,000 among males, and
3.79 per 1,000 among females was reported (15). The tradi-
tional female dominance (54%) was still present in accor-
dance with other studies reporting 51–56% females (7,9,15).
With a median age of 36 years (range 16–89), these patients
were considerably younger than the average age in our inter-
nal medicine ward (63.2 years). Compared to the former
study in Oslo (median 31 years (range 13–93)), the present
patients were older (difference of the mean: 3.9 years,
p<0.001) (7). Part of this age difference was due to the men-
tioned pre-hospital treatment of the (young) opiate overdose
patients (14). The present age fits another Norwegian study
on an unselected material from another city (mean age 34.4
years; ± 1 SD=14 years) (10) and a Spanish study (mean age
33 years SD ± 18.10 years) (9), while patients were younger
(mean age 25 years) in a study from Sri Lanka, mainly due to
many young people taking pesticides and a generally younger
population (16).
The number of patients admitted more than once during
one year (approximately 13%, whereas 5% were admitted
more than twice), increased from 1980. The part of admis-
sions representing readmissions was 18%, compared to 14%
in 1980 (7) (p=0.045).
Pattern of toxic agents
Benzodiazepines and ethanol were the main toxic agent in
the present study in 18% and 17% of admissions, respec-
tively (Table 1). The corresponding figures in 1980 were
18% and 20%. These agents were followed by paracetamol
(12%), opioids (7%), and GHB (7%) in the present study,
while the similar agents and figures in 1980 were opioids
(15%), neuroleptics (11%), and antidepressants (TCA)
(10%) (7). Paracetamol becoming more frequent (15,17)
and opiates becoming less frequent (15,18), corresponds
well to other reports. The present reduction of opiate admis-
sions can be attributed to the present pre-hospital treatment
of opiate overdoses (14). Although other studies also found
GHB frequently, the present 7% was somewhat surprising
and twice the amount found in a Spanish study (18).
Whether increased attention to the use of GHB leads to an
overestimate is possible, although studies based on urineT
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and/or serum samples rather suggest an underestimate (19).
The extensive use of SSRIs at present, and therefore lower
prescription rates of TCA, probably explains why TCA
were considered the main toxic agent in only 2% of the
admissions, corresponding to other studies (17).
Males were over-represented with illegal substances and
alcohol, while females were more susceptible to take pre-
scription drugs. This was in accordance with findings in
1980 (7), and other studies regarding paracetamol, antide-
pressants, opiates (15), and GHB (18,20). The EPSIS
study found only small differences between the genders,
but this study only included suicide attempts and excluded
all ethanol poisonings. Hence the lack of difference
between the genders may be explained by their different
intentions (17).
Different age groups had different preferences concerning
agent taken (see Fig. 3). As a whole, these findings corre-
spond well to other studies: paracetamol mainly dominates
among the younger patients (15,17,21), as does GHB (18)
and opioids (15,22). Antidepressants and tranquillizers were
more commonly found among the elderly people in the
EPSIS-study (17), while the highest rate of discharge with
antidepressants in a Scottish study was found among those
aged 25–34 years. These figures were, however, given as
incidence numbers and they were not compared to the actual
number of hospitalized patients in that particular age-group
(15).Availability is probably the main factor being associated
with the age-differences regarding intake of agents in most
studies, including the present.
Poly-pharmacy in general is underestimated (19,23,24),
and although comparison with studies with confirmed
serum/urine analysis (19) is difficult, comparison with other
studies based on clinical suspicion is interesting. In our
study, intake of multiple agents was commonly found
(62.5%), and one explanation could be that the impulsive
patient takes whatever agents are handy. Other explanations
could be that the patients wanted to obtain a stronger intoxi-
cating effect or easier reach lethal doses, especially regard-
ing benzodiazepines, paracetamol, and opioids (Table 2).
Others studies have found more than one toxic agent in 59–
63% (7,17).
Suicidal intention
Suicidal intention were more frequent among females, or
they seemed to do it more frequently to “escape problems”
or “influence relationship,” while the males more often did
it for intoxication purposes; and the intention was
reflected by the main agents taken by the two genders.
Similar differences in intention was also found in 1980
(7). The EPSIS-study of patients admitted for attempted
suicide found 60% of the patients to be females, but a lack
of variation in suicide intent scores between the different
drugs used (17). The reported gender preferences that
exists between males for violent, versus females for
non-violent methods of suicide (25), also supports the
present results.
Strengths and limitations
Due to psychiatric co-morbidity and substance abuse, these
patients are often less willing to participate in studies and
answering questionnaires. We tried to compensate for this
with a detailed questionnaire given to the interviewing physi-
cians, thoroughly explaining the patients the goal of the
study. Since only one patient denied participating, this may
have been effective. The prospective design, an unselected
group of poisoned patients, and a whole year study period
further strengthens the study.
The exclusion of patients with primary diagnoses other
than poisonings could have excluded important acute poison-
ings from the study. However, most of these patients would
have their clinical course affected by the primary, non-poi-
soning diagnoses. Since our aim was to study the clinical out-
come of acute poisonings in itself, the results would probably
have been biased by including these patients. It would also
have made the inclusion criteria too complex, taken into
account the study size and the number of collaborators.
The toxic agents was not always verified by laboratory
methods, but rather determined the way we do it in the clini-
cal routine. There were many participating physicians, and
we have not corrected for the inter-rater variability. However,
we included all the medical departments in Oslo, compensat-
ing for this. Further, we have not used a verified scale/test for
evaluation of suicidal intention, but the present method
equals the evaluation in the typical clinical setting.
Conclusion
Acute poisonings remain a frequent reason for hospitalization
of younger patients in particular. Females were still overrep-
resented (54%) and took prescription drugs more often, while
males were more frequently hospitalized with ethanol and
illegal drugs, especially GHB in the young. More females
claimed, and were suspected, to have a suicidal intention,
while males had a higher incidence of admissions due to
intoxication.
Acknowledgments
This study was supported by a grant from the Norwegian
Directorate for Health and Social Affairs, Department for
Emergency Medicine and Preparedness, and by a grant
from the Eastern Norway Regional Health Authority.
Thanks to the Departments of Clinical Chemistry and Inter-
nal Medicine of Aker University Hospital, Diakonhjemmet
Hospital, Lovisenberg Hospital, and Ullevaal University
Hospital for help with collection of the material. Thanks to
Acute poisonings in Oslo 7
Professor Leiv Sandvik, University of Oslo, for statistical
advice.
References
1. Statistics Norway. StatBank Norway—Health Service. http://statbank.
ssb.no/statistikkbanken/default_fr.asp?PLanguage=1. Accessed 1 Dec.
2. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss
J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 annual report of the
American Association of Poison Control Centers Toxic Exposure Sur-
veillance System. Am J Emerg Med 2004; 22:335–404.
3. Jacobsen D, Frederichsen PS, Knutsen KM, Sorum Y, Talseth T, Odegaard
OR. Clinical course in acute self-poisonings: A prospective study of 1125
consecutively hospitalised adults. Hum Toxicol 1984; 3:107–116.
4. Hawton K, Fagg J, Simkin S, Bale E, Bond A. Trends in deliberate self-
harm in Oxford, 1985–1995. Implications for clinical services and the
prevention of suicide. Br J Psychiatry 1997; 171:556–560.
5. Harchelroad F, Clark RF, Dean B, Krenzelok EP. Treated vs. reported
toxic exposures: discrepancies between a poison control center and a
member hospital. Vet Hum Toxicol 1990; 32:156–159.
6. Blanc PD, Jones MR, Olson KR. Surveillance of poisoning and drug
overdose through hospital discharge coding, poison control center
reporting, and the Drug Abuse Warning Network. Am J Emerg Med
1993; 11:14–19.
7. Jacobsen D, Frederichsen PS, Knutsen KM, Sorum Y, Talseth T,
Odegaard OR. A prospective study of 1,212 cases of acute poisoning:
general epidemiology. Hum Toxicol 1984; 3:93–106.
8. Kapur N, House A, Creed F, Feldman E, Friedman T, Guthrie E.
Management of deliberate self poisoning in adults in four teaching hos-
pitals: Descriptive study [see comment]. BMJ 1998; 316:831–832.
9. Burillo-Putze G, Munne P, Duenas A, Pinillos MA, Naveiro JM, Cobo J,
Alonso J. National multicentre study of acute intoxication in emergency
departments of Spain. Eur J Emerg Med 2003; 10:101–104.
10. Rygnestad T, Fagerhaug O. Acute deliberate self-poisonings in the area of
Trondheim, 1978–2002. Tidsskr Nor Laegeforen 2004; 124:2736–2739.
11. Lockhart SP, Baron JH. Changing ethnic and social characteristics of
patients admitted for self-poisoning in West London during 1971/2 and
1983/4. J R Soc Med 1987; 80:145–148.
12. Heyerdahl F, Bjornaas M, Hovda KE, Skog K, Opdahl A, Wium C,
Ekeberg O, Jacobsen D. Acute poisonings treated in hospital in Oslo: A
one-year prospective study (II): Clinical Outcome. Clin Toxicol 2007;
in press.
13. Rajka T, Heyerdahl F, Hovda KE, Stiksrud B, Jacobsen D. Acute poi-
sonings in children. A two-year prospective study in Oslo. Acta Paedi-
atrica 2007; 96: 1355–1359.
14. Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after
naloxone treatment of episodes of suspected acute opioid overdose. Eur
J Emerg Med 2004; 11:19–23.
15. Bateman DN, Bain M, Gorman D, Murphy D. Changes in paracetamol,
antidepressants and opioid poisoning in Scotland during the 1990s.
QJM 2003; 96:125–132.
16. Eddleston M, Gunnell D, Karunaratne A, de Silva D, Sheriff MH,
Buckley NA. Epidemiology of intentional self-poisoning in rural Sri
Lanka. Br J Psychiatry 2005; 187:583–584.
17. Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in
deliberate self-poisoning 1985–1997: Trends and associations with age,
gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epide-
miol 2001; 36:228–234.
18. Miro O, Nogue S, Espinosa G, To-Figueras J, Sanchez M. Trends in
illicit drug emergencies: The emerging role of gamma-hydroxybutyrate.
J Toxicol Clin Toxicol 2002; 40:129–135.
19. Bjornaas M, Hovda KE, Mikalsen H, Andrew E, Rudberg N, Ekeberg O,
Jacobsen D. Clinical versus laboratory identification of drugs of abuse
in patients admitted for acute poisoning. Clin Toxicol 2006; 44:127–
134.
20. Chin RL, Sporer KA, Cullison B, Dyer JE, Wu TD. Clinical course
of gamma-hydroxybutyrate overdose. Ann Emerg Med 1998;
31:716–722.
21. McLoone P, Crombie IK. Hospitalisation for deliberate self-poisoning
in Scotland from 1981 to 1993: Trends in rates and types of drugs used.
Br J Psychiatry 1996; 169:81–85.
22. Roberts I, Barker M, Li L. Analysis of trends in deaths from accidental
drug poisoning in teenagers, 1985–95. BMJ 1997; 315:289.
23. Montague RE, Grace RF, Lewis JH, Shenfield GM. Urine drug screens
in overdose patients do not contribute to immediate clinical manage-
ment. Ther Drug Monit 2001; 23:47–50.
24. Rygnestad T, Berg KJ. Evaluation of benefits of drug analysis in the
routine clinical management of acute self poisoning. J Toxicol Clin
Toxicol 1984; 22:51–61.
25. Schapira K, Linsley KR, Linsley A, Kelly TP, Kay DW. Relationship of
suicide rates to social factors and availability of lethal methods: Com-
parison of suicide in Newcastle upon Tyne 1961–1965 and 1985–1994.
Br J Psychiatry 2001; 178:458–464.

II

Clinical Toxicology, 44:127–134, 2006
Copyright © Taylor & Francis Group, LLC
ISSN: 0731-3810 print / 1097-9875 online 
DOI: 10.1080/15563650500514384
127
LCLTARTICLE
Clinical vs. Laboratory Identification of Drugs of Abuse in 
Patients Admitted for Acute Poisoning
CLINICAL Vs. LABORATORY IDENTIFICATION OF DRUGS oF ABUSEM. A. Bjornaas
Department of Acute Medicine, Ullevaal University Hospital, Oslo, Norway and Department of 
Behavioral Sciences in Medicine, University of Oslo, Norway
K. E. Hovda
Department of Acute Medicine, Ullevaal University Hospital, Oslo, Norway
H. Mikalsen and E. Andrew
Poisons Information, Directorate for Health and Social Affairs, Oslo, Norway
N. Rudberg
Department of Clinical Chemistry, Ullevaal University Hospital, Oslo, Norway
O. Ekeberg and D. Jacobsen
Department of Acute Medicine, Ullevaal University Hospital, Oslo, Norway
Objective. The extent of drug abuse in patients admitted for
self-poisonings is uncertain. The aim of this study was to assess
the pattern of drugs of abuse among patients admitted for acute
poisoning according to age and gender, and to study the concor-
dance between the clinical assessments by the physicians on duty
and the drug analyses. Methods. Prospective cross sectional
study of all patients (n = 405, 52% males, median age 31 years)
treated for acute poisoning in our department during one year
(2001). The physician on-call classified type of drug of abuse by
history and clinical assessment. This was later compared to urine
and blood samples analysed for ethanol, benzodiazepines, opiates,
cocaine, ecstasy, GHB, amphetamine and cannabis. Results. In
320 admissions (79%), the comparison between clinical diagnosis
and laboratory analyses could be performed. A total of 478 drugs
were suspected and 621 were found. The main toxic agents found
were benzodiazepines (49.7%), ethanol (40.3%), opiates (35.3%),
cannabis (23.8%) and amphetamine (21.3%). Ninety-two had
used drugs of abuse. The agreement between clinical assessments
and laboratory findings was best for GHB and ethanol (kappa =
0.43), and for opiates (k = 0.38). For benzodiazepines and can-
nabis, the concordance was poor (k = 0.18 and 0.10, respectively).
However, the correct clinical evaluation for these substances was
59% and 77%, respectively. Conclusions. Drugs of abuse were
more frequently found than suspected clinically. Benzodiazepines,
ethanol and opiates were most common. The agreement between
clinical assessment and drug analyses was moderate to low. Physi-
cians seem to underestimate the use of these drugs. 
Keywords Poisoning; Diagnosis; Analysis; Drug abuse
INTRODUCTION
Acute poisonings account for a substantial number of admis-
sions to hospitals. About 15 to 20% of the workload of medical
units, and 10% of the workload of accident and emergency depart-
ments in the United Kingdom are due to self-poisoning (1). In
Oslo, Norway, the incidence of 3.1 admissions per 1000 inhabit-
ants has been reported (2).
The patterns of drug abuse may provide a clue for the physician
when evaluating the intoxicated patient. Consumption of illicit
drugs is increasing (3,4). New drugs such as GHB (γ-hydroxy-
butyrate) and ecstasy are gaining popularity (5–7). At the same
time, drug histories are found to be imprecise (8,9). Inaccurate his-
tories are especially common when illegal substances are involved
(10). Thus, in combination with a changing diagnostic panorama,
diagnostic decisions have become more complex.
Diagnosis of patients treated for acute poisonings in the
emergency department is based upon clinical assessments and
routine laboratory analyses. Patient or companion histories,
findings on the scene of the overdose and clinical signs and
symptoms, are the main sources of information on drugs
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ingested (11). For drugs of abuse, routine drug screening, with
the exception of benzodiazepines and ethanol, are usually not
performed. The diagnosis of drugs of abuse is, therefore,
mainly clinical.
Previous studies report a significant amount of cases where
drug analyses and clinical diagnoses differ (10,12–15),
whereas other studies show a relatively good concordance
(2,16). All studies show that clinical assessments alone give
imprecise diagnoses. None of them, however, have focused on
drugs of abuse in particular, where the clinical evaluation is
more complicated due to uncertain patterns of use, and inaccu-
rate histories.
The clinical impact of an imprecise diagnosis in these
patients is being questioned. It is claimed that an inaccurate
diagnosis is not affecting mortality (8,12), nor being the cause
of complications (13). However, knowing the correct diagnosis
could enable optimal treatment of acute poisoning by reducing
the need for supervision and costly treatments, and facilitating
the identification of cases that require prompt drug-specific
treatment (10,12,13,17). Thus, both morbidity and costs may
be reduced.
Emergency departments can be important venues for detect-
ing persons in need of substance abuse treatment (18). Use of
illicit drugs may indicate substance abuse problems. A precise
identification of substances may help physicians to identify
patients who are using illicit drugs. This may help establish
appropriate aftercare.
The aims of this study were to assess the pattern of drugs of
abuse according to age and gender for all patients admitted to a
medical department for acute poisoning in Oslo in 2001; and to
evaluate the concordance between the clinical assessments
(including patient history), by the physicians on duty and the
drug analyses in these patients.
PATIENTS AND METHODS
This cross-sectional study included all patients admitted to
the Department of Acute Medicine at Ullevaal University Hos-
pital in Oslo, Norway, because of an acute poisoning between
January 1 and December 31, 2001. The department consists of
a Medical Intensive Care Unit (10 beds) and an Observatorial
Unit (17 beds). Ullevaal University Hospital covers about
140 000 inhabitants of Oslo, the capital of Norway, in addition
to seriously poisoned patients from other parts of Oslo as well.
The catchment area is based upon sectors of the city, and con-
stitutes of all social classes. Paramedics or general practitioners
referred patients to our hospital. Ullevaal is a university hospi-
tal and a tertiary care center for the most severely poisoned
patients. All patients treated as acute poisonings in the Depart-
ment of Acute Medicine were included. Both a completed form
and a urine or blood sample were needed to do the comparison,
and if either a form or a urine or blood sample was missing, the
patient was excluded.
Acute poisoning was defined as an acute exposure to a drug
or another agent in assumed toxic amounts leading to hospital
admission. The patient’s intention was not evaluated, and,
therefore, the study population includes both accidental poi-
sonings and poisonings with the intention of self-harm.
Drugs of abuse were defined as cannabis, cocaine, ecstasy,
GHB, amphetamine, opiates, ethanol and benzodiazepines.
The patients might have taken other drugs as well, but this was
not investigated. The term “drugs of abuse” therefore include
prescribed medication (benzodiazepines, opiates), illicit drugs
(cannabis, cocaine, ecstasy, GHB, amphetamine, opiates) and
alcohol.
Clinical Assessments
A form was filled in by the physician on duty, documenting
the clinical assessments. The physicians were informed to
write down all suspected toxic agents, not differentiating
between main and additional agents. They were asked to
include all suspected agents, and were not aware that drugs of
abuse were the main purpose of the study. The physicians on
duty were mostly residents in internal medicine. The treating
physicians did not know the results of the urine or blood
screening. They were asked to fill in whether their suspicion
was based upon patient history, information from companions,
clinical signs and symptoms, other information such as drug
packing, or a combination of these factors. The time from
administration of drugs to presentation at the hospital was
recorded if possible, as well as the amount of each drug taken.
The severity of the poisoning on arrival was classified as not
severe, moderate or severe. Age, gender and date of arrival
were recorded before the form was coded to ensure anonymity.
Urine and Blood Analysis
Urine sample was obtained if possible, either in the emer-
gency room or later when the patient had moved to another
unit. The time frame varied between 1–24 h after administra-
tion (median 4 h), but usually sampling was performed within
2 h after admission. If a urine sample was not obtained, a blood
sample was taken. Samples were frozen (−20°C) for later anal-
yses. Analyses were performed at the Department of Clinical
Chemistry, Ullevaal University Hospital. The laboratory, or
any other University hospital laboratory in Norway, is not cer-
tified by an accrediting professional organization.
Urine samples were analyzed for amphetamine, benzodiaz-
epines, cannabis, cocaine and opiates using an immunologic
assay (Hitachi 917; Roche Diagnostics, Basle, Switzerland).
The test principle was based upon the kinetic interaction of
micro particles in a solution (KIMS) and was measured by
changes in light transmission. The cut-off values were 500,
200, 50, 300 and 300 ng/mL, respectively. The samples were
analyzed for ethanol using an enzymatic assay (Hitachi 917;
Roche Diagnostics, Basle, Switzerland). Here, the test princi-
ple was based upon an enzymatic reaction, and the test
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measured the change in absorbance when ethanol was present
in the sample. The cut-off value was 0,2 g/L. Analysis of ecstasy
in urine was based upon fluorescence polarization immunoassay
(FPIA) and if above cut-off (250 ng/mL), by gas chromatogra-
phy with mass spectrometer (GC-MS) (Trace GC 2000 series,
Thermo Quest, CE Instruments, with Trace MS, Thermo Quest
Finnegan, Rodano, Italy). Cut-off for ecstasy by GC-MS was
100 ng/mL. GHB (γ-hydroxy-butyrate) was measured by a gas-
chromatographic method with flame ionization detection (GC-
FID) and a head-space-injector (GC 8000 series, Fisons Instru-
ments, Rodano, Italy). ). Cut-off for GHB was 5 μg/mL.
If the sample was positive for amphetamine, the cut-off
value for ecstasy was set to 250 ng/mL, and the sample was
analysed using GC-MS. This method would specify the pres-
ence of amphetamine, methamphetamine, MDMA and/or
MDA in the sample. With the exception of amphetamines, the
initial screening was not confirmed by a second test.
Serum analyses of benzodiazepines, cannabis, opiates and
cocaine were performed as for urine, except for the reagents
(Microgenics, Passau, Germany). The test principle was based
upon the cloned enzyme donor immunoassay (CEDIA) and
was measured spectrophotometrically as a color change. The
cut-off values were 50, 25, 50 and 75 ng/mL, respectively. Eth-
anol was measured with the same reagent as for urine, and with
the same cut-off value. Analyses for GHB were performed
with the same instrument and cut-off, and almost in the same
way as for urine. Amphetamine and ecstasy were analyzed by
GC-MS, in almost the same method as for analyses of ecstasy
in urine by GC-MS. Cut-off was 40 ng/mL for both.
The immunologic methods gave semi-quantitative answers
only. Four levels of calibration were used for benzodiazepines,
cannabis, cocaine and amphetamine, six levels of calibration
were used for opiates and two levels were used for ethanol.
There were three levels used for the controls. Specificity of the
screening techniques was > 0.95. Coefficient of variation (CV %)
was 10%. There were three levels used of calibration for GC-
MS and GC-FID and one level for the controls. The coeffi-
cient of variation was 5%. Although the chromatographic
methods for amphetamine and ecstasy gave quantitative
answers too, we only used qualitative results in the statistical
analysis. The relative importance of each substance is there-
fore not evaluated.
Statistical Analysis
Data analyses were carried out using SPSS version 12.01.
Cohen’s Kappa was used to measure agreement between clini-
cal assessments and laboratory analyses. Kappa > 0.21 was
considered fair, >0.41 was considered moderate and >0.61
was considered good (19). Kappa = 1 indicates complete
agreement. Comparisons between groups were carried out
using Chi square tests. Wilcoxon signed ranks test was used to
assess the difference between numbers of suspected and found
toxic agents. The agreement was also assessed as the percent-
age when the drug was suspected and found or when it was not
suspected and not found. P < 0.05 was considered statistically
significant.
Ethics
The Regional Ethics Committee approved the study, and
agreed that, given that the patients were likely to be distressed,
uncooperative or unconscious, and the blood or urine samples
would be collected routinely and then labelled anonymously,
informed consent was not required. The clinical form was
given a number corresponding to the number on the urine or
blood sample, and the link between the numbers and the names
of the patients were locked down in the senior physician’s
office.
RESULTS
There were 405 patients who fulfilled the inclusion criteria
during the one year study period. In 320 admissions (79%) the
comparison between clinical diagnosis and laboratory analyses
could be performed (Fig. 1). Median age was 31 years, (mean
37, range 14–84 years), 52% being males. Among the 320
patients that were included in the further analyses, 256 urine
samples and 64 blood samples were obtained. There were no
significant differences regarding age, gender, race and out-
come between those who were excluded and those who were
included in the analyses. Furthermore, there were no differ-
ences regarding how clinically severe the patients were, or the
time interval from the drug was taken and until the patients
presented at the hospital. There were no differences regarding
the substances suspected, but GHB and amphetamine were
more often found in the urine of the patients where the form
was not completed (n = 16).
All patients were alive leaving the emergency room, but six
died during the following days, two males and four females.
Those who died were generally older (median 63.5 years,
range 27–77). Two of them (aged 27 and 38) had injected her-
oin and died from anoxic brain damage, rhabdomyolysis and
FIG. 1. Patients included in the study.
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69 patients where 
urine and blood 
samples were 
missing (17 %) 
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Form only: 
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Form missing: 
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sepsis. The four older subjects had taken specific serotonin re-
uptake inhibitors (SSRI), tricyclic antidepressants (TCA), ben-
zodiazepines and ethanol, respectively. However, underlying
somatic disorders (i.e., cancer and cerebral infarction) contrib-
uted to the fatal outcome.
A total of 478 drugs of abuse were suspected from the clini-
cal evaluation, significantly less than the 621 drugs that were
found by drug analyses.
Patterns of Abuse
Benzodiazepines (50%) and ethanol (40%) were most com-
monly detected (Table 1). Opiates (35%), cannabis (24%) and
amphetamine (21%) were also common. There was a signifi-
cantly higher prevalence of cannabis among males than among
females. There were no other statistically significant gender
differences. Amphetamine, ecstasy and cannabis were signifi-
cantly more common among patients under the age of 30 years.
In this age group, 33% had taken opiates and 31% amphet-
amines. Benzodiazepines were more common in patients older
than 50 years, where 63% had used it. Otherwise, there were
no significant age differences. The use of illegal substances
was also rather high among patients over 50 years, as opiates
were found in 43%, cannabis in 12% and amphetamine in 8%.
Neither of the substances was found in 8.4% of the cases,
whereas only one drug was found in 31.3% of the cases. Thus,
in 60.4% of the cases, a combination of two or more drugs of
abuse was found.
Clinical Assessment
Ethanol (45%) and benzodiazepines (44%) were by far the
most frequently suspected agents, (Fig. 2). There were signifi-
cant gender differences for benzodiazepines, amphetamine,
GHB and ecstasy. Benzodiazepines were suspected in 50% of
the women and 38% of the men. Amphetamine was suspected
in 15% of the men and 5% of the women. GHB was suspected
in 19% of the men and 7% of the women. For all other sub-
stances, only minor gender discrepancies were found.
TABLE 1
Drugs identified by laboratory analyses according to age and gender (%)
Patients
Total 
n = 320
Men
n = 165
Women
n = 155
<30 years 
n = 128
30–49 years 
n = 136
>50 years 
n = 51
Ethanol n = 129 40 39 42 37 47 35
Amphetamine 
n = 68
21 26 17 31 17 8
Ecstasy n = 18 6 7 4 10 3 2
GHB n = 37 12 15 8 14 9 4
Benzodiazepines
n = 159
50 53 47 41 54 63
Cocaine n = 21 7 8 5 9 5 4
Opiates n = 113 35 32 39 33 36 43
Cannabis n = 76 24 31 16 31 21 12
FIG. 2. Percentage of drugs of abuse that was suspected and found in acute 
poisonings according to gender; (a) Females, n = 155 and (b) Males, n = 165.
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Relationship Between Clinical Assessment and Drug 
Analysis
For GHB and ethanol, the agreement between clinical diag-
nosis and drug analysis was moderate (Table 2). For ecstasy,
amphetamine, cocaine and opiates, the agreement was fair, but
for benzodiazepines and cannabis, kappa was lower than 0.20,
and the agreement was therefore considered to be poor. The
physician made the correct evaluation, (i.e., suspecting the
drug when it was found and not suspecting the drug when it
was not found), in more than 75% of the cases considering
amphetamine, GHB, ecstasy, cannabis and cocaine. For etha-
nol and opiates, the evaluation was correct in 72% and 73% of
the cases, respectively. The highest correct evaluations were on
cocaine and ecstasy with 93%.
TABLE 2 
Relationship between clinical diagnoses and laboratory findings (n = 320)
Toxic agents 
identified % Suspected %
Found %
Kappa
Correct
evaluation %Not found %
Not suspected %
Found %
Not found %
Benzodiazepines
50
n = 159
44 60
0.18 5940
56 4258
Ethanol 
40
n = 129
45 64
0.43 723655 22
78
Opiates
35
n = 113
25 68
0.38 7432
75 2575
Cannabis 
24
n = 76
3 68
0.10 7733
97 2377
Amphetamine 21 
n = 68
10 67
0.35 8233
90 1684
GHB
12
n = 37
13 47
0.43 8853
87 694
Cocaine
8
n = 21
4 46
0.32 9354
96 595
Ecstasy 
6
n = 18
6 39
0.35 93
61
94
4
96
Correct evaluation represents the proportion of cases (%) where the physicians made the correct assessments (i.e., did suspect the drug when
it was found, and did not suspect the drug when it was not found).
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DISCUSSION
There were 92% of all patients treated for acute poisoning
who had used one or more drugs of abuse prior to their admission
to the hospital. As the number of toxic agents was more than
30% higher than expected, physicians seem to underestimate
the extent of use of such drugs. With the exception of cannabis,
there were no significant gender differences in the use of dif-
ferent toxic agents.
Opiates and amphetamines were surprisingly common, and
this was also true for the older patient groups. For one out of
three patients, opiates could be traced in blood or urine, and 43%
of patients older than 50 years had positive findings for opiates.
Popular painkillers containing codeine is the most likely expla-
nation. Skelton et al. found that codeine accounted for 63% of all
opiate-positive samples (6). One fifth of all patients had used
amphetamine in our study, where other studies have found
amphetamine in only 2 to 7% of all cases (10,14,15). Eight per-
cent of patients aged 50 or older, had positive samples for
amphetamine. Amphetamine was detected about twice as often
as GHB in all age groups. This confirms a suspicion that this old
drug of abuse is still commonly used, although TV and newspa-
pers like to focus on GHB and ecstasy.
The physicians made the correct evaluation regarding drugs
of abuse in more than 70% of the cases, with the exception of
benzodiazepines. Benzodiazepines are the drug most com-
monly seen, but also most commonly misevaluated. All the
drugs were found in less than 68% of the cases even when the
physicians were suspecting the drug. Neither of the deaths
could have been prevented by a correct diagnosis regarding
drugs of abuse. On the other hand, in-hospital mortality is very
low (<1.5%), and our sample is not large enough to find even a
substantial reduction in mortality. Multiple drug administration
is common in our study, where 60.4% of all patients had taken
two or more substance use drugs. The lower number of sus-
pected than found toxic agents is clinically important, as
polypharmacy increases the risk for complications.
Although benzodiazepines and opiates can be misused as
drugs of abuse, they are not illicit, per se. The present finding
that 63% of the patients aged 50 or older had used benzodiaz-
epines, and 43% had used opiates, is therefore not necessarily
an indication of abuse. This also reflects therapeutic use, which
was not requested. However, GHB, amphetamine, ecstasy,
cocaine and cannabis were still represented in this group, sug-
gesting that drug abuse persists in this age group as well. As
there is no way of differing between therapeutic use and drug
abuse of opiates and benzodiazepines in a urine or blood sam-
ple, the cases constituting of drug abuse were included at the
cost of including cases of therapeutic use. However, the thera-
peutic use of such drugs must also be taken into account by the
treating physician.
Clinical assessments did not seem to uncover all substances
administrated. The physicians may, however, mainly have
focused on main toxic agents, while the laboratory screening
has uncovered a majority of additional agents, like ethanol and
cannabis. The physicians were aware of the ongoing study, and
may have posited more drugs of abuse clinically than they nor-
mally would have suspected in their patients as a result of an
information bias. Therefore, the difference between suspected
and found toxic agents may be seen as a minimum. The use of
several substances makes the clinical assessments more diffi-
cult. This may partly explain why benzodiazepines and ethanol
were only found in about 60% of what was suspected. The
clinical picture of these substances may be quite similar, mak-
ing the assessments more difficult. An unselected material of
all acute poisonings were included, meaning that some of the
patients were admitted because of poisoning due to a drug of
abuse, while others were admitted for poisoning due to thera-
peutic agents. To reflect the heterogeneity of the clinical chal-
lenges, all patients treated for an acute poisoning were
included.
Drug analyses may not be the gold standard in this field. The
immunologic methods provided semi-quantitative answers
only, and since the time interval from admission to the sample
was obtained could be as broad as 24 h, only qualitative
answers were used for analyses. Therefore, the relative impor-
tance of the substances is unknown. Small amounts of drugs
may easily be forgotten, both by physicians and patients. More-
over, many of the substances have long half-lives, and the time
of ingestion or inhalation may be different from the episode that
led to hospitalization. Cannabis could be traced in one fourth of
all patients, and one out of three males had positive findings.
Cannabis may be traced in the urine for up to 46 days in heavy
users (20), and passive smokers may also have positive findings
(21). However, presence of cannabis would not alter treatment,
although it may be seen as an indicator of possible use of illicit
drugs. Urine or blood samples may have been taken as late as
24 h after the time of administration, and substances with short
half-lives, such as GHB and ethanol, would not be traced. This
could result in a false negative test. Amphetamine, ecstasy and
GHB will be eliminated more quickly if the pH in the urine is
low. Small doses would also be easily eliminated. Urine and
blood specimens have different rates of false negatives and false
positives, and this contributes to a possible bias in the study.
But some of these patients were not able to cooperate in a way
that made a urine sample possible to obtain, due to drug induced
behavior or lower level of consciousness. The protocol, there-
fore, included blood samples as a second best.
The high incidence of amphetamine in this sample may
raise the question of true, but inadvert, positives in the drug
screening. However, the specificity of the method used for
urine was found to be 98%, and the sensitivity was 73% (per-
sonal communication; Sheik, NA; Amphetamine screening–
comparison of reagents in 130 samples. Ullevaal University
Hospital, 2003). The rate of false positives is therefore low,
only 0.8%, whereas the rate of false negative tests are high,
17.8%. Serum was analyzed by gas-chromatography (GC-MS).
The possibility of not having uncovered a true positive test is
therefore more likely than having included a false positive test.
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All initial test results positive for amphetamine were confirmed
by GC-MS, and all initial results were found to be true. As for
opiates, the KIMS assay is found to pick up true negatives, but
misses true positives (22). The specificity is high, and our find-
ings must therefore be considered a minimum estimate. Lu et al.
have compared gas chromatography with KIMS assay for opi-
ates, amphetamines, benzodiazepines, cannabis and cocaine,
and concluded that KIMS has a strong capability to accurately
detect the drugs (22). However, the methods are developed to
investigate not only the drugs, but also their metabolites. For
amphetamine, for example, ephedrine from cold remedies may
be detected, if it is found in high doses.
There were incomplete data from 21% of the subjects avail-
able for the study. This may be seen as a possible bias. How-
ever, the excluded patients did not differ significantly from the
patients we were able to include regarding age, gender, race,
clinical outcome, time of presentation to the emergency depart-
ment or severity of the intoxication. But amphetamine and
GHB were significantly more common in samples of patients
where the form was not completed by the physician. These
patients usually want to leave the hospital as soon as possible,
and they tend to stay in the hospital for a very short time, prob-
ably because of the short half life (30 min) of GHB. The fact
that the drugs are illicit in Norway, may also contribute to the
urge to leave hospital. The percentage of these substances may
have been higher in the real population, and our findings must
be considered as a minimum estimate.
There are weaknesses in several of the measures of agree-
ment. Both Cohen’s kappa and the percent of correct evalua-
tion are rather high when the toxic agent is seldom found and
seldom suspected. Cocaine was only suspected in 4.1%. When
suspected, the physicians only made the correct evaluation in
about 50%. Even so, the total correct evaluation was 93% and
the kappa 0.32. It is accordingly easier to get better mathemati-
cal expressions of agreement for events that occur more sel-
dom. GHB and ethanol have the highest agreement, and in
most cases this was likely the presenting complaint. The thera-
peutic use of benzodiazepines and opiates may be reflected in
the lower agreement for these substances. Low agreement for
cannabis is probably due to its longhalf-life.
Comparing our findings with other studies is difficult due
to different exclusion and inclusion criteria. Amphetamine
seems to have increased since the 1980s, where Taylor et al.
found a proportion of only 2% among all intoxicated patients
treated in the emergency department (10). Jacobsen et al.
found that 1.8% of their self-poisonings had used amphet-
amines in Oslo in 1980 (2), corresponding to the numbers
from Taylor et al. in Washington D.C. Since then, there has
been no study in Norway where the prevalence of amphet-
amines in self-poisonings have been studied. However, Oslo is
known to have a relatively higher number of drug abusers
compared to the rest of Norway, due to the tendency of clus-
tering in urban areas. The study of Jacobsen et al. from 1980
included Ullevaal University Hospital, as well as all other hos-
pitals in Oslo. In this present study, only one hospital is
included, with the possibility of a selection bias. The hospital
does, however, serve an area including all social classes, and it
represents a fairly good cross-section of the population of
Oslo, but being a tertiary care center means that severe poison-
ings are overrepresented. GHB and ecstasy were not present
15 years ago, but these drugs now contribute to a substantial
number of cases; 12% and 6% respectively. Skelton et al.
found similar proportions of benzodiazepines and opiates
among patients treated for deliberate self-harm as in our sam-
ple (15), while Montague et al. found only 21% benzodiaz-
epines among deliberate self-poisonings (12).
Clinical assessments alone are known to be imprecise, and
our finding is consistent with this statement. Pohjola-Sintonen
et al. found that clinical evaluation was in complete accordance
with laboratory findings in only 27% of the cases (13), while
Brett et al. found this in 47% (8). However, Rygnestad et al.
found a concordance of 86 to 96% when combining results from
routine screening and clinical evaluation of the patient (23).
The impact of an imprecise clinical diagnosis is debated. No
studies have been large enough to investigate a possible effect
on mortality. Different outcome measures have been used, like
complications, change of treatment or whether or not the treat-
ing physicians felt that drug screen results had an impact on the
treatment of their patients. Skelton et al. found that drug screen
results could facilitate the extent of supervision needed (15).
Ray et al. pointed out the importance of precise identification
in order to evaluate drug interactions (14). Some patients may
try to hide a potentially life threatening overdose, while others
exaggerate the amount of drugs taken (13). However, all agree
that laboratory analyses are important in the comatose patient –
not only to optimize treatment, but to rule out acute poisoning
as the cause of the patient’s condition.
The physician must be aware of the extended use of drugs
of abuse in poisoned patients, both when considering acute
treatment and aftercare. Direct questions regarding each sub-
stance may uncover important additional toxic agents. Using
more tests for drugs of abuse will give the clinicians feedback
regarding their assessments, and evaluation of the intoxicated
patient may be better. Being aware of the individual patient’s
patterns of abuse may also have implications for a proper after-
care. However, the use of antidote (naloxon and flumazenil) in
the acute setting will always be guided by the clinical evalua-
tion, and not by drug analyses.
In the future, predictors of a correct diagnosis may be
sought. Are patient and companion histories truthful when it
comes to drugs of abuse? The relative importance of these
substances in the intoxicated patient may also be further
examined.
CONCLUSION
Drugs of abuse were more commonly found than suspected
clinically. Ninety two percent of all patients had used such
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drugs, and ethanol, benzodiazepines and opiates were most
common. Even though such drugs are more commonly found
among patients under the age of 30 years, the use is also exten-
sive in patients older than 50 years. Physicians seem to under-
estimate the use of drugs of abuse. Therefore, laboratory
analyses may aid the clinicians both in acute treatment, and in
tailoring proper aftercare for these patients.
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Objectives. The changing pattern of acute poisoning may affect complications and outcome in these patients. An update study on acute
poisonings was therefore performed and compared to similar data from 1980. Design. A prospective cross-sectional multi-center study of
all adult patients (≥ 16 years) hospitalized in Oslo with a main diagnosis of acute poisoning, irrespective of intention, over a one-year
period. Results. Of 947 admissions, 222 (23%) were comatose. Complications were observed in 173 (18%), slightly reduced from 1980
(22%). Ten (1.1%) died and six (0.6%) got permanent sequelae, of which seven and five were drug- or alcohol-related, respectively.
Seventy-five percent received treatment besides observation; 39% received antidotes, increased from 21% in 1980, most frequently
flumazenil (23%) and naloxone (14%). Conclusions. In-hospital mortality in poisoned patients remained low, few patients entailed
complications, and most patients survived without permanent sequelae. Drug- and alcohol-abuse related poisonings were most severe.
Keywords Toxicology; Acute poisoning; Consciousness; Mortality; Drug abuse; Alcohol
Introduction
Acute poisonings represent a major health problem, and fre-
quently cause hospitalizations (1). In 1980, a prospective
study of all hospitalized poisoned patients in Oslo revealed a
low in-hospital mortality of 0.5%. Of all patients, 1/4 were in
deep coma upon admission, slightly more than 1/5 experi-
enced complications, and 1/4 needed special treatment of
some kind (2). Changes in the pattern of poisonings over the
last decades affect clinical outcome and treatment (3–6).
While barbiturates were common in the 1960s and 1970s (5),
opioids and benzodiazepines increased in the 1980s and
1990s (7,8), and new recreational drugs like ecstasy (9,10)
and gamma-hydroxybutyric acid (GHB) (10–12) became
popular in the late 1990s. There has also been a marked
reduction in salicylate poisoning (3) almost inversely propor-
tionate to the increase in paracetamol poisoning (4,13). Poi-
sonings with antidepressants have been frequent for many
years, but the change in prescription patterns from tricyclic
antidepressants to selective serotonin reuptake inhibitors
(SSRIs) is associated with less severe complications and bet-
ter outcome after antidepressant poisonings (4,5,14).
We wanted to study the impact on clinical outcome and
treatment from the apparent changes in the toxicological pan-
orama. In order to compare the present study with the study
from 1980, we designed the new study as similar as possible
and included patients from the same geographical region. Our
aims were to register the level of consciousness, use of anti-
dotes and other treatments, complications, and outcomes
related to toxic agents, gender, age, and the intentions of the
poisonings.
Methods
Design of the study
This was part of a prospective, cross-sectional, multi-center
study designed to register acutely poisoned patients in contact
with all parts of the emergency health care system in Oslo
during one year (15). This article presents data from the clini-
cal course of hospitalized adults (≥16 years of age). Data
were collected from April 1, 2003 until March 31, 2004.
The inclusion criteria for the present study were admission
to hospital with a main diagnosis of acute poisoning; both
intentional and unintentional. Exclusion criteria were chronic
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poisoning and patients with other primary diagnosis, such as
traumas, even if there was an additional acute poisoning.
Data collection and statistics
Physicians obtained data by completing a standardized regis-
tration form. The forms were optically scanned and processed
using TeleForm Desktop version 9.1 (TeleForm, Verity Inc.,
Sunnyvale, California). Statistics were performed using
SPSS, version 12 (SPSS inc., Chicago, Illinois). When com-
paring frequencies, Pearson Chi square test was used with a
5% significance level. Logistic regression analysis was used
to adjust for independent variables. The study from 1980
included self-poisonings only, while the present study also
included accidental poisonings. All comparisons with the
former study were corrected for this difference by excluding
accidental poisonings in the calculations.
Criteria for classifications
The main agent was defined as the substance supposed to be
most toxic in the amount taken: The physicians made an
overall evaluation of the substance thought to cause the most
severe toxicity based on as much information as possible
from patients, bystanders, clinical manifestations and routine
laboratory analyzes. Other ingested agents were defined as
additional agents. Important information in this regard was
from the patients in 72% and/or companions in 35%, clinical
observations (including routine laboratory analyses) in 26%,
and other sources such as paramedics in 8%.
The physicians evaluated the intentions of poisoning based
upon the patients’ own reported intention and information
from other sources like paramedics and companions. Special
attention was paid to possible written letters confirming their
suicidal intent, supposed lethal doses of the toxic agent, or
other active procedures to secure lethal outcome, for example
intake in remote places, or hiding after intake. The self-
poisonings were hence classified as definite suicidal, possible
suicidal, appealing, or drug/alcohol-abuse related. The non-
self-poisonings were classified as accidental poisonings. The
appealing category was defined as deliberate, but non-sui-
cidal self-poisonings, mainly explained by a wish to influence
relations with other people.
Consciousness was classified according to the following
classification: 1) awake, 2) somnolent – can be kept awake
when stimulated, 3) coma, response to painful stimuli, and 4)
deep coma, no response to painful stimuli.
Respiratory insufficiency was defined as either arterial
blood-gas analysis showing respiratory acidosis by standard
criteria (pH<7.3, pCO2>7.0 kPa) or hypoxia (pO2<8.0 kPa),
or clinical need for ventilation support. Hypotension was
defined as systolic blood pressure below 85 mmHg in at least
two subsequent measurements. Cardiac arrhythmias were
registered from the cardiac monitoring screens or ECG. Con-
duction disturbances were classified as arrhythmia, but sinus
tachycardia was not. Cardiac arrest was classified as such, not
as arrhythmia. Hypothermia was defined as body temperature
below 35ºC and hypoglycaemia as serum-glucose level
below 3.5 mmol/L. Further criteria were according to general
clinical terminology.
The use of antidotes and treatment were recorded. Antidote
doses were not registered in each case, but in most cases stan-
dard Norwegian dosing regimes were followed: naloxon 0.4
mg, which can be repeated to a maximum of 2 mg, in extreme
cases up to 10 mg, and flumazenil 0.5 mg, which can be
repeated to a maximum of 2 mg.
Ethics
Treatment was given according to the standard hospital pro-
tocols, and in accordance with the Helsinki Declaration. Per-
mission was obtained from The National Data Inspectorate
and the Regional Ethics Committee. Informed consent was
asked for, and only one patient refused to participate. All data
were stored anonymously.
Results
A total of 947 admissions in 780 patients were recorded. Figure 1
gives an overview of the study and main outcome. In total,
these patients stayed 2,109 days in hospital (median 1, range
1–106 days); 58% were discharged after only one day, 31%
stayed two days, and 11% stayed three days or more. 381
(40%) of the admissions were treated in the intensive care
unit (ICU), of which 100 (11%) for more than one day.
Consciousness
Drug/alcohol-abuse related poisonings led to coma more fre-
quently (36%) than the other poisonings (p<0.005 for all com-
parisons) (Table 1). Since 51% of the male versus 24% of the
female poisonings were classified as drug abuse-related (15),
there was also a significant difference in consciousness
Fig. 1. Complications and outcome in acutely poisoned adults
admitted to hospital during one year.
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according to gender; males were more often comatose (27%)
than females (20%) (p=0.009). Among patients presenting with
coma on admission, GHB and ethanol (both 23%) were by far
the most common main toxic agents (Table 2). The coma
observed in the 13 paracetamol poisoned subjects was due to
additional toxic agents in 12 cases (codeine in combination
products with paracetamol); none had liver coma on admission,
but one was admitted late with coma due to multiorgan failure.
The patients with coma on admission entailed more often com-
plications (37%) than the non-comatose (13%) (p<0.001).
Complications
No complications were recorded in 774 (82%) admissions. In
the 173 (18%) admissions with complications, two or more
complications were recorded in 54(6%). Respiratory
depression (7%), hypotension (4%), pneumonia (4%) and
arrhythmia (3%) were the most common problems. Table 3
presents the complications related to the different toxic
agents. Complication rates were highest for methanol (67%),
cardiovascular drugs (55%), amphetamine (44%), and opioid
(42%) poisonings. Poisonings with multiple toxic agents had
the same frequency of complications as single agent
poisonings (82% vs. 81%). Concerning the reported inten-
tions of poisoning, complications were more frequently seen
for drug/alcohol-abuse related intoxications (26%), accidental
(26%) and definite suicidal (23%) poisonings than for possi-
ble suicidal (13%) and appealing (9%) patients (p<0.05 for
all). Regression analysis revealed an odds ratio for complica-
tions in drug/alcohol-abuse related poisonings to be 2.2 (95%
CI 1.5 – 3.1), compared to the other self-poisonings as one
group, corrected for gender.
Use of antidotes
Antidotes were used in 371 (39%) of the admissions (Table
4), and more than one antidote in 107 (11%). Flumazenil was
given in 220 cases (23%): 42% of the cases with benzodiaz-
epines as the main agent, 34% of the cases with
benzodiazepines as an additional agent, and 39% of the cases
with zopiclone as the main agent. Ten patients with cariso-
prodol (without benzodiazepine) poisonings received fluma-
zenil, of which none had seizures. Naloxone was given in 130
cases (14%): 52% of the cases with opioids as the main agent
and 20% of the cases with opioids as additional agents. Forty-
nine percent of the patients receiving flumazenil and 28% of
the patients receiving naloxone were not comatose.
Both flumazenil and naloxon were frequently given diag-
nostically. In 50 such cases (23% of the flumazenil given),
comatose or somnolent patients received flumazenil without
clinical effect, weakening the suspicion of benzodiazepine or
zopiclone poisonings. Equivalently, in 75 cases (58% of the
naloxon given), comatose or somnolent patients were given
naloxon diagnostically without effect, weakening the suspi-
cion of opioid poisonings.
Among all admissions, 11 (1.2%) had convulsions: 1/127
(0.8%) treated with flumazenil as the only antidote, 1/37
(2.7%) treated with naloxone alone, 4/93 (4.3%) treated with
both flumazenil and naloxone, and 5/690 (0.7%) who did not
receive either of the two antidotes. Logistic regression analy-
sis of convulsions in these groups revealed that only those
receiving both flumazenil and naloxone had significantly
more convulsions than the others, OR 6.1 (95% CI 1.6–23.4).
As seen from Table 4, paracetamol poisonings were most
often given treatment (91%), and N-acetylcysteine (NAC)
Table 1. Level of consciousness compared to intention of the poisonings
Definitely 
suicidal
Possibly 
suicidal Appeal* Drug abuse Accident Total
n (%) n (%) n (%) n (%) n (%) n (%)
Awake 33 (36) 114 (48) 141 (61) 119 (35) 31 (79) 438 (46)
Somnolent 40 (43) 73 (30) 69 (30) 101 (29) 4 (10) 287 (30)
Coma 9 (10) 37 (15) 14 (6) 80 (23) 1 (3) 141 (15)
Deep coma 10 (11) 16 (7) 8 (3) 44 (13) 3 (8) 81 (9)
Total 92 (100) 240 (100) 232 (100) 344 (100) 39 (100) 947 (100)
*Deliberate but non-suicidal self-poisonings, mainly explained by a wish to influence relations with other people.
Table 2. Main toxic agents in 222 comatose patients
Main agent n
% of comatose 
patients
GHB 51 (23)
Ethanol 50 (23)
BZD 28 (13)
Opioids 25 (11)
Paracetamol 13 (6)
Carisoprodol 12 (5)
TCA 10 (5)
Nevroleptics 9 (4)
Others 24 (11)
Total 222 (100)
Both coma and deep coma are included.
GHB=gamma-hydroxybutyric acid, BZD=benzodiazepines,
and TCA=tricyclic antidepressant.
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was given to 79% of these poisonings. In addition, 28 of 97
(29%) cases with paracetamol as an additional agent were
treated with NAC. Fomepizole was given to ethylene glycol
(n=3) and methanol (n=3) poisonings.
Other treatments and observations
Treatment other than antidote was given in 638 (67%) of the
admissions (Table 4). Of all admissions, 240 (25%) received
no further treatment than observation. Seventy-eight percent
of the gastric lavages were performed within two hours after
ingestion of the toxic agents. There was no increased fre-
quency of pneumonia in the gastric lavage group (4%) com-
pared to the other (4%).
Hemodialysis was performed in nine patients (1%); 3/3
methanol poisonings, 1/4 ethylene glycol poisonings, 2/7 lith-
ium poisonings, and as a result of acute renal failure in three
other patients.
Resuscitation was performed in eight patients: five died,
two survived with permanent brain damage and one recov-
ered completely after multi-substance poisoning with tricy-
clic antidepressant (TCA) as the main agent. The latter had
hypothermia (24°C) and cardiac arrest on admission, and was
successfully warmed with cardiopulmonary bypass.
Mortality and permanent sequelae
Ten patients died in hospital; total mortality among all admis-
sions was 1.1% (Table 5). Mortality among those presenting
with coma on admission was 3% (7/222), and mortality
among the mechanically ventilated patients was 21% (7/33
patients). The four patients with lethal ethanol or benzodiaz-
epine poisonings were all found late with pronounced aspira-
tion pneumonia. Six patients (0.8%) survived with permanent
sequelae, mainly due to ischemic brain damage (Table 6),
while 764 patients (931 admissions; 98%) survived with no
permanent injury recorded.
Discussion
Complications were noted in less than 1/5 of the admissions,
although about 1/4 were comatose on admission. 3/4 of the
Table 3. Complications and main agents
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N poisonings 3 11 16 69 20 68 15 35 4 9 162 64 13 116 172 170 947
N with complications 2 6 7 29 6 19 4 9 1 2 29 10 2 16 17 14 173
% with complications 67% 55% 44% 42% 30% 28% 27% 26% 25% 22% 18% 16% 15% 14% 10% 8% 18%
mean number of 
compl / admission
4.0 0.6 0.7 0.8 0.5 0.4 0.5 0.4 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.1 0.3
N % %
Respiratory 
depression
2 12 4 5 2 4 1 13 2 1 9 10 2 67 (24) 7
Hypotension 2 2 1 7 2 2 3 2 6 5 1 4 4 2 43 (15) 5
Pneumonia 2 1 11 1 1 1 1 9 2 4 4 2 39 (14) 4
Arrhytmias 2 4 3 3 1 4 1 2 1 2 1 3 27 (9) 3
Hypothermia 4 1 4 5 4 1 19 (7) 2
Convulsions 2 3 1 3 1 1 11 (4) 1
Rhabdomyolysis 3 1 1 1 4 1 11 (4) 1
Cardiac arrest 2 3 1 2 1 1 10 (4) 1
Renal failure 1 1 1 2 1 6 (2) 1
Brain damage 1 1 1 1 1 5 (2) 1
Hypoglycemia 1 1 1 1 4 (1) 0
Others 1 2 4 7 4 1 8 1 1 6 2 6 43 (15) 5
Total n compl 12 7 11 52 9 25 7 13 1 2 53 13 4 35 23 18 285 (100)
The list is sorted by agents producing relatively most complications and complications after frequency.
TCA=tricyclic antidepressant, GHB=γ-hydroxybutyric acid, and BZD=benzodiazepines.
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admissions received treatment of some kind. Drug/alcohol-
abuse related poisonings were the most severe in terms of
depressed consciousness, complications, permanent sequelae
and in-hospital-mortality, with a male dominance.
Although the overall mortality was low, and the median
duration of the hospital stay was only one day, 40% of the
patients were treated in the ICU. This was similar to the study
from 1980 (37%) (2), and reflects the typical episode, being
Table 4. Treatment for the most common main agents
BZD Ethanol Parac. Opioids GHB Others Total
Treatment n % n % n % n % n % n % n %
Observation only 38 (22) 52 (32) 11 (9) 16 (23) 21 (31) 102 (28) 240 (25)
Treatment (incl. antidotes) 134 (78) 110 (68) 105 (91) 53 (77) 47 (69) 258 (72) 707 (75)
Total 172 (100) 162 (100) 116 (100) 69 (100) 68 (100) 360 (100) 947 (100)
Antidote 74 (43) 45 (28) 97 (84) 39 (57) 27 (40) 89 (25) 371 (39)
Flumazenil 73 (42) 30 (19) 12 (10) 15 (22) 25 (37) 65 (18) 220 (23)
Naloxone 12 (7) 24 (15) 8 (7) 36 (52) 23 (34) 27 (8) 130 (14)
N-acetylcysteine 3 (2) 8 (5) 92 (79) 4 (6) 18 (5) 125 (13)
Fomepizole 6 (2) 6 (1)
Vitamin K 1 (1) 2 (1) 3 (-)
Physiostigmin 1 (2) 2 (1) 3 (-)
Deferoxamine 3 (1) 3 (-)
Other 1 (1) 1 (-) 2 (-)
Other treatment 116 (67) 100 (62) 90 (78) 45 (65) 40 (59) 247 (69) 638 (67)
General treatment* 76 (44) 82 (51) 42 (36) 32 (46) 37 (54) 149 (41) 418 (44)
Activated charcoal 54 (31) 21 (13) 56 (48) 10 (14) 2 (3) 138 (38) 281 (30)
Gastric lavage 26 (15) 10 (6) 41 (35) 7 (10) 1 (2) 77 (21) 162 (17)
Oropharyngeal intubation 1 (1) 7 (4) 5 (4) 8 (12) 2 (3) 16 (4) 39 (4)
Mechanical ventilation 1 (1) 6 (4) 5 (4) 8 (12) 2 (3) 11 (3) 33 (4)
Haemodialysis 2 (1) 1 (1) 6 (2) 9 (1)
Resuscitation 1 (1) 1 (1) 3 (4) 3 (1) 8 (1)
Other 7 (4) 13 (8) 15 (13) 8 (12) 4 (6) 35 (10) 82 (9)
*General treatment means IV fluid, warming, non-antidote medication, and supportive care.
Note that some patients received more than one treatment or one antidote. Treatment and use of antidote may also be due to suspected additional agents not
listed above.
BZD=benzodiazepines; GHB= γ-hydroxybutyric acid.
Table 5. Fatal poisonings
Gender and age Main agent Additional agents Comments
 86 Opioid Cancer. Suicidal ingestion, found after 2 days, aspiration pneumonia.
 45 Opioid Cardiac arrest after heroin overdose. Resuscitated but anoxic brain 
damage.
 37 Opioid Amphetamine Found with respiratory arrest. Resuscitated but anoxic brain damage.
 63 Ethanol Alcoholism, found comatose outside, hypothermia (28.5°C), 
aspiration pneumonia.
 54 Ethanol Benzodiazepines Found comatose with aspiration pneumonia, global cortical 
ischemia.
 84 Benzo-diazepines Previous stroke. Aspiration pneumonia.
 73 Benzo-diazepines Zopiclone Carbamazepine Aspiration, hypothermia and hypotension.
 46 Methanol Admitted late with coma and metabolic acidosis.
 24 Paracet-amol Codeine Hypothermia. Cardiac arrest during warming. Resuscitated. ECMO. 
Multiple thrombosis.
 24 Cocaine
Myocardial ischemia and cardiac arrest. Resuscitated but anoxic 
brain damage.
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dramatic on admission, but resolving to a stable situation
within one day, if complications are avoided. There are few
similar studies which include all hospitalized poisonings in a
geographical area regardless of intention.
Consciousness
The present frequency of comatose patients was similar to the
1980 study (24% vs. 25% in 1980) (2), but agents causing
coma have changed: Opioids and TCA have been replaced by
GHB and ethanol as the most common causes of coma.
Opioid overdoses are now routinely treated with naloxone by
the paramedics on site, and only those with complications are
admitted to hospital (16). The increase in opioid overdoses
since 1980 is therefore not reflected in the number of hospi-
talized opioid poisonings. However, the frequency of coma-
tose patients in the present study outnumbers a Spanish study
from 2003 by four-fold (24% vs. 6 %) (9), and only 5.6%
were comatose in a Greek study (17). This may be due to
treatment policy in Oslo, with outpatient treatment of the
mild drug poisonings instead of hospitalization.
Complications
Complications from self-poisonings have changed since 1980
(Table 7). The decrease in respiratory depression in hospital
was due to increased outpatient treatment of heroin over-
doses. Rhabdomyolysis was not widely known before creat-
ine phosphokinase (CK) analyzes became part of routine
analyzes later in the 1980s. Although not significant
(p=0.06), the possible increase in anoxic brain damage may
be seen as a side-effect of modern intensive care medicine,
where an increased survival rate may lead to an increased
number of survivors with permanent brain damage. While
opioids, carisoprodol and antihistamines were the agents with
the highest complication rates in 1980, methanol, cardiovas-
cular drugs and amphetamine had the highest rates in the
present study. Since as much as 62.5% of the patients had
taken more than one toxic agent, it was, however, difficult to
relate specific complications to one single toxic agent. The
complication rate in this study was higher than in another
Norwegian study, 18% vs. 8% (3), while a Greek study
reports complications in 26% of parasuicide patients (17).
Use of antidotes
The use of antidotes was extensive (39% of all admissions)
compared to 1980 (21%). Even in 1980, the use of antidote
was considered liberal, but more effective antidotes are
Table 6. Poisonings resulting in permanent sequelae
Gender and age Main agent Additional agents Comments
 57 Ethanol Paracetamol Salicylates Alcoholism. Pneumonia, sepsis, and stroke.
 45 Ethanol Ethylene glycol (minor ingestion) Alcoholism. Found comatose. Bleeding oesophagus varices, 
aspiration pneumonia, cardiac arrest, resuscitated. Mild 
cerebral damage.
 62 Methanol Alcoholism. Severe methanol poisoning admitted late. Brain 
damage.
40 Amphetamine Opioid Benzodiazepines cannabis Drug abuse. Brain damage due to hypoxia and hypoglycemia.
 36 Opioid Amphetamine Drug abuse. Cardiac arrest. Resuscitated, but severe brain 
damage.
 28 Sildenafil Additional unknown impotence agents Cerebral infarctions
Table 7. Complications among self-poisonings in the present study
and in 1980
Total number of 
admissions
Present 
study n=908
1980
n=1125
n (%) n (%) p-value
Admissions with 
complications
163 (18) 244 (22) 0.04
Admissions with ≥ 
two complications
48 (5.3) 78 (6.9) NS
Respiratory 
depression /arrest
64 (7.0) 152 (13.5) <0,001
Hypotension 41 (4.5) 60 (5.3) NS
Pneumonia 37 (4.1) 49 (4.4) NS
Arrhythmia 22 (2.4) 16 (1.4) NS
Hypothermia 18 (2.0) 18 (1.6) NS
Cardiac arrest 10 (1.1) 8 (0.7) NS
Convulsions 11 (1.2) 15 (1.3) NS
Rhabdomyolysis 11 (1.2) – –
Renal failure 5 (0.6) 4 (0.4) NS
Brain damage 5 (0.6) 1 (0.1) NS
Others 39 (4.3) 62 (5.5)
Total no. of 
complications*
267 – 336 –
Note that only self-poisonings are included in this comparison due to inclu-
sion criteria in 1980.
*Total number of complications includes more than one complication in
some patients; hence, percentage of total number of complications is not
applicable.
NS=non-significant.
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available since then (e.g., flumazenil and NAC), which
may explain part of the increase. Flumazenil was the most
commonly used antidote, as shown elsewhere (9), also
given to many of the zopiclone poisonings (18). The use of
flumazenil as a diagnostic tool was too extensive since only
half of these patients were comatose. In Spain, 80% of the
flumazenil-treated were reported non-comatose (9), and a
Canadian study concluded that empirical use of flumazenil in
intentional drug overdose of unknown aetiology was not cost
effective (19). Flumazenil may cause seizures (20), but others
consider flumazenil to be a safe and valid diagnostic tool
(21). In our study, there were not significantly more convul-
sions in the group receiving only flumazenil, indicating that
the present (over-) use was not harmful at the doses typically
utilized. The patients receiving both flumazenil and naloxone
had, however, significantly more convulsions, although the
numbers were low, and hence no correction was made statis-
tically to evaluate other possible causes. Interestingly,
seizures were not significantly more frequent when naloxone
was used alone, although a former prospective study from
Oslo showed that 4% of opioid poisoned patients treated with
naloxone had seizures (16). This may support the clinical
experience that seizures in most cases result from cerebral
hypoxia, or that they are rather unspecific signs in the
severely poisoned – or critically ill – patient.
Allergic reactions are reported in up to 5% in patients treated
with NAC intravenously (22). We found no such adverse
events, probably because the presence of paracetamol may
have protected against anaphylactic reactions (22), or because
of small numbers. L-methionine was the antidote for paraceta-
mol poisonings in 1980, given to 47% of these poisonings (3%
of total), compared to 56% of paracetamol poisonings (13% of
total) receiving NAC in the present study. Physostigmine was
given to only 3 patients (0.3%) in this study, compared to 46
(4%) patients in 1980 (2). Physiostigmine has been replaced by
other treatment regimens as “diagnostic” or first-line antidote,
in accordance with reports on complications (23).
Other treatment
Gastric lavage was performed in 162 (17%) of the cases; in
78% less than two hours after ingestion. There is no evidence
based routine indication for gastric lavage after 1–2 hours
(24), except for very toxic agents with anticholinergic effects.
This is probably not the case in all of the “late” gastric
lavages performed in this study, indicating over-use of the
procedure. However, no complications were recorded due to
the present use of the procedure, and in particular, there were
not more aspiration pneumonias than in those not lavaged.
Mortality
The mortality of hospitalized self-poisonings was 1.1%,
compared to 0.5% in 1980 (2) (p=0.15). This resembles mortal-
ity from a large Finnish retrospective study from 1992, reporting
in-hospital mortality of 0.7% (25). A retrospective study from
Zimbabwe revealed an overall in-hospital mortality of 4.4%,
emphasizing differences to poisonings in developing countries
with more pesticide and chemical poisonings (26). In the present
study, four patients died from illicit drugs, of which three from
opioids, compared to only one in 1980. The two lethal benzodi-
azepine poisonings, one in combination with other drugs, and
one with previous stroke, supports recent studies from Belgium,
where three of ten lethal intentional poisonings were due to
benzodiazepines (27). Because few studies report similar high
numbers, the cause of death may often be diagnosed as the respi-
ratory complications, such as aspiration pneumonia observed in
our patients, rather than the actual poisoning. The number of
such lethal cases may therefore be underestimated.
Study limitations
There were several collaborators in four different hospitals
participating in the study. However, due to the prospective
design and thorough follow-up of all the participating hospi-
tals, we believe that the number of possible missed cases was
low. The data collection was made by several physicians, and
the inter-rater variability is not known. Scanning of forms
may lead to errors, which were manually corrected by enter-
ing the original forms. Random cases (120 variables) were
checked afterwards, revealing <0.06% errors.
The exclusion of patients with primary diagnoses other
than poisonings could have excluded important acute poison-
ings from the study. However, most of these patients would
have their clinical course affected by the primary, non-
poisoning diagnoses. Since our aim was to study the clinical
outcome of acute poisonings in itself, the results would prob-
ably have been biased by including these patients. It would
also have made the inclusion criteria too complex, taken into
account the study size and the number of collaborators.
The clinical diagnosis of the toxic agents is difficult (28), and
the suspected agents were not always verified by laboratory
tests. Laboratory screening of all patients for all agents would
require a very comprehensive screening in almost one thousand
patients. Although there were variations in the amount of infor-
mation which the diagnoses were based on, the results were in
each case based on as much information as possible. Recent
data indicate underestimation of drugs of abuse (29), and the
reliability of the clinical assessment of agents could be ques-
tioned. The intentions of the poisonings were categorized to
resemble the clinical everyday life, rather than to divide patients
into accurate categories. The categories were not a validated
scheme, the distinctions between them are vague, and compari-
sons to other studies are difficult due to lack of uniformity.
Conclusion
In-hospital mortality in poisoned patients remained low, few
patients entailed complications and most patients survived
Acute poisonings in Oslo (II): Clinical course 49
without permanent sequelae. Drug- and alcohol-abuse related
poisonings were the most severe.
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LCLTARTICLE
Mortality and causes of death after hospital-treated self-poisoning 
in Oslo: A 20-year follow-up
Mortality and causes of death after self-poisoningMARI ASPHJELL BJORNAAS1, DAG JACOBSEN2, TOR HALDORSEN3, and OIVIND EKEBERG2
1University of Oslo, Department of Behavioural Sciences in Medicine, Oslo, Norway
2Ullevaal University Hospital, Department of Acute Medicine, Oslo, Norway
3University of Oslo, Department of Biostatistics, Institute of Basic Medical Sciences, Oslo, Norway
Introduction. Self-poisoning is a risk factor for premature death and for suicide, but for how long? The aims were to examine the mortality
rate, causes of death, and risk factors for mortality and suicide during 20 years. Method. Prospective cohort study including all patients
discharged after self-poisoning from all medical departments in Oslo in 1980 (n = 946, 51 % females, median age 31 years). Standardized.
mortality ratios (SMRs) and Cox regression analysis were used. Results. During follow-up, 355 (37.5%) of the patients died, SMR 4.6
(95% CI, 4.2–5.1). After 15 years, the SMR was still 3.3 (95% C.I., 2.5–4.2). Sixty-seven (7.1%) committed suicide, SMR 26.7 (95% CI,
21.0–33.9). The risk of death from all causes was significantly higher. Unspecific risk factors for death were found. A suicidal motive was
the only risk factor for suicide. Conclusion. The mortality rate implies a poor prognosis in this patient group.
Keywords Acute poisoning; Suicide; Mortality
Introduction
Suicidal behavior and substance abuse are the main reasons
why people self-poison. Both suicidal behavior and acciden-
tal self-poisonings as a result of substance abuse are aspects
of self-destructive behavior (1), the latter classified as risk-
taking thoughts and behaviors (2). Self-poisonings can there-
fore in many respects be studied as a common risk group.
Many studies focus on subgroups of self-poisonings, such as
suicide attempters (3), medically serious suicide attempters
(4), deliberate self-harm (5), deliberate self-poisonings (6),
and non-fatal drug overdoses (7). The fundamental principle
in this classification is the correct evaluation of the intention.
However, evaluation of intention among patients presenting
with self-poisonings at the Emergency Department can be
difficult; the patients are often comatose, unwilling to report
the use of illicit drugs, and even the ambivalence and instabil-
ity in the wish to die can complicate the evaluation. The valid-
ity of the patient’s own given reason for the self-poisoning has
been questioned (8). When including all self-poisonings pre-
senting at the Emergency Department, the generalization from
the sample back to a well-defined background population is
possible. The intention may be studied as one of the factors
characterizing the patients.
A previous suicide attempt is the strongest known predic-
tor of later suicide (9). A history of a suicide attempt
increases suicide risk both in the first years after the episode
(10), and over the long term (3). Suicide attempts are
included in the broad spectrum of self-harm, as well as self-
injury without an explicit wish to die. Owens et al. found in a
meta-analysis of risk of suicides following self-harm that the
strong connection between self-harm and later suicide lies
somewhere between 0.5% and 2% after 1 year and above 5%
after 9 years. Suicide risk among self-harm patients is more
than one-hundred times higher than in the general population
(11). However, there is a considerable co-morbidity between
psychiatric disorders and substance abuse, and substance
abuse is an independent risk factor for later suicide among
suicide attempters (12). Both suicide attempts and suicides
occur more frequently among heroin users (13) and chronic
alcohol consumers (14), which emphasizes the need to
address both the intention and the history of substance abuse
when a patient presents with self-poisoning (15).
Excess mortality of suicide attempters by natural and unnat-
ural causes has been noted after five years (16,17), eight years
(10), 10 years (18), and 12 years (19). The same pattern of
excess mortality is seen in drug abusers, both over the short
term (15) and in a 20-year follow-up study (20). However,
does the identification of high suicidal intention or substance
abuse include all patients at increased risk of premature death
and committing suicide among self-poisonings?
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Patients presenting at an emergency department for self-
poisoning is a risk group both for excess mortality and
completing suicide. In previous studies, we have presented
the causes of death in unselected five- and 10-year follow-ups
of all patients treated for self-poisoning in all medical depart-
ments in Oslo during one year (21). In the present study, we
conducted a follow-up of the same cohort over 20 years. The
aims of the study were to determine: (1) the 20-year overall
mortality rate for all patients admitted to medical departments
for self-poisoning in Oslo in 1980; (2) the mortality in the
cohort compared with the general population of Norway; (3)
the causes of death; (4) factors that might differentiate those
who died in the follow-up period from those who survived;
and (5) factors that might predict suicide or other causes of
death.
Methods
All patients discharged following treatment for self-poisoning
in 1980 in the medical departments in Oslo (454,000 inhabit-
ants) were included in an original cross sectional study (22).
Patients leaving the emergency room after treatment were
also included. There were 952 patients who had a total of
1125 admissions during one year, giving an annual incidence
in Oslo in 1980 of 2.8/1000. Six patients were foreigners who
could not be traced and thus were excluded from the follow-
up study. The present cohort study therefore consists of 946
patients, and the cohort was compared to the general popula-
tion in Norway. There were 51% females in the cohort. The
median age was 31 years (range 13–93 years). The cohort
was unselected and included all self-poisonings from drugs,
narcotics, alcohol, or combinations regardless of suicidal
motive. The first or the most serious admission (i.e., relating
to the toxic agent and the amount taken) was chosen as the
index episode. Patients were followed to death, emigration,
or to the end of year 2000, whichever occurred first. The
follow-up included 15 055 person-years.
The mortality in the cohort was compared to the mortality
in the general population, with reference rates according to
age and gender. Reference rates were computed in five-year
calendar periods and five-year age groups (15–19, 20–24, etc)
for each sex. Expected death was computed by multiplying
the observed person-time in the cohort by the reference rate.
Standardized mortality ratios (SMRs) were computed by
taking the ratio of observed to expected deaths (i.e., the ratio
of the number of deaths observed in the cohort to the number
of deaths that would be expected if the cohort had the same
specific rates as the general population). The mortality ratios
were adjusted for age changing in the cohort over time.
At the end of follow-up, the status of each patient (i.e.,
whether alive, emigrated or dead) was checked according to
the Central Population Register. The causes of death were
classified according to the death certificates provided by
Statistics Norway and grouped according to the standards
used by Statistics Norway. Death certificates were based on
forensic autopsy records in all cases that were not due to natu-
ral causes of death. International Classification of Diseases-8
(ICD-8) was used for deaths occurring before 1987, ICD-9
for deaths from 1987 until 1996, and ICD-10 for deaths from
1996 to 2000. Accidental poisonings were included in the
group called accidents, whereas deaths by drug dependence
(category 304 or 305 in ICD-9) were classified as other dis-
eases. The categories for different causes of death were the
same for the cohort as for the general population.
As for possible predictive factors for later suicide or death,
these were noted at time of admission. Consciousness was
classified according to the following: (1) awake; (2) sopo-
rous; (3) somnolent – can be kept awake when stimulated; (4)
coma – response to painful stimuli; and (5) deep coma – no
response to painful stimuli (Table 1). Coma and deep coma
corresponded to a Glasgow Coma Score < 8.
Classification of abuse was based upon patient interviews
and records. The basic criteria included information on daily
or regular use of the respective compound, including with-
drawal symptoms if the compounds were not administered.
As shown in Table 2, 34% of the females and 59% of the
males were abusers, mainly of alcohol for both sexes.
In classifying suicide attempt, we emphasized measures
taken by the patient to ensure a lethal outcome, such as
ingesting a supposedly lethal dose without making contact
with others shortly after or writing a farewell letter. The act
Table 1. Description of patients at time of admission
Males (%) Females (%) Total (%)
Socio-economic group
1 9 (3) 18 (5) 27 (4)
2 41 (12) 73 (20) 114 (16)
3 173 (51) 207 (56) 380 (54)
4 114 (34) 70 (19) 184 (26)
Not evaluated 122 119 241
Suicidal motive
Suicidal 54 (12) 100 (21) 154 (17)
Non-suicidal 391 (88) 371 (79) 762 (83)
Not evaluated 14 16 30
Substance abuse
No abuse 172 (39) 314 (65) 486 (53)
Opioid addict 67 (15) 43 (9) 110 (12)
Alcohol abuse 163 (37) 77 (16) 240 (26)
Drug abuse 19 (4) 31 (6) 50 (5)
Other abuse 15 (3) 15 (3) 30 (3)
Not evaluated 23 7 30
Level of consciousness
Awake 107 (23) 116 (24) 223 (24)
Somnolent 131 (29) 155 (32) 286 (30)
Soporous 83 (18) 99 (20) 182 (19)
Comatose 90 (20) 81 (17) 171 (18)
Deep coma 48 (10) 36 (7) 84 (9)
Seen by psychiatrist
No 380 (83) 378 (78) 758 (80)
Yes 79 (17) 109 (22) 188 (20)
Mortality and causes of death after self-poisoning 3
was considered an appealing act if the patient had contacted
others after the self-poisoning or otherwise behaved in a way
that made a lethal outcome unlikely. The distinction between
suicide attempt and an appealing act, although seen as a
continuum, was made between a wish to die versus merely a
wish for changes, in concordance with the definition of
suicide attempt by Retterstol (23). The clinical evaluation
was done by the physician treating the patient. The physician
referred patients to see the liaison psychiatrist based on the
clinical evaluation of each patient.
Education level and yearly income were used to define
four socio-economic groups, where socio-economic group 1
was considered the highest and 4 the lowest. For those under
30 years of age the same parameters in the parents in part also
determined the socio-economic groups. The spouses’ income
and/or educational level were taken into consideration where
appropriate. The highest level of education were noted; lower
secondary education or less, upper secondary education, or
postsecondary education (college or university). This infor-
mation was combined with the yearly income, according to
the system used by Statistics Norway in 1980.
Statistical analyses
For SMRs, the 95% confidence intervals (95% CI) were com-
puted, based on the assumption that observed deaths follow
the Poisson distribution. Predictors for death and for suicide
were found using Cox regression analyses. In the analysis of
total mortality, attained age was chosen as the time variable.
In the analysis of suicide, time since discharge was used as
the time variable. Univariate analysis was performed first,
followed by multivariate analysis, which included all
variables with P < 0.15 in the univariate analysis. All clinical
parameters used in the Cox regression analysis were used as
categorical data, with the exception of the variable called
“duration of stay”, which was continuous. Data were
analyzed using programs for survival analysis and for Cox
regression analysis in Stata (StataCorp 2003, Stata Statistical
Software Release 8.0, Stata Corporation, College Station,
TX, USA). For other data analyses, SPSS was used (2005
SPSS version 14.0, SPSS Inc., Chicago, IL, USA). Groups
were compared using chi-square tests. P < 0.05 was consid-
ered significant.
Results
Mortality
During the 20-year follow-up, 355 (37.5%) of the patients
died. Among males, 45.3% died, and 30.2% of all females
died. The SMRs were 4.6 (95% CI, 4.2–5.1) in total, 5.0
(95% CI, 4.3–5.7) for males, and 4.2 (95% CI, 3.6–4.9) for
females. There was an excess risk of death in all age groups,
but the SMR was highest for patients younger than 30 years
at the time of discharge, for whom observed number of
deaths were between 10 and 16 times higher than expected.
The mortality was higher in the cohort than in the general
population during all five-year periods after discharge; the
SMR was 6.3 (95% CI, 5.3–7.5) in the first five-year period
and declined to 3.3 (95% CI, 2.5–4.2) in the final five-year
period (Table 3).
Socio-economic groups 3 and 4 had a higher excessive
mortality than social groups 1 and 2. The SMR was 1.0 in
group 1 (95% CI 0.46–2.3), 2.5 in group 2 (95% CI, 1.7–3.6),
4.1 in group 3 (95% CI, 3.4–4.8), and 7.3 in group 4 (95%
CI, 6.0–8.9). The mortality was significantly higher than
expected for females in social group 1 (SMR, 2.8; 95% CI,
1.2–6.8).
A suicidal motive upon admission was not associated with
a significantly higher SMR during the period. The SMR was
3.4 (95% CI, 2.6–4.3) in patients considered to be suicidal
and 4.8 (95% CI, 4.3–5.4) in non-suicidal patients. For those
Table 2. Substance abuse in patients admitted for self-poisoning in Oslo 1980 according to sex and suicide attempts. Substance abuse
(alcohol and opiates) occurred more frequently in males (P < 0.001). There was no sex difference for other types of abuse
Females Males All patients
No. of 
females (%)
No. of whom 
considered 
suicidal (%)
No. of 
males (%)
No. of whom 
considered 
suicidal (%)
No. of all 
patients 
(%)
No. of whom 
considered 
suicidal (%)
No abuse 314 (65) 77 (25) 172 (38) 37 (22) 486 (51) 115 (24)
Substance abuse* 166 (34) 19 (11) 234 (59) 15 (6) 430 (45) 34 (8)
Alcohol abuse 77 (16) 8 (10) 133 (36) 67 (16) 240 (25) 20 (7)
Opioid abuse 43 (9) 3 (7) 67 (16) 2 (3) 110 (12) 5 (3)
Drugs abuse 31 (6) 6 (19) 19 (4) 1 (5) 50 (5) 7 (14)
Other abuse 15 (3) 2 (13) 15 (3) – 30 (3) 2 (7)
Unknown abuse 7 (1) 3 (42) 23 (5) 2 (7) 30 (42) 5 (6)
Total 486 (100) 96 (22) 459 (102) 52 (11) 946 (100) 154 (16)
*The category substance abuse is the sum of alcohol, opioid, drugs and other abuse.
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classified as substance abusers, the SMR was 7.3 (95% CI,
6.3–8.3), compared to the SMR of 2.9 (95% CI, 2.5–3.4) for
the non-abusers. Of the 354 patients considered to be neither
suicidal nor substance abusers, 90 (25%) died during the fol-
low-up, and the SMR was 2.8 (95% CI, 2.3–3.5). For this
subgroup, the SMR was also significantly higher for both
sexes in all age groups and during each five-year period.
Causes of death
After 20 years, 7.4% of all patients had died from cardiovas-
cular diseases, 7.1% by suicide, 4.3% by accidents, 3.3%
from cancer, 1.1% from other violent death, and 14.4% from
other diseases. The SMRs were significantly elevated for
death of all causes (Table 4). For cancer, the SMR was 1.5
(95% CI, 1.04–2.10). The SMR for cardiovascular diseases
was 2.3 (95% CI, 1.8–2.9). The risk of dying of cardiovascu-
lar diseases was not elevated in social groups 1 and 2. The
SMR for death by other diseases was 7.5 (95% CI, 6.3–8.9)
and for death by accidents 9.3 (95% CI, 6.8–12.6). Other
violent death occurred in 10 patients, SMR 17.7 (95 % CI,
6.6–47.2) for males and 40.3 (95 % CI, 18.1–89.7) for
females.
Of all deaths, three were classified as accidental poisonings,
and none of these were initially classified as abusers. A total of
39 deaths were caused by drug dependence, 36 of these among
abusers. There were 217 deaths among substance abusers
(Table 4); hence 47% were dead at the end of follow-up.
For patients considered to be neither suicidal nor substance
abusers at time of admission, the SMR for death by all causes
except cancer and accidents was significantly higher.
Risk of suicide
Sixty-seven suicides occurred during the follow-up period:
31 in males and 36 in females. The SMR for suicide was 17.8
(95% CI, 12.5–25.4) for males and 46.4 (95% CI, 33.5–64.4)
for females. Based on the number of suicides in the general
population, the estimated number of deaths from suicide was
2.51, whereas 67 suicides were observed, thus giving an
SMR of 26.65. The risk of suicide was highest in the first five
years, SMR 36.1 (95% CI, 25.1–.51.9). The mortality rate
during the first year after the index episode was 0.014,
whereas the mortality rate had declined to 0.007 one year
later. The maximum risk of suicide therefore occurred in the
first year after admission and then declined. However, the
risk of suicide remained high, the SMRs ranging between
20.1 and 23.4 for the rest of the five-year periods (Table 3).
Twenty-four patients considered to be suicidal at admission
died by suicide (SMR, 64.1; 95% CI, 43.0–95.7). This equates
to 14.9% of those considered suicidal on admission died by
suicide during the follow-up. Forty patients considered to be
non-suicidal at the time of admission died by suicide during
the follow-up period (SMR, 19.3; 95% CI, 14.2–26.3), of
whom 19 were classified as substance abusers. Among those
classified as substance abusers, the SMR was 21.5 (95% C.I.,
14.6–31.5). In patients considered to be neither suicidal nor
substance abusers at admission, 21 (5.9%) died by suicide
during follow-up (SMR, 22.9; CI, 14.9–35.1).
Self-poisoning was the most frequent suicide method
among both males and females, accounting for 57% of all
suicides (Table 5). Hanging was used by 19%; and 9% used
firearms or guns. Firearms or guns were used by 13% of
males and 6% of females.
Factors predicting death
Cox regression analysis demonstrated that the relative risk of
death within 20 years after discharge after self-poisoning was
higher in men. Lower social group, drug abuse, and lower
level of consciousness were all independent predictors of
death (Table 6(a)). Suicidal motive upon admission, having
been seen by a psychiatrist, and duration of stay were not sig-
nificant predictors of death in general.
Table 3. Mortality and suicide by period Standard mortality ratio
(SMR), the ratio of observed to expected deaths (i.e., the ratio of the
number of deaths observed in the study group to the number that
would be expected if the study population had the same specific
rates as the standard population)
Overall mortality Suicides
Deaths SMR 95 % C.I. Deaths SMR 95 % CI
1980 – 85 124 6.3 5.3 – 7.5 29 36.1 25.1 – 51.9
1986 – 90 86 4.5 3.6 – 5.5 15 20.6 12.4 – 34.2
1991 – 95 85 4.3 3.5 – 5.4 13 23.4 13.6 – 40.3
1996 – 00 60 3.3 2.5 – 4.2 10 23.4 12.6 – 43.5
Total 355 4.6 4.2 – 5.1 67 26.7 21.0 – 33.8
Table 4. Standard mortality ratio (SMR) for different causes of
death being significantly higher than expected for all causes The
numbers of deaths which originally presented as patients with
suicidal intent and those who were classified as substance abusers
are outlined separately
N
Suicidal 
intent*
Substance 
abusers* SMR 95% CI
Cancer 31 4 20 1.5 1.0 – 2.1
Cardiovascular 
diseases 70 10 35 2.3 1.8 – 2.9
Other diseases 136 14 95 7.5 6.3 – 8.9
Accidents 41 6 32 9.3 6.8 – 12.6
Suicides 67 24 28 26.7 20.8 – 33.9
Other violent 
deaths 10 1 7 26.7 14.4 – 49.6
Total 355 59 217 4.6 4.2 – 5.1
*Not all patients were classified as either suicidal or substance abusers, thus
giving a sum less than the total number of deaths.
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Factors predicting suicide
Cox regression analysis demonstrated that a suicidal motive
at the index self-poisoning episode was the only relevant
factor significantly associated with suicide during the 20
years (P < 0.001; 95% CI, 0.19–0.56) (Table 6(b)). The pres-
ence of a suicidal motive increased the risk of suicide by 3.1
times (95% CI, 1.8–5.7) in the follow-up period. The increase
was significant for both men and women. Age, sex, drug
abuse, and social group did not predict later suicide. How-
ever, no suicides occurred in social group 1.
Discussion
This is a prospective cohort study of all self-poisonings
treated in the emergency departments in Oslo, thus study-
ing a patient group easily identified in clinical practice.
Possible selection biases were minimized by including all
hospitals in Oslo in the study and tracing all patients
throughout follow-up. Therefore, the generalization from
the sample back to a well-defined background population
was possible.
Our main finding was the high mortality of 37.5 %. Almost
half of all males and one-third of all females treated for
Table 5. Suicide methods used by patients after hospital-treated
self-poisonings
Males n=31 Females n=36 Total n=61
n % n % n %
Self-poisoning 16 52 22 61 38 57
Hanging 6 19 7 19 13 19
Firearms, guns 4 13 2 6 6 9
Jumping from a 
high place 2 6 2 6 4 6
Gas 1 3 1 3 2 3
Cutting/piercing 1 3 1 3 2 3
Unspecified 1 3 1 3 2 3
Total 31 99 36 101 67 100
Table 6(a). Factors at the time of admission that predicted death during the 20-year follow-up
No. of patients No. of deaths Hazard ratio p 95 % CI
Sex
Females 487 147 1 Ref
Males 459 208 1.59 <0.001* 1.3–2.0
Socio-economic group
1 27 6 1 Ref
2 114 29 1.8 0.22 0.70 – 4.8
3 380 136 2.6 0.04* 1.1–6.6
4 184 97 3.3 0.02* 1.3–8.4
Not evaluated 241 87 3.1 0.02 1.2–7.8
Suicidal motive
Non-suicidal 762 280 Ref
Suicidal 154 59 0.9 0.66 0.68–1.3
Not evaluated 30 16 1.8 0.06 0.98–3.3
Substance abuse
No abuse 486 138 1 Ref
Opioid addict 110 47 2.0 <0.001* 1.4–3.0
Alcohol abuse 240 125 1.6 0.001* 1.2–2.2
Drug abuse 50 20 1.7 0.02* 1.1–2.8
Other abuse 30 8 0.80 0.55 0.36–1.7
Not evaluated 30 17 1.6 0.10 0.92–2.7
Level of consciousness
Awake 223 50 1 Ref
Somnolent 286 113 1.8 0.001* 1.3–2.5
Soporous 182 80 2.0 <0.001* 1.4–2.9
Comatose 171 69 1.5 0.03* 1.0–2.2
Deep coma 84 43 2.1 0.001* 1.4–3.2
Duration of stay
i.e. increasing 
number of days
946 355 0.066
Seen by psychiatrist
No 758 284 1 Ref
Yes 188 71 0.88 0.33 0.67–1.1
6 M.A. Bjornaas et al.
self-poisoning had died by the 20-year end point. This was a
high mortality rate in a young cohort, whose median age in
1980 was 31 years. The SMRs show that the mortality was
much higher than expected after correcting for age. Even
though the relative risk of dying declined after the first five
year period, there was no statistically significant reduction in
SMR during the next fifteen years, as the risk was still more
than three times the risk in the general population. This find-
ing indicates that an episode of self-poisoning is a serious
risk factor for death during the next 20 years. Although com-
paring these findings with other studies is difficult because of
the different definitions of cohorts, the increased risk of
dying among those treated for self-poisoning corresponds to
the increased risk seen after suicide attempts (18), self-harm
(24), for drug misusers (25), and opioid addicts (26). The
inclusion criteria are overlapping, but the increased mortality
seen in this cohort implies that patients presenting with self-
poisonings can be seen as a common risk group, which may
be useful in the clinical setting in the Emergency Department.
For patients considered to be neither suicidal nor classified as
substance abusers, the SMR was significantly increased, indi-
cating that the classification of subgroups in this sample
based on intention and substance abuse did not capture all
individuals at increased risk. The excess mortality in this
group of self-poisonings shows that an index episode of treat-
ment for acute poisoning is by itself a risk factor for prema-
ture death and that this risk persists for 20 years after the
poisoning episode.
The suicide rate, like the mortality rate, remained high dur-
ing the entire 20-year follow-up. A previous study of the
same cohort reported a particularly high suicide ratio during
the first two years of follow-up (21). However, the SMR
remained high during the whole period, and after the first
5-year period no further decline was seen. The continuing
risk of suicide after self-poisonings is consistent with the life-
time risk after suicide attempts reported by Suominen et al. in
Finland (3). A suicidal motive upon admission was a strong
risk factor for later suicide during the entire 20-year period,
Table 6(b). Factors at the time of admission that predicted suicide during the 20-year follow-up
No. of patients No. of suicides Hazard ratio p 95 % C.I.
Gender
Females 487 36 1 Ref
Males 459 31 1.2 0.48 0.73–1.9
Social group
1 27 #
2 114 11 1 Ref
3 380 38 1.5 0.23 0.77–3.0
4 184 7 0.69 0.45 0.26–1.8
Not evaluated 241 11 0.87 0.76 0.36–2.1
Suicidal motive
Non-suicidal 762 40 1 Ref
Suicidal 154 24 2.4 0.002* 1.4–4.3
Not evaluated 30 3 2.4 0.15 0.72–7.9
Substance abuse
No abuse 486 39 1 Ref
Opioid addict 110 5 0.38 0.30 0.23–1.5
Alcohol abuse 240 18 1.0 0.78 0.61–1.9
Drug abuse 50 3 0.86 0.75 0.26–2.7
Other abuse 30 0 – – –
Not evaluated 30 2 0.97 0.91 0.22–3.8
Level of consciousness
Awake 223 7 1 Ref
Somnolent 286 24 3.0 0.01* 1.3–7.0
Soporous 182 18 2.6 0.01* 1.3–7.7
Comatose 171 10 1.9 0.21 0.70–4.9
Deep coma 84 8 2.6 0.07 0.94–7.4
Duration of stay
i.e. increasing 
number of days
946 67 0.75 0.16 0.5–1.1
Seen by psychiatrist
No 758 47 1 Ref
Yes 188 20 1.1 0.74 0.63–1.9
# No suicides occurred in social group 1. Social groups 1 and 2 were combined and used as a reference in these analyses.
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which is in concordance with other studies (5,18,19). How-
ever, a high suicidal intention was not an independent risk
factor for mortality in general, although this has been demon-
strated in other cohorts (18,19).
The SMR of suicide was increased for all self-poisonings,
as well as for subgroups of suicide attempters and substance
abusers. This is in consistence with risk factors for suicide
seen in other studies (11). However, the increased number of
suicides among patients considered to be neither suicidal nor
substance abusers indicates that the assessment of suicidality
and substance abuse did not capture all patients at risk of
completing suicide when evaluating self-poisonings. This
could be because their ideation was either missed or inade-
quately investigated, or because the burden of mental ill-
nesses including personality disorders was higher among
these patients than for the general population. However, this
also reflects that having suicidal ideation is not a permanent
state of mind. It is common to see patients that have ingested
toxic agents in small amounts or with other people present. If
so, they generally know that they will survive. Such acts were
not considered suicide attempts, but an act of appeal. This
may invite clinicians to underestimate the seriousness of such
acts. The study therefore demonstrates that a substantial pro-
portion of them may proceed and make more serious suicidal
attempts later and even suicide. The finding that a substantial
proportion show more serious suicidal behavior later on, calls
for more systematic follow-up of these patients.
The risk of death from all causes was very high in this
cohort. Accidents and other violent deaths may reflect that
people are living in a situation involving drug abuse, where
they are often balancing between life and death. We also
observed an increase in deaths due to cardiovascular diseases.
Intravenous drug abuse is a major risk factor for infectious
endocarditis, which may contribute to this increased risk of
death by cardiovascular diseases (27). Interestingly, there
was an increased risk of death from all causes except for can-
cer and accidents in the subgroup considered to be non-
suicidal and non-abusers at the time of admission. This indicates
that drug abuse cannot fully explain the increased mortality
in patients admitted for self-poisoning, nor can a high sui-
cidal intention at time of admission.
Although death from unintentional overdoses was of major
concern in these patients, the classification of such deaths in
accordance with the ICD system proved to be problematic, as
there are no category literally equivalent to the term uninten-
tional overdose. Of all deaths, only three were classified as
accidental poisonings (E850–858 in ICD-8 and ICD-9, T36-50
in ICD-10), and none of these were initially classified as abus-
ers. A total of 39 deaths were caused by drug dependence (304
in ICD-8 and 9, but no category is literally in ICD-10), and 36
were classified as abusers. However, there were 217 deaths
among the substance abusers, and drug dependence therefore
accounted for only a small proportion of these.
Lower socio-economic class was seen as a predictor of
death during the follow-up. Mortality is known to be higher
in lower social classes, and this was not controlled for in the
analyses for overall mortality. As for cause-specific mortal-
ity, this is known to be related to socio-economic status as
well – for cardiovascular diseases (28), cancer (29), and sui-
cide (30). However, the sample included patients from all
socio-economic groups, as did the data from the general pop-
ulation used for comparison. The relative importance of
socio-economic status in mortality was not calculated, but it
could presumably not completely explain the increased mor-
tality, as the absolute differences between socio-economic
groups are relatively small in Norway compared with other
countries.
Lower level of consciousness at the time of admission was
a significant predictor of death during the follow-up period.
This may reflect that these patients had taken a higher dose or
agents that were more toxic. The time between exposure and
admission to hospital may have been longer, as seen with
more serious suicide attempts, when the patients did not
make contact with the health services after the ingestion. This
variable may therefore be a marker of a more serious poison-
ing, i.e., more serious suicide attempt or a more serious over-
dose. This is in accordance with studies defining medically
serious suicide attempters as a group at increased risk (17).
Factors contributing to the suicidal behavior or the act of
appeal, as well as the reasons behind the drug abuse were not
investigated in this study. The contribution of these factors to
the eventual outcome may therefore be evaluated in further
studies. The increased mortality and suicide risk among those
considered to be neither suicidal nor substance abusers may
also be investigated further.
Limitations
The physician on duty classified a suicidal motive upon
admission according to the clinical evaluation. No forms or
scales were used. The inclusion criteria were very strict and
tried to rule out cases considered to be solely an appeal, i.e.,
where there was no wish to die. A strong suicidal motive was
required for classifying a patient with suicidal intent. As for
the classification of substance abuse, the evaluation was
based upon all information available, with reference to the
ICD criteria. However, this is a subjective measure, and the
inter-rater reliability was not evaluated. The lack of standard-
ization of this evaluation may be questioned. However, the
assessments made by the physicians turned out to be clini-
cally relevant. These also reflect the method for evaluating
patients in the clinical setting. Our method allows us to
generalize our findings to clinical practice.
The causes of death were obtained from Statistics Norway,
and our group reported on the validity of these data in 1985
(31). Since then, autopsy rates have been declining in
Norway, and the reliability of death certificates has been
questioned. Our numbers on suicide ratios should therefore
be considered a minimum.
The SMRs were calculated based on mortality data from
Norway in general, not Oslo in particular. However, around
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1980 the clustering of substance abusers was more extensive
in Norway than today, and people moved from rural areas to
Oslo where the drug market was more substantial. Thus,
patients treated at medical departments in Oslo could be seen
as representing other parts of the country as well.
Conclusions
The high mortality among this group of patients calls for
improved aftercare. Although risk factors could be identified,
they are not specific enough to identify individual patients at
particular risk. Our data show that a suicidal motive upon
admission for self-poisoning is a marker for a long-term
increased risk for later suicide, but the risk remains increased
for the rest of the patients as well. Therefore, strategies to
prevent death must be directed toward the majority of those
who are treated for self-poisonings. Although all patients
treated for self-poisonings have increased risk of death in
general and suicide in particular, different prevention strate-
gies must be sought and individual plans for aftercare con-
ducted in order to prevent death. More information about the
effectiveness of treatment offered to these patients is needed.
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Self-poisonings are known to have increased long-term mortality, even among the 
nonsuicidal. By using multinomial regression analyses with suicide attempts as reference, 
differences in psychosocial factors and referral to follow-up were studied. Of 908 admissions, 
37 were suicide attempts, 26 were appeals and 38 were drug-related poisonings. Fifty-
five percent reported previous suicide attempts, 58 previous or current psychiatric treatment 
and 32 daily substance use. One-third of suicide attempters had used substances daily. One-
third of drug-related poisonings had previous suicide attempts. All patients had risk factors for 
suicidal behavior. The nonsuicidal were often discharged without plans for follow-up. 
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Long-term mortality after self-poisoning, by both natural and unnatural causes (Owens, 
Wood, Greenwood, Hughes, & Dennis, 2005), is much higher than for the general population, 
irrespective of intention (Bjornaas, Jacobsen, Haldorsen, & Ekeberg, 2008). In a 20-year 
follow-up study of self-poisonings in Oslo, male gender, lower social group, drug abuse, and 
lower level of consciousness were all independent predictors of death. Suicidal intention was 
not an independent predictor of death in general, but it was the only independent predictor of 
later suicide. For suicide attempters, both sociodemographic and psychiatric factors are 
associated with later suicide (Nordentoft, Breum, Munck, Nordestgaard, Hunding, & Laursen 
Bjaeldager, 1993: Owens, Horrocks, & House, 2002). For the nonsuicidal, there is less 
literature, although the risk of death both in general and by suicide is increased for substance 
use disorders (Harris and Barraclough, 1998). 
One would expect suicidal patients to differ from nonsuicidal patients in more than the 
evaluated intention, even among self-poisonings. However, recent research indicates that the 
populations are overlapping, with repetitions of self-poisonings during the same year differing 
in their evaluated intentions (Heyerdahl, Bjornaas, Dahl, Hovda, Nore, Ekeberg et al, 2008). 
Therefore, more information about patients treated for self-poisonings, even the nonsuicidal, 
are needed. 
A major part of the studies in the field focus on subgroups of self-poisonings, such as 
medically serious suicide attempters (Beautrais, Joyce, Mulder, Fergusson, Deavoll, & 
Nightingale, 1996), deliberate self-harm (Hawton, Zahl, & Weatherall 2003), and nonfatal 
drug overdoses (Pfab, Eyer, Jetzinger, & Zilker, 2006). The fundamental principle behind this 
classification is the correct evaluation of the intention. Patients presenting at emergency 
departments with self-poisoning are often comatose, and the immediate evaluation is difficult. 
Furthermore, they can be reluctant to report the use of illegal substances. The variability over 
time of the wish to die among suicidal patients can further complicate the evaluation of 
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intention. Different approaches in follow-up may therefore be necessary for drug-related 
poisonings and suicide attempters. However, there are questions whether or not the morbidity 
of the substance users treated in emergency departments has been underestimated (Rockett, 
Putnam, Jia, & Smith, 2003). The risk of further suicidal behavior in patients reporting 
suicidal intention has led to psychiatric follow-up of these patients; being referred for 
specialist follow-up reduces the risk of repetition (Kapur, Turnbull, Hawton, Simkin, 
Mackcway-Jones, & Gunnell, 2006). Suicide attempters suffering from substance use 
disorders are less likely to receive psychiatric follow-up (Suokas and Lonnqvist, 1991). More 
information about the follow-up of these patients is needed, irrespective of intention. 
Accordingly, the aims of this study on patients presenting with self-poisonings in 
emergency departments in Oslo during a one-year period were to study: 1) the evaluation of 
intention made by patients and physicians, 2) the sociodemographic and psychiatric 
characteristics of these patients, 3) how these characteristics vary according to the evaluated 
intention among self-poisonings, and 4) the plans for follow-up of these patients at discharge. 
MATERIAL AND METHODS 
Design of the study 
This cross-sectional multicenter study was performed from April 1, 2003 until March 31, 
2004 and involved all four hospitals treating patients with self-poisoning in Oslo, together 
with pediatric departments, the Oslo Emergency Ward (outpatient clinic), the ambulance 
service, and the Institute of Forensic Medicine. This was done to obtain a complete one-year 
picture of all patients contacting health care services because of self-poisonings in the capital 
of Norway. 
This paper presents data from all hospitalized adults in Oslo regarding evaluation of 
intention, psychiatric history, sociodemographic variables and referral to follow-up. Clinical 
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and epidemiological data have been presented separately (Hovda, Bjornaas, Skog, Opdahl, 
Drottning, Ekeberg et al, 2008: Heyerdahl, Bjornaas, Hovda, Skog, Opdahl, Wium et al 
2008). 
The inclusion criteria for the present part of the study were exposure to a drug or 
another agent in toxic amounts leading to hospital admission in adults (16 years). Exclusion 
criteria were chronic poisoning and patients with other primary diagnoses, such as 
pneumonia, even if there was an additional self-poisoning. All cases considered to be 
accidental non-self-poisonings were excluded from further analyses, including carbon 
monoxide poisonings caused by fire accidents (n=13), taking prescribed medication in wrong 
doses because of lack of understanding (n=24), and forced intake or accidental poisoning 
(n=2). The study population included 908 admissions, of which 54 were females. Median 
age was 36 years, range 16–89 years. The population of Oslo in 2003 was 521 886, of whom 
428 198 were 16 years, which gives an annual incidence of 2.1‰. 
Data collection 
Physicians obtained data by completing a standardized registration form as soon as the patient 
was ready for an interview. For patients who did not regain consciousness or had cerebral 
damage (n=16), data were obtained from medical files. Only one patient refused to 
participate. 
Criteria for classifications 
Physicians’ evaluations of the reasons for poisoning were based on all information available, 
including patients’ own reported intentions. Special attention was given to letters confirming 
suicidal intent, supposed lethal doses of the toxic agent or other active procedures to ensure a 
lethal outcome, in addition to information from other sources such as ambulance personnel 
and companions. Four categories were used: definite suicide attempt, possible suicide attempt, 
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appeal (for help) and drug-related poisoning. The data were analyzed in three main categories: 
suicidal, appeal and drug-related poisonings. Accidental non-self-poisonings were excluded 
from further analyses; see above. 
For patients’ own evaluations of intent, there were eight different categories: intention 
to die, to escape from problems, to make an impact on personal relationships, drug-related 
poisoning, do not remember, do not want to give information, other reasons and unknown. 
Only one category was chosen for each patient. Subsequently these answers were grouped 
into the following categories: suicidal (intention to die), appeal (to escape from problems and 
to make an impact on personal relationships) and drug-related poisonings (the same category 
was used). Other answers were excluded from the studies of agreement. 
Sociodemographic variables recorded were marital status, living conditions, country of 
origin according to place of birth or parental place of birth, occupational status and education 
(highest level completed according to the Norwegian education system). 
Previous suicide attempts and psychiatric treatment (both current and former) were 
recorded, as reported by patients. For former psychiatric treatment, the highest level of 
treatment was used in further analyses; i.e., psychiatric ward admission was rated higher than 
psychiatric outpatient treatment. Patients were also asked to report the frequency of their 
substance use and what kind of substances they were using. 
Referrals to further follow-up services at the time of discharge were recorded. The 
categories were: referral to a General Practitioner (GP), a suicide prevention team, substance 
abuse treatment, psychiatric outpatient clinic, psychiatric ward (voluntarily or involuntarily), 
other arrangements and no plans for aftercare. Some patients left the hospital against medical 
advice, and they were not included in the group discharged without plans for follow-up. More 
than one category could be offered to each patient. 
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Statistics 
The standardized registration forms were optically scanned and processed using TeleForm 
Desktop version 9.1 (TeleForm, Verity Inc., Sunnyvale, California). Statistics were performed 
using SPSS, version 16.0 (SPSS Inc., Chicago, Illinois). To compare agreement between the 
doctor’s and the patient’s evaluation of intention, Cohen’s Kappa was used. Multinomial 
regression analyses were used to compare the groups according to psychosocial factors, with 
the doctor’s evaluation of intention (suicide attempt, appeal, drug-related poisoning) as the 
dependent variable. Suicide attempt as assessed by physicians was used as the reference 
category. Crude and adjusted ORs were computed, with a 95% confidence interval. Only 
variables with a significant crude value (p0.02) were included in the multinomial analyses. 
Variables where only the proportion of unknown answers was significantly different between 
the groups were excluded from the multinomial analyses. 
Ethics 
Treatment was given according to the standard hospital protocols and in accordance with the 
Helsinki declaration. Permission was obtained from The National Data Inspectorate and the 
Regional Ethics Committee. The links between patients’ names and social security numbers 
and the study case numbers were stored by Statistics Norway. 
RESULTS 
Intention 
Of the 908 admissions, 10 were evaluated by the physician as definite suicide attempts and 
26 as possible suicide attempts (Table 1). All patients evaluated as definite suicide attempts 
stated a wish to die. However, 5 of those eventually evaluated as acts of appeal also stated a 
wish to die. In total, 36 were evaluated as suicidal and 26 as appealing for help. Drug-
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related poisonings were seen in 38 of cases, of whom 22 also stated drug use/abuse as the 
reason for the self-poisoning. 
When the patients evaluated their intention, 30 stated a wish to die, 23 stated drug 
use/abuse as the reason for the admission and 19 wanted to escape from problems. For the 
appeal group, 11 wanted to escape from problems and 6 wanted to make an impact on 
personal relationships. Both answers were seen as acts of appeal. 
The overall agreement between the physician’s and the patient’s evaluation of 
intention was good when patients’ answers were grouped in the three main categories: suicide 
attempts, appeals and drug-related poisonings. The agreement had a Kappa value of 0.68. 
Sociodemographic characteristics 
There were more females in the suicidal (63) and the appeal groups (72), whereas males 
dominated among drug-related poisonings (65) (Table 2). Males were more likely to be 
evaluated as drug-related poisonings than suicidal compared with females, OR 3.16 (95 
C.I., 2.27–4.41) (Table 3). 
Males were less likely to be evaluated as appealing than females, adjusted OR 0.63 
(95 C.I., 0.43–0.92). There were no other statistically significant differences in 
sociodemographic variables between the appeal group and the suicide attempters in the 
multinomial analyses. 
There were, however, several significant differences between the suicide attempters 
and those with drug-related poisonings. Patients who were 30–49 years old were less likely to 
be in the drug-related group than those who were younger, compared with suicide attempters, 
OR 0.51 (95 C.I., 0.34–0.77) (Table 3). 
The majority of the patients were originally from Norway (84), while 8 were 
immigrants from Asian countries. Immigrants from Asia were less likely to be in the drug-
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related poisoning group than in the suicidal group compared with native Norwegians, OR 0.23 
(95 C.I., 0.11–0.49). 
Fifty-three percent of all patients were living alone. Even when correcting for age 
differences, those who were living with their parents were more likely to be in the drug-
related poisoning group than in the suicidal group when compared with those living alone, OR 
2.21 (95 C.I., 1.12–4.37). 
Only 33 of the patients were employees/students, 32 were permanently disabled 
and 16 unemployed. The proportion of suicide attempters on sick leave was 16, compared 
with 6 of drug-related poisonings. Those on sick leave were less likely to be in the drug-
related poisoning group than in the suicidal group, compared with employees, OR 0.30 (95 
C.I., 0.15–0.61). 
Overall, 34 were married, 19 were divorced, 4 were widows/widowers and 42 
had never been married. Thirty-eight percent of all patients had only completed the minimum 
9 years of primary and secondary school required by law. Twenty-six percent had completed 
occupational high school, 16 academic high school and 21 had studied at college or 
university. There were no statistically significant differences between the three groups 
according to marital status or educational status. 
Psychiatric characteristics 
Previous suicide attempts were reported among 55 of all patients: 68 of the suicidal 
group, 62 of the appeal group and 32 of the drug-related poisoning group (Table 4). There 
were no statistically significant differences between the appeal group and the suicidal group. 
However, even when correcting for age, those who had previous suicide attempts were less 
likely to be in the drug-related poisoning group than in the suicidal group compared with 
those without such an attempt, OR 0.33 (95 C.I., 0.22–0.49) (Table 5). 
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At time of admission, 41 were having current/ongoing psychiatric treatment, 9 as 
inpatients. A total of 33 had previously been psychiatric inpatients, 42 among the suicidal, 
35 among appeals and 19 among drug-related poisonings. There was a strong correlation 
between current and previous psychiatric treatment, Pearson correlation coefficient 0.46 
(p0.001). Psychiatric treatment, current or previous, was reported by 58 of all patients, 
while there was no information about this for 16. Only 26 of self-poisonings had never 
received psychiatric treatment. Those who reported any psychiatric treatment were less likely 
to be in the drug-related poisoning group than in the suicidal group, OR 0.33 (95 C.I., 0.22–
0.49). There was no significant difference in the level of psychiatric treatment between the 
appeal and suicide attempt groups. 
Gender and age were included in the multinomial analyses of psychiatric factors but 
did not alter the main findings. 
Substance use 
Frequency of substance use was reported by 716 (79) of the patients (Table 6). Among 
these, daily substance use was reported by 37, while 11% reported no use of substances. 
Among drug-related poisonings, 48 reported daily substance use, while among 
appeals and suicide attempters the figures were 25 and 35 respectively. Those who 
reported daily substance use were more likely to be in the drug-related poisoning group, OR 
5.57 (95 C.I., 2.63–11.79). There was no significant difference in substance use between the 
appeal and suicide attempt groups. 
Among suicide attempters, daily use of alcohol was reported by 18. Nineteen 
percent used prescription drugs daily. Opioids and amphetamines were used weekly or more 
frequently by 6. 
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In the appeal group, 13 reported daily use of alcohol and 14 reported daily use of 
prescription drugs. Daily use of opioids was reported by 4. Six percent reported any use of 
ecstasy, gamma-hydroxy butyrate (GHB), amphetamines and/or cocaine. 
Among drug-related poisonings, 25 reported daily alcohol use and 23 reported 
daily use of prescription drugs. Thirteen percent used opioids on a daily basis, with another 
4 using these less often. Eight percent used GHB weekly or more, but 13 used 
amphetamines in the same pattern. Cocaine was used by 7 of drug-related poisonings in 
total. 
Referral to follow-up 
Of all patients, 18 were discharged without plans for further treatment or follow-up; 36 
among drug-related poisonings, 10 among appeals and 5 among suicide attempters. Those 
who were discharged without plans for follow-up were more likely to be in the drug-related 
poisoning group than those who received follow-up, OR 11.0 (6.35–19.02). Only 10 of 
drug-related poisonings had plans for follow-up from substance abuse treatment services, 
while 28 were discharged with plans for follow-up only from their general practitioners. 
Those who received any psychiatric follow-up were more likely to be in the suicide 
attempt group than those who did not receive such treatment—irrespective of level of 
treatment (Table 7). Of drug-related poisonings, 10 were referred to a psychiatric outpatient 
clinic, 0.6 to a psychiatric ward voluntarily and 3 involuntarily. Those evaluated as 
appeals were more often referred to psychiatric outpatient treatment than those evaluated as 
suicidal, 47 versus 39. However, among suicide attempters, 18 were admitted 
voluntarily to a psychiatric ward, and 20 were admitted involuntarily. 
Of all patients, 3 left hospital against medical advice, 6 of drug poisonings and 2 
of suicide attempters. These were not included in the figures for no referral. Those who left 
 12 
hospital against medical advice were more likely to be in the drug-related poisoning group, 
OR 3.18 (1.25–8.06). 
DISCUSSION 
The study included all self-poisonings irrespective of intention, which made it possible to 
study characteristics of this patient group. More than half of the patients reported previous 
suicide attempts, and 58 reported previous or current psychiatric treatment. Daily substance 
use was reported by one-third of all patients. Furthermore, one-third were listed as 
permanently disabled, and one-third had only completed the lowest mandatory level of 
education. In this context, 18% of the patients were discharged without plans for follow-up, 
including 36 of all drug-related poisonings. 
The patient’s intention was evaluated by both patient and physician in each self-
poisoning episode, and the overall agreement was good. The patient’s evaluation was known 
to the physician at the time, and the variables were therefore not independent as evaluation of 
intention is always based partly on the patient’s intention. A wish to die may vary over time, 
and ambivalence is a major characteristic of suicidal behavior (McAuliffe, Arensman, Keeley, 
Corcoran, & Fitzgerald, 2007). One-third of all patients were evaluated as definite or possible 
suicide attempts, and the importance of recognizing these patients is demonstrated by the 
increased risk of completing suicide among suicide attempters (Suominen, Isometsa, Suokas, 
Haukka, Achte, & Lonnqvist, 2004). However, being evaluated as suicidal was not an 
independent predictor of death in general in a study of self-poisonings in Oslo in 1980 
(Bjornaas et al., 2008), although other studies have found increased mortality among suicide 
attempters compared with the general population (Nordentoft et al., 1993). This pinpoints the 
fact that the risk of death is increased among nonsuicidal self-poisonings as well (Bjornaas et 
al., 2008). Therefore, characteristics other than intention alone may explain this increased 
mortality. 
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Only one-third of the patients were employed, one-third were married, and half of 
them were living alone. Lack of social integration is known from studies of suicide attempters 
and is thought to be an important risk factor for suicidal behavior (Duberstein, Conwell, 
Conner, Eberly, Evinger, & Caine, 2004). The low level of education, lack of association with 
the labor market and high proportion of being single found here among self-poisonings was in 
agreement with studies on suicide attempters (Bille-Brahe, Hansen, Kolmos, & Wang, 1985). 
In a recent cross-national study on suicide attempters, the same picture was seen, with the 
exception of employment status, which did not appear as a risk factor for suicidal behavior 
(Nock, Borges, Bromet, Alonso, Angermeyer, Beautrais et al., 2008). However, in the present 
study, these risk factors were found even among patients evaluated as drug-related poisonings 
and appeals. Lack of social integration has been found to be a risk factor for increased 
mortality even among samples of healthy employees (Berkman, Melchior, Chastang, 
Niedhammer, Leclerc, & Goldberg, 2004), and the lack of social integration may therefore 
partly explain the increased mortality observed among self-poisonings, as well as the 
increased suicide risk irrespective of intention (Bjornaas et al., 2008). 
Previous suicide attempts were reported by more than half of all self-poisonings, more 
among suicide attempters than among drug-related poisonings. The appeal group was not 
significantly different from the suicide attempters in this respect, with 62 and 68 
respectively reporting previous attempts. The evaluation of whether or not these previous acts 
were in fact suicide attempts may differ between patients and physicians, but the good 
agreement in the evaluation of the present self-poisoning episode indicates that the figures are 
valid. A previous suicide attempt is the strongest known predictor of completing suicide 
(Harris and Barraclough, 1997), and the high proportion of such acts among self-poisonings is 
therefore alarming. Those evaluated as suicidal at present were more likely to be treated at a 
higher level of care at discharge than those evaluated as appeals. If the intention at the present 
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episode is given too much weight, this may lead physicians to underestimate the risk of 
suicide in the long term among those evaluated as nonsuicidal, especially among the appeals. 
There was considerable substance use among patients treated for self-poisonings, as 
one-third reported daily substance use. More substance use was reported by those evaluated as 
drug-related poisonings, but even among those evaluated as suicide attempters, 32 reported 
such use daily. In a study of self-poisonings from 2001, nine out of ten patients had traces of 
drugs of abuse in their blood or urine samples (Bjornaas, Hovda, Mikalsen, Andrew, Rudberg, 
Ekeberg, et al., 2006). The present figures may therefore be considered a minimum. Ethanol 
and prescribed medication such as benzodiazepines were most commonly reported, and this 
corresponds to the most common toxic agents seen in the actual self-poisoning episodes in 
this study population (Hovda et al., 2008). The availability of these substances was therefore 
important both for daily use and in the actual self-poisoning episode. Substance use is the 
second most frequent psychiatric precursor to suicide, only exceeded by depressive disorders 
(Murphy, 2000). The increased mortality found among substance users is also well known 
(Harris and Barraclough, 1998). The high proportion of daily substance use seen in this study 
may therefore partly explain the increased mortality of self-poisonings, even among the 
nonsuicidal. 
Males younger than 30 years old, who were living with their parents or who reported 
substance use of any frequency, were more likely to be evaluated as drug-related poisonings 
than suicide attempters. Being from Asia, being temporarily on sick leave or reporting 
previous suicide attempts and/or psychiatric treatment reduced the likelihood of the episode 
being evaluated as a drug-related poisoning. The gender difference corresponds to other 
studies, with more males among substance users (Gossop, Stewart, Treacy, & Marsden, 2002) 
and more females among suicide attempters, although being male is a risk factor for 
completing suicide (Canetto and Sakinofsky, 1998). The age difference is also confirmed by 
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other studies (Townsend, Hawton, Harriss, Bale, & Bond, 2001). Being from Asia reduced the 
likelihood of the episode being evaluated as a drug-related poisoning. In Oslo, the largest 
group of Asian immigrants is from Pakistan (3.7 of all inhabitants), and Islam is the 
dominant religion. Differences in substance use may be explained partly by religious beliefs 
(Bradby and Williams, 2006), but information about this subgroup is scarce. 
Those on sick leave were less likely to be evaluated as drug-related poisonings than 
suicide attempters. This may be related to a higher proportion stating they were unemployed 
among the drug-related poisonings, although this was not statistically significant. The higher 
proportion undergoing psychiatric treatment among the suicide attempters may imply a higher 
burden of psychiatric illness at present, which may contribute to this difference as well. 
Females were more likely to be evaluated as appeals, but in all other respects, there were no 
differences between these patients and those evaluated as suicide attempters. The gradient of 
suicidal intent affects the risk of completing suicide in the long term, as medically serious 
suicide attempts are at higher risk and use different substances (Townsend et al., 2001; 
Beautrais, 2003). Appeals and suicide attempters may therefore be considered the same 
patient group, although the suicide attempters were probably in a deeper crisis at the time of 
admission and hence were evaluated differently regarding intention. Among repeaters of self-
poisoning, intention has been shown to vary between different admissions during the same 
year (Heyerdahl et al., 2008). The proportion of risk factors for suicidal behavior among drug-
related poisonings and the extent of substance use among suicide attempters may explain 
some of these findings. 
Almost one in five patients was discharged without any plans for follow-up, even 
when excluding those who left hospital against medical advice. Although different approaches 
are probably needed for suicide attempters and drug abusers, the number of patients 
discharged without follow-up seems too large in the context of increased mortality and suicide 
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risk in this patient group (Bjornaas et al., 2008). Among drug-related poisonings, more than 
one-third were discharged without follow-up. Only 10 had plans for substance use 
treatment. It could be argued that many of these patients did not want further follow-up, or at 
least not the kind of follow-up they were offered, but the proportion of patients reporting daily 
substance use, previous suicide attempts and psychiatric treatment indicates that these patients 
are in need of follow-up as well. The difference in follow-up according to intention 
corresponds to previous studies finding that suicide attempters suffering from substance use 
disorders are less likely to receive psychiatric follow-up (Suokas and Lonnqvist, 1991). 
Suicide attempters were admitted to psychiatric ward treatment in 38 of cases, 20 
involuntarily. In a Swedish study from 1994, 57 of suicide attempters were admitted to 
psychiatric inpatient care, but since then, outpatient care has been used more extensively in all 
health care services (Runeson and Wasserman, 1994). Still, 5 of suicide attempters were 
discharged without plans for follow-up, despite their well-known risk of further suicidal 
behavior, especially in the short term (Harris and Barraclough, 1997). According to 
guidelines, they should have been assessed, but some leave hospital before assessment, 
mainly during holidays, weekends and nights. Only 10 of drug-related poisonings were 
referred to substance use treatment. Although the treatment need may vary within this 
subgroup of patients, the low percentage who were referred to substance use treatment is 
similar to a study of opioid addicts treated for acute overdose that found 67 were not 
referred to further follow-up (Cook, Moeschler, Michaud, & Yersin, 1998). However, there 
are few studies regarding the follow-up of patients treated for self-poisoning, even for the 
subgroups, and we do not know enough about the effectiveness of the treatment offered 
regarding mortality and suicide risk. 
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Strength and limitations 
All medical departments in Oslo were included over one year in order to minimize selection 
bias and in order to generalize from the study population to a well-defined background 
population. Whether or not all eligible patients were included can always be questioned when 
so many coworkers are involved, but careful follow-up of the participating departments 
throughout the study period was done to minimize the number of missed cases. 
No validated scales or forms were used in the evaluation of intention, and this might 
be seen as a possible bias of this study. However, our method resembles the evaluations done 
in emergency departments every day, and it is therefore possible to generalize to clinical 
practice. The validity of self-reported psychosocial factors may also be questioned, but in 
general, the information obtained in this study matches what is available in the clinical 
setting. 
Not all forms were complete, but for most cases, the percentage of ‘not known’ 
responses was less than 10, with the exception of educational status, which was 32. 
Overall, ‘not known’ responses were more common among drug-related poisonings, probably 
related to a shorter duration of stay for these patients. This is also a possible reason for the 
limited knowledge about this patient group in previous studies. 
Conclusion 
The present study demonstrated considerable similarities between suicidal and nonsuicidal 
patients regarding lack of social integration, substance use, previous suicide attempts and 
previous or current psychiatric treatment. Suicidal patients were more often referred to further 
treatment, while drug-related poisonings were often discharged without such plans. The 
concordance between patients’ and physicians’ evaluations of intention was good. However, 
if intention is given too much weight, a large group of drug-related poisonings seem to be 
excluded from further aftercare, despite their well-known risk of increased mortality and their 
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substantial number of risk factors for suicidal behavior. Patients who were assessed as suicide 
attempters and those who were considered appeals were generally quite similar apart from the 
intention. 
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Table 1 Assessment of intention by physicians and patients. 
 
Physicians’ 
assessment 
of intention 
Patients’ assessment of intention 
To die 
 
 
 
n=271 
Escape 
from 
problems 
 
n=171 
To make an 
impact on 
personal 
relationships 
n=66 
Drug 
use/abuse 
 
 
n=212 
Will 
not 
tell  
 
n=65 
Unknown 
 
 
 
n=123 
Total 
 
 
 
n=908 
Definite 
suicide 
attempt 
10     0.01 10 
Possible 
suicide 
attempt 
14 6 2 0.5 2 1 26 
Appeal 
 
 
5 11 6 0.5 1 3 26 
Drug-
related 
poisoning 
0.5 2  22 4 9 38 
Total 30 19 8 23 7 13 100 
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Table 2 Description of sociodemographic characteristics of patients treated for self-
poisonings in Oslo during one year according to intention. 
 Suicide attempt 
 
n=332  
Appeal 
 
n=232 
Drug-related 
poisoning 
n=344  
Total 
 
n=908  
Male gender 37 28 65 45 
Age 
16–29 
30–49 
50 
 
27 
52 
21 
 
34 
47 
19 
 
37 
39 
24 
 
33 
46 
22 
Country of origin 
Norway 
Other European country 
Asian country 
Other 
Unknown 
 
81 
5 
10 
4 
n=1  
 
82 
6 
11 
0.01 
n=3  
 
88 
5 
4 
3 
n=6  
 
84 
6 
8 
3 
n=10  
Living conditions 
Living alone 
With parents 
With spouse/others 
In institution 
Unknown 
 
51 
7 
37 
5 
n=67  
 
53 
11 
31 
5 
n=40  
 
55 
15 
27 
3 
n=94  
 
53 
11 
32 
4 
n=201  
Occupational status 
Employee/student 
Sick leave 
Unemployed 
Retired 
Permanent disability 
Other/Unknown 
 
30 
16 
12 
7 
35 
n=54  
 
36 
11 
13 
3 
37 
n=44  
 
34 
6 
23 
11 
27 
n=79  
 
33 
11 
16% 
7 
32 
n=177  
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 Table 3 Comparisons of sociodemographic characteristics in patients treated for self-
poisonings in Oslo according to intention. Suicide attempt is used as reference category. 
 Drug-related poisoning 
vs. suicide attempt 
Crude Adjusted 
p OR 95 CI OR 95 CI 
Male gender <0.001  3.13* 2.29–4.29 3.16** 2.27–4.41 
Age 
16–29 
30–49 
50 
0.007  
ref 
0.53** 
0.80 
 
0.38–0.76 
0.52–1.21 
 
0.51* 
0.87 
 
0.34–0.77 
0.50–1.53 
Country of origin 0.002     
Norway  ref    
Other European country  0.91 0.46–1.78 0.72 0.35–1.47 
Asian country  0.34* 0.17–0.67 0.23** 0.11–0.49 
Other   0.83 0.36–1.91 0.71 0.28–1.75 
Unknown  5.43 0.65–45.43 5.21 0.59–46.0 
Occupational status <0.001     
Employee/student  ref    
Sick leave  0.31** 0.16–0.59 0.30** 0.15–0.61 
Unemployed  1.83* 1.09–3.08 1.65 0.95–2.86 
Retired  1.32 0.69–2.52 1.13 0.51–2.50 
Permanent disability  0.70 0.46–1.07 0.73 0.45–1.20 
Other/unknown  1.38 0.87–2.18 1.11 0.67–1.83 
Living conditions 0.003     
Living alone  ref    
Living with parents  2.10* 1.14–3.85 2.21* 1.12–4.37 
Living with others  0.68 0.46–1.00 0.74 0.49–1.13 
In institution  0.61 0.25–1.52 0.74 0.28–1.95 
Other/unknown  0.79 0.50–1.26 1.40 0.90–2.17 
*p<0.05 
**p<0.001 
The appeal group did not differ from suicide attempters in any respect other than gender in the 
multinomial analyses, and therefore the figures are not included here. 
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Table 4 Description of psychiatric characteristics of self-poisonings according to intention. 
 Suicide attempt 
 
n=332 () 
Appeal 
 
n=232 () 
Drug-related 
poisoning 
n=344 () 
Total 
 
n=908 () 
Previous suicide attempt(s) 
Yes 
None 
Unknown 
 
68 
32 
n=38  
 
62 
38 
n=19  
 
32 
68 
n=110  
 
55 
45 
n=167  
Previous psychiatric treatment† 
Yes, outpatient clinic 
Yes, psychiatric ward 
None 
Unknown 
 
15 
42 
43 
n=36  
 
23 
35 
41 
n=23  
 
21 
19 
60 
n=86  
 
19 
33 
48 
n=145  
Current psychiatric treatment 
Yes, outpatient clinic 
Yes, psychiatric ward 
None 
Unknown 
 
44 
9 
47 
n=29  
 
40 
9 
51 
n=19  
 
18 
3 
79 
n=87  
 
34 
7 
59 
n=135 
† Highest level of treatment registered. 
 25 
Table 5 Comparisons of psychiatric characteristics of patients treated for self-poisonings in 
Oslo according to intention. Suicide attempt is used as reference category.  
 Drug-related poisoning 
vs. suicide attempt 
Crude Adjusted 
p OR 95 CI OR 95 CI 
Male gender <0.001 3.13** 2.29–4.29 2.81** 1.99–3.97 
Previous suicide attempt <0.001     
No  ref  ref  
Yes  0.23** 0.16–0.33 0.33** 0.22–0.49 
Unknown  1.72* 1.10–2.70 1.62 0.97–2.73 
Psychiatric treatment† <0.001     
No  ref  ref  
Yes  0.27** 0.18–0.39 0.42** 0.27–0.63 
Unknown  1.21 0.74–1.97 0.84 0.47–1.49 
† “Psychiatric treatment” includes both current and previous treatment, as these variables 
were highly correlated (p=0.46). 
*p<0.05 
**p<0.001 
The appeal group did not differ from suicide attempters in any respect other than gender in the 
multinomial analyses, and therefore the figures are not included here. Age groups were 
included in the analyses (see table 3 for crude ORs).  
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Table 6 Substances of abuse among 716 patients treated for self-poisonings (192 did not 
report their use of substances). 
 Never 
 
n=81  
Daily 
 
n=265  
Weekly 
 
n=162 
More seldom 
than weekly 
n=208 
Total 
 
n=716 
Ethanol – 19 19 24 62 
Prescribed drugs – 19 5 3 27 
Opioids – 8 1 0.5 9 
Cocaine – 1 2 2 4 
Ecstasy – 0.5 1 1 3 
GHB – 1 3 2 6 
Amphetamines – 4 3 2 9 
Cannabis – 3 2 1 6 
Other substances – 1 0.5 0.5 2 
Total† 
 
– 56.5 36.5 36 128 
† More than one substance possible per patient, i.e. more than 100% in total. 
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Table 7 Referral to follow-up among patients treated for self-poisonings. More than one 
category is possible for each patient. In the multinomial analyses, each group is compared 
with suicide attempters, which is therefore listed as reference category. 
  Compared with suicide attempts  
Referral to follow-up Suicide attempt Appeal Drug-related 
poisoning 
Total 
No referral 
OR (95 C.I.) 
5 
ref 
10 
2.28* (1.18–4.39) 
36 
11.0 ** (6.35–19.02) 
18 
 
General practitioner 
OR (95 C.I.) 
19 
ref 
31 
1.96* (1.32–2.90) 
28 
1.69* (1.17–2.42) 
25 
 
Suicide prevention team 
OR (95 C.I.) 
11 
ref 
10 
0.98 (0.57–1.70)  
2 
0.18** (0.08–0.40) 
7 
 
Substance abuse treatment 
OR (95 C.I.) 
4 
ref 
7 
1.70 (0.79–3.64) 
10 
2.69* (1.39–5.20) 
7 
 
Psychiatric outpatient clinic 
OR (95 C.I.) 
39 
ref 
47 
1.14* (1.00–1.98) 
11 
0.19** (0.13–0.29) 
30 
 
Psychiatric ward, voluntarily 
OR (95 C.I.) 
18 
ref 
9 
0.44* (0.26–0.75) 
1 
0.03** (0.01–0.11) 
9 
 
Psychiatric ward, involuntarily 
OR (95 C.I.) 
20 
ref 
6 
0.25**(0.14–0.46) 
3 
0.13** (0.07–0.13) 
10 
 
Other referral 
OR (95 C.I.) 
9 
ref 
7 
0.70 (0.37–1.33) 
17 
2.08 * (1.31–3.33) 
11 
 
Left hospital against medical advice 
OR (95 C.I.) 
2 
ref 
0.1 
0.24 (0.03–1.97) 
6 
3.18* (1.25–8.06) 
3 
*p<0.05 
**p<0.001 
 

